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Abstract of the Thesis 
Trypanosoma brucei, a member of the early diverged phylogenetic order Kinetoplastida, is a 
vector-borne parasite that causes lethal disease in both humans and livestock. Unfortunately, 
progress has been slow on developing new treatments, and there is a need for new therapeutics, as 
current therapies have issues of resistance, toxicity, and difficult administration. In order to design 
new therapeutics, molecules and interactions unique to the parasite must be detailed, in hopes that 
some will afford suitable drug targets. 
One unique process in T. brucei that might be targeted is RNA polymerase I-mediated 
transcription. T. brucei is unique in that RNA polymerase I not only transcribes ribosomal gene 
units, as in all other organisms, but is also used to transcribe gene arrays that encode its major cell 
surface proteins, namely the variant surface glycoprotein, or VSG in the mammalian bloodstream 
stage of the parasite. The importance of VSG to T. brucei is highlighted by the fact that interference 
with VSG mRNA rapidly halts bloodstream form culture growth and leads to the clearance of 
trypanosomes from infected mice. Thus, targeting proteins and interactions essential for VSG 
production is a valid strategy against T. brucei.  
 Chapter II details an investigation of the interaction between LC8 and a class I 
transcription factor A (CITFA) subunit, CITFA2, which was the focus of my thesis work. Both of 
these proteins, and their interaction, are essential for VSG transcription and trypanosome viability, 
Justin K. Kirkham – University of Connecticut, 2017 
 
 
and interrupting either protein or their interaction could be a potential anti-trypanosome therapy. 
Chapter III contains the generation of a method that allows for gene silencing using heterologous 
sequences, which was necessary for the work in chapter II. Chapter IV focuses on RPB7, an RNA 
pol II subunit, which was published to be utilized by RNA pol I for transcription. While this finding 
was intriguing, it contradicted our biochemical RNA pol I characterizations. Data presented in this 
chapter clearly demonstrated that RPB7 is not a subunit of RNA pol I and not required for the 
transcription process by this polymerase.  
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Chapter I 
Introduction 
I-1. Kinetoplastids, trypanosomatids, and relevant human disease 
Kinetoplastida comprise a group of flagellated unicellular eukaryotes which contain a uniquely 
organized collection of DNA in their single, large mitochondrion known as a ‘kinetoplast’ (Stuart 
et al., 2008). This phylogenetic order contains Trypanosoma brucei, T. cruzi, and Leishmania spp., 
parasites which cause a number of devastating diseases in both humans and livestock (Brun and 
Blum, 2012). T. brucei is the causative agent of Human African Trypanosomiasis, while T. cruzi 
causes Chagas disease in Central and South America. Leishmania spp. cause the leishmaniases, 
including visceral, mucosal, and cutaneous leishmaniasis, in 88 different tropical and subtropical 
countries. In total, kinetoplastids account for 17% (3 of 17) of neglected tropical diseases, 
according to the World Health Organization (WHO, 2015). Collectively, they currently infect 20 
million people worldwide, resulting in ~100,000 deaths a year, and place half a billion people at 
risk for infection in over 100 countries (Bilbe, 2015; Stuart et al., 2008). While 6,000 of 8,000 
protein coding genes are shared among these parasites, their vectors, mechanisms of immune 
evasion, and resulting infections are quite different (Bilbe, 2015; Stuart et al., 2008). Yet despite 
these differences, it is an obvious hope that chemotherapies designed against any one kinetoplastid 
parasite may be useful against all members of this order.  
T. brucei consists of three subspecies: T. brucei gambiense, T. brucei rhodesiense, and T. 
brucei brucei. While closely related, T. b. brucei is unable to cause human infection, due to the 
trypanolytic effect of apolipoprotein L1 (ApoL1), a regular constituent of human serum (Pays et 
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al., 2006; Vanhamme et al., 2003). ApoL1, as part of a distinct class of high density lipoproteins, 
after endocytosis, is inserted into the membrane of the lysosome, resulting in a pore which causes 
the lysosome to swell, resulting in osmotic stress and cell death (Wheeler, 2010). T. b. rhodiense 
is characterized by resistance to lysis by ApoL1 due to the presence of the serum resistance 
associated (SRA) gene (Shiflett et al., 2007; Vanhamme et al., 2003). The SRA protein binds 
ApoL1 in the endosome, preventing its insertion into the lysosomal membrane, thereby blocking 
its trypanolytic effect. T. b. gambiense’s resistance to ApoL1-induced lysis, however, is primarily 
due to a T. b. gambiense-specific glycoprotein (TgsGP), which is present in parasitic cellular 
membranes. The insertion of this glycoprotein results in a stiffer membrane that is resistant to the 
effects of ApoL1, a resistance that is not mediated by a direct interaction between host and parasite 
proteins (Berberof et al., 2001; Uzureau et al., 2013). Though T. b. brucei is an important animal 
parasite, its inability to combat human ApoL1 has resulted in it being widely used in laboratory 
investigations of T. brucei, as it represents a safe alternative which is, genetically, almost identical 
to the infective subspecies.  
All subspecies of T. brucei are introduced into a mammalian host by the bite of an infected 
tsetse fly (genus Glossina), which currently limits the range of this disease to Sub-Saharan Africa 
(Franco et al., 2014). Though only 1% of tsetse flies are infective for T. brucei, a single bite is 
sufficient to establish infection (Maudlin and Welburn, 1989; Thuita et al., 2008). T. b. gambiense, 
which is responsible for almost all cases (98%) of Human African Trypanosomiasis (HAT) also 
known as Sleeping Sickness, results in a chronic disease. After introduction of the parasite into the 
bloodstream, individuals experience a hemolymphatic stage of the disease. The primary symptoms 
during this stage are headache, pruritus, and lymphadenopathy, which are all non-specific for HAT 
(Brun and Blum, 2012). Upon entry of the parasite into the central nervous system (CNS), 
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however, the neurological deficits characteristic of the second stage of this disease are observed. 
These include disturbances of the sleep cycle, presented as both daytime sleep and insomnia, 
alterations of mood and behavior, and muscular disturbances, such as weakness and tremors (Blum 
et al., 2006; Brun and Blum, 2012). If untreated, infection will almost invariably lead to death after 
an average of 3 years (Checchi et al., 2008). Infection with T. b. rhodesiense results in progression 
through the same stages, but at a much faster rate, resulting in death after an average of 6 months. 
Clinically, there is a greater likelihood of symptoms related to an acute infection, including fever, 
malaise, abdominal discomfort, and vomiting with T. b. rhodesiense-related HAT (Kato et al., 
2015). 
I-2. Current chemotherapeutics for HAT 
Though these diseases have been well documented as important to both humans and livestock for 
over a century, treatment options remain poor (Bilbe, 2015; Lutje et al., 2010; Steverding, 2008). 
Four compounds are currently used for the treatment of HAT and will be briefly reviewed. 
Pentamidine is effective against the hemolymphatic, or first stage, of T. b. gambiense infection, 
and is one of the easiest anti-trypanosome therapies to administer, requiring only 7-10 daily 
intramuscular injections (Babokhov et al., 2013). It is not effective against either stage of T. b. 
rhodesiense, nor can it be used against stage II T. b. gambiense infection, as it does not cross the 
blood brain barrier (BBB), which limits its use. Suramin is the T. b. rhodesiense counterpart to 
pentamidine, as it is effective against stage I T. b. rhodesiense, but not against stage I T. b. 
gambiense, and is not effective against stage II of either disease. Even though it cannot cross the 
BBB, it does have some synergistic effects with stage II therapies, and can be used to pre-treat 
stage II T. b. rhodesiense HAT. It requires five intravenous (IV) injections, repeated every 5-7 
days, over a period of 4 weeks (Brun et al., 2010). While resistance has not been seen, the length 
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of treatment, the requirement for IV injection, and the lack of activity against stage II disease limit 
the usefulness of this drug, as well. Melarsoprol, on the other hand, is an arsenic-based compound 
which is widely used due to its effectiveness against stage II HAT involving either subspecies 
(Brun et al., 2010). Furthermore, it is the only treatment for stage II T. b. rhodesiense HAT. 
Different dosing schedules are in use, with the current recommendation being one IV injection 
each day for ten consecutive days (Schmid et al., 2005). These dosing schedules have resulted 
from attempts to alleviate some of the difficulties and dangers of melarsoprol treatment. Firstly, 
the compound must be dissolved in a propylene glycol solution for injection, which causes 
significant irritation and discomfort in recipients. Secondly, due to the arsenic group within the 
drug, 5-10% of patients given melarsoprol experience post-treatment reactive encephalopathy 
(PTRE) (Babokhov et al., 2013). PTRE has a 50% mortality rate, resulting in the death of up to 
5% of patients treated with this drug. Lastly, a significant increase in melarsoprol resistance has 
been observed, with relapse rates rising from 17.7% to 25.4% over the course of one 3-year study 
(Robays et al., 2008). This has resulted in melarsoprol being used at historically low levels 
(Babokhov et al., 2013). The last treatment to discuss is nifurtimox-eflornithine combination 
therapy (NECT), which is effective against stage II T. b. gambiense HAT. Current 
recommendations are for orally active nifurtimox to be taken three times daily, for ten days. At the 
same time, eflornithine is given as twice daily IV infusions for seven days. While this treatment 
has much lower toxicity and lower rates of relapse than melarsoprol, administration of NECT 
requires a skilled medical team, due to the need for IV infusions, is expensive, and resistance has 
been seen in the laboratory setting (Babokhov et al., 2013). In summary, few compounds are 
currently available to treat HAT, all of which are difficult to administer, costly, or have issues of 
resistance. There is a great need, therefore, for the pursuit of new compounds which can treat 
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trypanosomiasis. This would be aided by an improved understanding of molecules essential to the 
parasite which could serve as drug targets (Bilbe, 2015). Although not yet approved, two 
promising, orally available drugs are currently in the later stages of development: fexinidazole, 
currently in phase III clinical trials, and oxaborole SCYX-7158, which is in phase I clinical trials 
(Matthews, 2015). 
I-3. VSG and antigenic variation 
One molecule that is absolutely essential to T. brucei but absent from any of its host species is its 
variant surface glycoprotein, or VSG. VSG is a 58-kDa glycophosphatidylinositol (GPI)-anchored 
glycoprotein, with most of the protein, therefore, existing extracellularly (Manna et al., 2014). A 
single trypanosome produces 10 million identical copies of the VSG protein from a single VSG 
gene, all of which is sent to the cell surface, which results in VSG constituting 90% of cell surface 
peptides. This dense coat has numerous known functions: it prevents activation of the complement 
system (Ferrante and Allison, 1983), it allows for the removal of bound antibody through 
endocytosis of antibody-bound VSG (Engstler et al., 2007), after which the VSG molecule is 
returned to the cell surface (Pal et al., 2003), and, most importantly, it acts as a barrier to host 
antibodies (Schwede et al., 2011). Specifically, it was shown that antibody raised against the N-
terminus of the VSG protein, the portion that is furthest away from the cell surface, is able to bind 
VSG, while antibody targeting the C-terminus of VSG, which is near the cell surface, is unable to 
bind (Schwede et al., 2011). The net result of densely packing 10 million copies of VSG protein 
on the cell surface is, therefore, to block recognition of its C-terminus and other constituents of the 
parasite surface from immune recognition. This, by itself, does not protect the parasite from 
clearance by the immune system, as numerous studies have demonstrated that the immune system 
is capable of generating antibodies which target VSG, and that this response is capable of clearing 
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an infection. For one such study, see Hall et al. (2013). Trypanosomes have evolved a system of 
VSG switching, however, which, coupled with its dense VSG coat, allows for antigenic variation 
and immune evasion. T. brucei possesses more than 2,500 VSG genes and pseudogenes (Cross et 
al., 2014), which vary dramatically in their sequence and antigenicity, while having a remarkably 
conserved structure, likely through disulfide bonds (Blum et al., 1993). Every 102 to 106 cell 
divisions, the specific VSG expressed stochastically changes, resulting in a parasite which is 
antigenically different, allowing it to escape recognition by antibodies generated against the last 
expressed VSG (Horn, 2014; Turner, 1997; Turner and Barry, 1989). This leads to an expansion 
of parasites with newly-expressed VSGs. Once antibodies are generated which bind a new VSG 
well, the clonal expansion is halted, and parasites are rapidly cleared. Repetitions of this cycle are 
observed in an infected host as waves of parasitemia, which occur approximately every seven days 
(Ross and Thomson, 1910). The switch to an alternative VSG gene is not in response to immune 
pressure, as switching is observed with in vitro cultures (Doyle et al., 1980). While the antigenic 
variation of VSG is essential for the parasite to maintain an infection, the importance of VSG to 
T. brucei is not limited to immune evasion. VSG silencing experiments demonstrated that a drop 
in VSG mRNA, even without a detectable drop in VSG protein levels, causes a specific cell cycle 
arrest in culture and a rapid clearance of parasites from infected mice (Sheader et al., 2005).  
VSG genes exist in several genetic contexts (Cross et al., 2014), yet are invariably 
expressed from only one of 15 specialized bloodstream expression sites (BESs) (Hertz-Fowler et 
al., 2008). BESs contain an array of, typically, 8–9 expression-site associated genes (ESAGs), 
followed by a terminal VSG gene (Hertz-Fowler et al., 2008). ESAGs are likely important for the 
successful infection of the mammalian host, as they encode a variant heterodimeric transferrin 
receptor (ESAG6 and ESAG7), whose varying affinity for the transferrins of different host species 
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is thought to expand the parasite's list of potential hosts (Bitter et al., 1998). These also encode 
adenylate cyclases (ESAG4) that inhibit the innate immune system upon trypanosome lysis 
(Salmon et al., 2012). Switching from the expression of one VSG to another can be done by gene 
conversion, telomere exchange, or transcriptional switching, which are represented in Figure I-1, 
as reviewed in Horn (2014), and Schwede and Carrington (2010). In the case of gene conversion, 
an active expression site has its VSG gene replaced with a VSG gene from another location in the 
genome. This leaves the promoter region, ESAGs, and telomere unchanged. A second method of 
VSG switching involves a larger scale recombination, which exchanges the VSG gene and 
associated telomere, while leaving the promoter and ESAGs intact. An additional nuance is that 
VSGs need not be exchanged as indivisible units. Recombinations involving only portions of a 
given VSG gene, resulting in the formation of a new, mosaic VSG, have been shown to further 
increase VSG diversity beyond the 2,500 VSG genes contained in the genome, and appears to be 
important for the maintenance of a persistent infection (Cross et al., 2014; Hall et al., 2013; 
Mugnier et al., 2015). The last type of switching involves no recombination, occurring instead 
through in situ [in]activation. In transcriptional switching, the active BES is down-regulated, while 
expression of a second, formerly silent BES increases. An additional unique aspect of VSG 
transcription in T. brucei is that the active VSG gene is located in an extranucleolar focus. This 
subnuclear compartment contains both the actively transcribed BES and an accumulation of RNA 
pol I and VSG mRNA, and was maintained after DNase digestion (Chaves et al., 1998; Navarro 
and Gull, 2001). It was termed the expression site body, or ESB. The importance of this location 
was confirmed by experiments in which the integration of selectable markers into two BESs 
allowed for the partial co-activation of two BESs within the same cell (Chaves et al., 1999). When  
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Figure I-1. Antigenic variation can occur through three different mechanisms. In bloodstream 
form (BF) T. brucei, the actively expressed VSG gene is located within a subtelomeric array known 
as a BES. Each BES contains a promoter, a variable number of ESAG genes, typically 8-9, and a 
terminal VSG gene near the telomere. Only one of the approximately 15 BESs within a cell is 
active, indicated here by a green flag, representing an active site of transcription initiation, and a 
green arrow, indicating transcription. T. brucei can switch from the actively expressed VSG (blue) 
to a silent VSG (orange) by three different mechanisms. Gene conversion allows for VSG genes 
from any genomic context, here shown as a silent BES, to be introduced into the active site, leaving 
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(Figure I-1 legend cont.) all other elements of the active BES intact (A). Telomere exchange, a 
similar process, results in the exchange of both the VSG gene and its associated telomere (B). This 
method of switching can only be used with a VSG gene adjacent to a telomere. Transcriptional 
switching, on the other hand, is accomplished through epigenetic mechanisms, and results in a 
change of expression in both VSG and ESAGs (C). Figure not to scale. For a scaled depiction of a 
BES, see Figure V-1.  
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co-selection was induced, the two BESs were found to be in close spatial proximity, and the 
authors concluded that some factor in the active site was essential for BES activation. 
I-4. Polycistronic transcription and RNA pol I 
The majority of eukaryotic genomes are arranged for monocistronic transcription, with a 
stoichiometry of one promoter to one gene to one transcription termination site. T. brucei is one 
notable exception to this rule, however, along with a number of other eukaryotic organisms (Lasda 
and Blumenthal, 2011). T. brucei’s genome is organized into functionally unrelated polycistronic 
gene arrays which, after transcription, are resolved into individual mRNAs by spliced-leader (SL) 
trans-splicing and polyadenylation (Günzl, 2010; Michaeli, 2011). BESs are one such 
polycistronic array, in which a single BES promoter drives the expression of 8-9 ESAGs, in 
addition to one VSG gene (Hertz-Fowler et al., 2008). This process of adding a 39-bp long SL cap 
to every mRNA in the cell by trans-splicing has an additional implication beyond allowing for 
fewer promoters and termination sites. It decouples the process of mRNA capping from 
transcription by RNA polymerase (pol) II (Günzl, 2010; Michaeli, 2011; Preußer et al., 2012), and 
has allowed for the evolution of a unique characteristic of T. brucei, namely the use of RNA pol I 
for protein coding gene expression. 
  The ability for RNA pol I to synthesize functional mRNA in trypanosomes was first 
appreciated when an RRNA promoter was used to express a reporter gene. In mice, the reporter 
gene was well transcribed, yet the resulting protein levels were very low (Grummt and Skinner, 
1985). In trypanosomes, however, the RRNA promoter caused a high level of functional reporter 
protein to be produced (Rudenko et al., 1991;  Zomerdijk et al., 1991a). Additional evidence for 
RNA pol I having a role in protein coding gene expression in the mammalian-infective 
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bloodstream form (BF) trypanosomes came when α-amanitin, an amatoxin found in the Aminita 
genus of mushrooms which blocks RNA pol II transcription, was shown to not block VSG 
transcription (Kooter and Borst, 1984). These implications were directly tested by silencing the 
largest subunit of RNA pol I, which resulted in a drop in transcription of RRNA, VSG, and 
procyclin, without affecting RNA pol II-mediated transcription (Günzl et al., 2003). Furthermore, 
it was shown that depletion of RNA pol I from extract by immunoprecipitation resulted in a drop 
of in vitro transcription from RRNA and BES promoters, while RNA pol II transcription was 
unaffected (Günzl et al., 2003). Procyclin, the major cell surface antigen in insect-stage, or 
procyclic form (PF) T. brucei is thought to protect against the digestive enzymes of its host 
(McConville and Ferguson, 1993). Though this is different from VSG in the type of protection it 
provides the parasite, it has been shown to be essential for full PF infectivity, and is somewhat 
considered, therefore, the PF counterpart to VSG (Ruepp et al., 1997).  
I-5. The search for a class I transcription factor  
After it was established that VSG transcription relies on RNA pol I, the search for other proteins 
essential to the production of VSG began. Given the high level of divergence between 
kinetoplastids and other eukaryotes, no class I transcription factors were annotated by sequence 
homology in completed trypanosome genomes (Berriman et al., 2005; Ivens et al., 2005). A first 
indication as to the nature of T. brucei’s class I factor came from in vitro transcription experiments 
using the RRNA, BES, and procyclin promoters. The BES promoter is short, extending 67 bp 
upstream of the transcription initiation site, and only contains two small required sequence 
elements (Pham et al., 1996; Vanhamme et al., 1995). The RRNA and procyclin promoters, on the 
other hand, are much longer, reaching ~250 bp upstream of the transcription initiation site (TIS), 
each containing four sequence elements (Brown et al., 1992; Janz and Clayton, 1994; Laufer and 
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Günzl, 2001; Sherman et al., 1991). Despite these differences, it was observed that all of these 
three promoters were capable of competing for a common trans-activating factor, making it likely 
that a common class I transcription factor was being utilized in all three cases (Laufer and Günzl, 
2001). Additionally, it was shown that trypanosome nuclear extract was capable of specifically 
binding and shifting the BES promoter in an electrophoretic mobility shift assay (EMSA) (Pham 
et al., 1997). Deoxycholate treatment, which is able to disrupt protein-protein interactions, led to 
multiple, faster migrating bands in an EMSA, which the authors suggested were indicative that the 
promoter binding element consisted of more than one protein, which perhaps formed a larger 
complex. These two observations led to the key series of experiments that revealed the trans-
activating factor (Günzl, 2012). Brandenburg et al. prepared crude trypanosome extract from 30 
liters of trypanosome culture, and tested fractions for BES promoter binding using EMSA 
(Brandenburg et al., 2007). EMSA, in combination with ion exchange, heparin affinity, and DNA 
affinity chromatography, allowed the authors to partially purify the BES promoter binding activity. 
Since a ~50 kDa protein band was found to specifically UV-crosslink to the BES promoter, mass 
spectrometric analysis of the final eluate was concentrated on proteins migrating in SDS-PAGE at 
this size range. Seventeen putative BES promoter interactors were identified, most of which were 
without annotation. Tagging four of these proteins in individual trypanosome cell lines, combined 
with a promoter pull-down assay, identified one protein that bound the BES promoter while not 
binding an RNA pol II promoter or a non-specific DNA control. This binding required both 
promoter elements, and this protein was also found to bind to the RRNA and procyclin gene 
promoters, indicating that it could be the general trans-activating factor suggested in earlier work. 
Brandenburg et al. went on to show that silencing this gene by RNAi resulted in rapid cell death 
and a decrease in RRNA and VSG mRNA, while RNA pol II and RNA pol III transcripts were 
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unaffected (Brandenburg et al., 2007). In vitro transcription assays in the presence of an immune 
serum raised against this protein then unambiguously showed that it was absolutely essential for 
transcription from the RRNA, BES, and procyclin promoters.  
Tagging of this protein, followed by tandem affinity purification and mass spectrometry, 
identified six proteins unique to kinetoplastids, which were all annotated as ‘hypothetical’ proteins, 
and a dynein light chain, termed DYNLL1 (Brandenburg et al., 2007) (Please note that due to work 
presented in Chapter II of this thesis, it has been proposed to rename DYNLL1 as LC8). Co-
immunoprecipitation and sucrose gradient sedimentation confirmed that these proteins formed a 
complex, and the purified complex was capable of specifically binding the BES promoter in 
EMSAs. Finally, depleting the complex from extract via a tag abolished the ability of that extract 
to initiate transcription from RRNA, BES, or procyclin gene promoters. Adding back the purified 
complex to these depleted extracts was able to partially reconstitute transcriptional activity 
(Brandenburg et al., 2007). Since, together, these experiments identified this protein complex as 
the first promoter-binding factor essential for RNA pol I-mediated transcription in a kinetoplastid 
organism, it was termed class I transcription factor A, or CITFA, with subunits numbered 
according to their predicted size, from largest to smallest. Due to high sequence conservation of 
CITFA subunits in other kinetoplastids, and CITFA’s indispensability for RRNA transcription, it 
is likely that its function in RNA pol I-mediated transcription is shared with other members of this 
order.  
I-6. The discovery of an additional CITFA subunit  
The lack of sequence homology to known transcription factors and of recognizable amino acid 
sequence motifs has hindered attribution of specific functions to individual CITFA subunits. 
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Nevertheless, additional studies built upon the above work, provided new insights into the 
composition of the complex, and its role in transcription by RNA pol I in T. brucei. Through 
tandem affinity purification of CITFA6, in conjunction with mass spectrometry, an additional 
CITFA subunit, CITFA7, was identified (Nguyen et al., 2012). In turn, co-immunoprecipitation 
and tandem affinity purification of a tagged CITFA7 quantitatively co-precipitated and copurified 
all other CITFA subunits confirming it as a bona fide subunit of CITFA. As expected, CITFA7 
silencing in BF T. brucei resulted in a drop in both rRNA and VSG mRNA, and was lethal. 
Furthermore, similar experiments were performed to investigate CITFA7 as had been done in 
CITFA2, and revealed that depletion of CITFA7 in cells or in extract greatly reduced in vitro 
transcription from both a BES and an RRNA promoter (Nguyen et al., 2012). In accordance with 
CITFA7 being a vital component of CITFA, immunofluorescence revealed that CITFA7 and 
RPB6z, an RNA pol I-specific subunit (Nguyen et al., 2006), colocalized in both the nucleolar 
periphery, where RRNA genes are transcribed, and in an extranucleolar foci, likely representing 
the ESB. These results confirmed that CITFA7 is a class I transcription factor subunit required by 
RNA pol I. No new members of CITFA have since been identified. The complete list of CITFA 
subunits, along with their predicted sizes and accession numbers, is presented in Table I-1.  
I-7. A possible role for CITFA in monoallelic VSG expression  
Silent BESs are not completely silent in their promoter region. A selectable marker gene inserted 
downstream of a silent BES is able to make trypanosomes resistant to the corresponding antibiotic 
at a level 100 fold below that achieved when the marker gene is inserted at the same position in 
the active BES (Horn and Cross, 1997). Moreover, a study using mild DNase I digestion of 
chromatin showed that the same DNase-sensitive sites, indicative of specific protein binding, were 
observed at both silent and active BES promoters, leading to the conclusion that promoters of both 
  
15 
  
active and silent BESs are occupied by the same transcription factor (Navarro and Cross, 1998). 
Since this factor likely was CITFA, Nguyen et al. next quantitatively investigated whether CITFA 
was associating with all BES promoters to the same extent, or if it was predominately associating 
with the promoter of the active BES. To test this, they used a previously published cell line in 
which two BESs had selectable markers integrated downstream of the promoter (Figueiredo et al., 
2008). Through addition of antibiotics, neomycin-resistance or puromycin-resistance could be 
selected for. The changing of medium antibiotics did not convert the population of T. brucei to be 
resistant, rather it allowed those stochastic switchers, which had activated the alternative BES with 
the selectable marker through transcriptional switching (see Figure I-1), to be resistant to the new 
antibiotic. 
An extensive chromatin immunuprecipitation study revealed that CITFA7 predominately 
associated with the active BES promoter (Nguyen et al., 2014). This biased association was 
maintained through consecutive rounds of antibiotic-selected transcriptional switching between 
the two marked BESs. In every experiment a high level of CITFA7 occupancy correlated with a 
high degree of promoter-proximal transcripts originated from that BES, while a low level of 
occupancy correlated with a low level of expression. They also showed, through ChIP experiments 
involving RPB6z, an RNA pol I subunit, that RNA pol I had a promoter occupancy similar to 
CITFA7 – it was present at the active BES, while being relatively absent from the marked silent 
BES. These data showed that CITFA7 and RNA pol I are both predominately associated with the 
active site, revealing that the activation of a single BES and the monoallelic expression of VSG 
may be regulated at the level of transcription initiation, perhaps through sequestering CITFA or 
RNA pol I to the active BES.  
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Subunit  GeneDB accession Approximate 
    size (kDa) 
CITFA1 Tb927.11.1390  55 
CITFA2 Tb927.9.12450 55 
CITFA3 Tb927.11.1410 55 
CITFA4 Tb927.11.8310 43 
CITFA5a Tb927.8.4030 28 
  Tb927.8.4080  
CITFA5b Tb927.8.4130 28 
CITFA6 Tb927.5.970 23 
CITFA7 Tb927.7.2600 17 
LC8 Tb927.11.18680 10 
  Tb11.0845   
 
 
Table I-1. T. brucei CITFA subunits, along with their GeneDB accession numbers and 
approximate sizes.  
  
17 
  
Analyzing RRNA units, a key experiment demonstrated that CITFA is directly responsible 
for RNA pol I occupancy of chromatin. Nguyen et al. performed ChIP experiments with RPA31, 
another RNA pol I subunit (Nguyen et al., 2007), in cells wherein CITFA7 could be conditionally 
silenced through addition of doxycycline. While in non-induced cells RNA pol I was found to be 
present at both the RRNA promoter and the downstream 18S rDNA gene, it became relatively 
depleted from both of these regions upon CITFA7 silencing, with RPA31 occupancy dropping 
~80% compared to non-induced cells (Nguyen et al., 2014). This confirmed in vivo that CITFA is 
required for the recruitment of RNA pol I to its cognate genes. 
Given that CITFA2 had previously been shown to be essential for RNA pol I-mediated 
transcription (Brandenburg et al., 2007), Nguyen et al. sought to determine whether CITFA2 
showed the same preferential occupancy of the active BES promoter as CITFA7. Using cells with 
two marked BESs, as before, ChIP experiments revealed that CITFA2, like CITFA7, was 
predominately associated with the active BES, and that this relationship was maintained through 
multiple rounds of transcriptional BES switching. To further confirm the predominant association 
of CITFA with the actively transcribed BES, a cell line was created in which CITFA7 and RPB6z 
were tagged with eYFP and mCherry, respectively, allowing detection by direct fluorescence 
microscopy. The enhanced sensitivity of this method revealed that CITFA7 and RPB6z colocalized 
both in the nucleolus and the extranucleolar ESB, the sites of RRNA and VSG transcription, 
respectively. Given that there are approximately 15 BESs in T. brucei (Hertz-Fowler et al., 2008), 
with one being active and 14 being silent, distributed extranucleolarly throughout the nucleus, the 
failure to detect additional foci of CITFA and RNA pol I, beyond the ESB, confirmed that CITFA 
and RNA pol I are not concentrated at the silent BESs.  
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Through quantification of immunoblots and fluorescence images, Nguyen et al. estimated 
that approximately 180 molecules of CITFA7 are present in the ESB. This number was 
surprisingly high, since DNA-bound RNA pol I transcription factors in other systems are known 
to remain associated with the promoter through multiple rounds of transcription initiation and the 
short BES promoter could only accommodate one or two CITFA complexes at a time. To 
investigate whether CITFA was accumulating in the ESB through binding additional regions of 
the BES, beyond the promoter, CITFA7 ChIP-seq was performed. In line with their earlier CITFA7 
ChIP results, ChIP-seq revealed a strong read density peak at the BES promoter, which declined 
rapidly both upstream and downstream of the promoter. No other peaks were observed along a 
BES. This confirmed that CITFA is a promoter binding factor, and that it does not travel with the 
polymerase during transcription. The amount of CITFA7 present in the ESB is likely the result, 
therefore, of a concentration of CITFA to the active BES by a DNA-independent process. Taken 
together, these data confirmed that CITFA is a promoter binding RNA pol I transcription factor, 
and show that CITFA predominantly associates with the active site. They also show that the 
recruitment of RNA pol I to the RRNA promoter requires CITFA. It is possible, therefore, that 
monoallelic expression of VSG is achieved through the association of CITFA with a single BES.  
Several molecules, in addition to CITFA, have been shown to predominately associate with 
either active or silent BESs and appear to play a role in monoallelic VSG transcription. These were 
recently reviewed by Günzl et al. (2015), which was included as Chapter V. 
I-8. The development of new tools required for further investigations of CITFA 
During their efforts to characterize the function of individual CITFA subunits, Park et al. attempted 
to silence CITFA1 by RNAi. Though different regions of CITFA1 were targeted for degradation, 
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none of these efforts led to a detectable reduction in CITFA1 mRNA. In order to circumvent this 
problem, we developed a new system of gene silencing, which relied on targeting heterologous 
sequences fused to the gene of interest (Park et al., 2014). This work is covered in depth in Chapter 
III, and only a brief summary is included here. As proof of principle, the system was first 
developed for CITFA7 since this subunit had been meticulously analyzed before. CITFA7 was 
exclusively expressed with a 3/ UTR from a T. brucei-related trypanosomatid, T. cruzi, or with the 
PTP tag sequence. Expression of double-stranded RNA (dsRNA) targeting either heterologous 
sequence resulted in a strong reduction of CITFA7 mRNA, and caused the same RNA pol I defects 
as before, when CITFA7 was silenced by a dsRNA that targeted its coding sequence. Fusing the 
T. cruzi 3/ UTR to CITFA1 then indeed enabled a specific knockdown of this gene and caused a 
drop in RRNA and VSG mRNA levels similar to those observed upon silencing CITFA7 (Park et 
al., 2014). CITFA1 silencing was equally lethal to the parasite. Immunoblotting and sucrose 
gradient sedimentation of the CITFA complex showed that the expression of other CITFAs was 
not affected and the formation of the CITFA complex not disrupted by this knockdown. Similarly, 
immunofluoresence microscopy using a polyclonal antiCITFA3 antibody revealed that the 
localization of the CITFA complex was not affected by CITFA1 silencing. Finally, ChIP 
experiments revealed that depletion of CITFA1 caused CITFA to no longer occupy either the 
RRNA or BES promoters, indicating a specific function of this subunit in DNA binding of the 
complex. The fact that CITFA remains localized to the nucleolus, and to an extranucleolar focus 
likely to be the ESB, upon CITFA1 silencing indicates that CITFA does not rely on DNA binding 
for localization. This supports the notion that the ESB specifically contains a factor that is required 
for transcription of the active BES (Nguyen et al., 2014), and suggests that CITFA may be that 
factor.  
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I-9. The discovery and essential nature of a widely-conserved dynein light chain homologue 
The only CITFA subunit conserved outside of kinetoplastids is the dynein light chain LC8. LC8 
was originally discovered as a component of the outer arm axonemal dynein in Chlamydomonas 
reinhardii (Pfister et al., 1982). Genetic analysis suggested that this light chain was 88% identical 
to a homologue in C. elegans (King and Patel-King, 1995). Given that nematodes do not have 
flagella or motile cilia at any stage of their life cycle, the authors suggested that this dynein light 
chain homologue must function in the cytoplasm, likely as a component of cytoplasmic dynein. 
This was shortly thereafter confirmed, when the mammalian homologue of the dynein light chain 
was found to specifically co-purify with cytoplasmic dynein (King et al., 1996). 
Immunofluorescence microscopy revealed that this homologue co-localized with cytoplasmic 
dynein, but not with kinesin, providing additional evidence to the concept that this light chain 
homologue was shared between axonemal and cytoplasmic dynein, and that it was widely 
conserved among eukaryotes. Most commonly, this dynein light chain is termed DYNLL or LC8, 
though gene names vary based on organism and discovery history.  
 Cytoplasmic dynein exists as two different complexes: dynein-1, which has been better 
characterized, is involved in membrane trafficking, organelle dynamics, and chromosome 
segregation during mitosis (Paschal and Vallee, 1987), and dynein-2, which regulates retrograde 
intraflagellar transport (IFT), a process important to motile cilia and flagella (Criswell et al., 1996; 
Gibbons et al., 1994). LC8 has been shown to be a part of both of these cytoplasmic dynein 
complexes (Asante et al., 2014), where it binds to intermediate chains, as shown by Lo et al. (2001) 
and reviewed by Wu and King (2003), and appears to contribute to their structural arrangement 
(Makokha et al., 2002). Additional complexity became appreciated when it was demonstrated that 
two, nearly identical LC8 genes exist in humans and numerous other organisms (Naisbitt et al., 
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2000; Wilson et al., 2001). These two genes, termed DYNLL1 and DYNLL2, give rise to proteins 
that differ in only six of 89 amino acids, and many investigation of LC8 function do not allow for 
differentiation between these two proteins (Pfister et al., 2006). Furthermore, it has been shown 
that DYNLL1 and DYNLL2 are shared between dynein-1 and dynein-2, making a general 
differentiation of their functions difficult (Asante et al., 2014). Hereafter, DYNLL1 and DYNLL2 
will be collectively referred to as LC8. LC8 is conserved throughout eukaryotic genomes 
(Wickstead and Gull, 2007), and while not essential in yeast (Stuchell-Brereton et al., 2011), 
mutation or knockdown of LC8 causes a mitotic block in HeLa cells (Asthana et al., 2012), and is 
embryonic lethal in animals (Dick et al., 1996; Goggolidou et al., 2014; Li et al., 2015; Lightcap 
et al., 2009), causing pleiotropic defects. 
I-10. LC8 outside of the dynein motor complex 
Given that LC8 is more conserved between species than other components of the dynein motor, 
and that LC8 is present in organisms which lack a dynein motor, it was likely that LC8 had non-
dynein functions (King and Patel-King, 1995; Wickstead and Gull, 2007). LC8 has since been 
shown to interact with 50+ different proteins and to affect numerous cellular processes independent 
of its involvement with dynein, as reviewed by Barbar (2008) and Rapali et al.,(2011b). Though 
diverse in their function, LC8’s binding partners tend to congregate into the functional categories 
of intracellular transport, nuclear transport, mitosis, apoptosis, and transcriptional regulation 
(Rapali et al., 2011b).  
At physiological pH, LC8 exists almost exclusively as a dimer (Barbar et al., 2001; Benashski 
et al., 1997), interacting with partner proteins via two identical sites generated at the dimer 
interface which bind to diverse short, linear motifs (Benashski et al., 1997; Lo et al., 2001; Rapali 
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et al., 2011a). Structurally, each LC8 monomer possesses five β-strands and two α-helices, and 
LC8 dimerization requires β-strand swapping (Wang et al., 2003). LC8 promotes the dimerization 
of its binding partners through aligning dimerization domains present in the partner protein 
(Barbar, 2008; Barbar and Nyarko, 2014; Hodi et al., 2006; Wagner et al., 2006). Thus, while it 
was previously hypothesized that LC8 functions as a linker, allowing attachment of the dynein 
motor to its cargo, the emerging view is that interaction with LC8 induces homodimerization, 
imparting new structure and function, which is supported by detailed investigations of LC8 
interactions (Barbar and Nyarko, 2015; Radnai et al., 2010; Wang et al., 2004; Williams et al., 
2007). Figure I-2 depicts a simplified current model of LC8 binding: LC8 binds a protein that is 
already dimerized, as depicted, or which has a propensity for self-association. Through interacting 
with a partner protein via a binding site created at its dimer interface, LC8 confers stability and 
structure, which often includes an increase in self-association. Due to the conserved nature of LC8, 
its diverse binding network, and its ability to modulate several aspects of cell biology, it has been 
termed a molecular hub (Barbar, 2008).  
In addition to this improved understanding of LC8, interest in this molecule has grown as LC8 
has been shown to have unique and important roles in an increasing number of human pathogens. 
These include viruses, such as HIV (Jayappa et al., 2015), Ebola (Luthra et al., 2015), and rabies 
(Tan et al., 2007), and the protistan parasite Toxoplasma gondii (Qureshi et al., 2013). 
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Figure I-2. Current model of LC8 interaction with a generic partner protein. LC8 exists as a dimer, 
which creates two identical binding sites at its dimer interface. The structure and/or dimerization 
state of the partner protein is often affected through interaction with LC8.   
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Chapter II 
The dynein light chain LC8 is required for RNA polymerase I 
mediated transcription in Trypanosoma brucei, facilitating assembly 
and promoter binding of class I transcription factor A 
 
Abstract 
Dynein light chain LC8 is highly conserved among eukaryotes and has both dynein motor and 
dynein-independent functions. Interestingly, LC8 was identified as a subunit of the class I 
transcription factor A (CITFA), which is essential for transcription by RNA polymerase (pol) I in 
the parasite Trypanosoma brucei. Given that LC8 has never been identified with a basal 
transcription factor and that T. brucei relies on RNA pol I for expressing the variant surface 
glycoprotein (VSG), the key protein in antigenic variation, we investigated the CITFA-specific 
role of LC8. Depletion of LC8 from mammalian-infective bloodstream trypanosomes affected cell 
cycle progression, reduced the abundances of rRNA and VSG mRNA, and resulted in rapid cell 
death. Sedimentation analysis, co-immunoprecipitation of recombinant proteins, and 
bioinformatic analysis revealed an LC8 binding site near the N-terminus of the subunit CITFA2. 
Mutation of this site prevented the formation of a CITFA2-LC8 heterotetramer and, in vivo, was 
lethal, affecting assembly of a functional CITFA complex. Gel shift assays and UV-crosslinking 
experiments identified CITFA2 as a promoter-binding CITFA subunit. Accordingly, silencing of 
LC8 or CITFA2 resulted in a loss of CITFA from RNA pol I promoters. Hence, we discovered an 
LC8 interaction that, unprecedentedly, has a basal function in transcription. 
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II-1. Introduction 
Dynein light chain LC8 was originally discovered as a component of the outer arm axonemal 
dynein in Chlamydomonas reinhardii (Pfister et al., 1982), but was later found to also be present 
in cytoplasmic dyneins 1 and 2 (Asante et al., 2014; Hou and Witman, 2015; King and Patel-King, 
1995; Pfister et al., 2006). LC8 is conserved throughout eukaryotic genomes (Wickstead and Gull, 
2007). As a part of the dynein motor, it is important for fundamental cellular processes, such as 
tubulin minus end-directed intracellular transport, chromatid separation during mitosis, and 
nuclear migration (Fridolfsson et al., 2010), as well as flagella-specific functions, namely motility, 
intraflagellar transport (Pazour et al., 1998), and ciliogenesis (Goggolidou et al., 2014; Li et al., 
2015). While not essential in yeast (Stuchell-Brereton et al., 2011), mutation or knockdown of LC8 
is embryonic lethal in animals (Dick et al., 1996; Goggolidou et al., 2014; Li et al., 2015; Lightcap 
et al., 2009). Given that LC8 is more conserved between species than other components of the 
dynein motor, and that LC8 is present in organisms which lack a dynein motor, it was likely that 
LC8 had non-dynein functions (King and Patel-King, 1995; Wickstead and Gull, 2007). LC8 has 
since been shown to interact with several different proteins and to affect various cellular processes, 
including protein localization and stability, transcription regulation, and apoptosis (Asthana et al., 
2012; Barbar, 2008; Rapali et al., 2011b). 
It was previously hypothesized that LC8 functions as a linker, allowing attachment of the 
dynein motor to its cargo. It has been shown since, however, that at physiological pH, LC8 exists 
almost exclusively as a dimer (Barbar et al., 2001; Benashski et al., 1997), interacting with partner 
proteins via two identical sites generated at the dimer interface which bind to diverse short, linear 
motifs (Benashski et al., 1997; Lo et al., 2001; Rapali et al., 2011a). LC8 promotes the dimerization 
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of its binding partners through aligning dimerization domains present in the partner protein 
(Barbar, 2008; Barbar and Nyarko, 2014; Hodi et al., 2006; Wagner et al., 2006). The emerging 
view, therefore, is that interaction with LC8 induces dimerization, imparting new structure and 
function, which is supported by detailed investigations of LC8 interactions (Barbar and Nyarko, 
2015; Radnai et al., 2010; Wang et al., 2004; Williams et al., 2007). In addition to this improved 
understanding of LC8, interest in this molecule has grown as LC8 has been shown to have unique 
and important roles in an increasing number of human pathogens. These include viruses, such as 
HIV (Jayappa et al., 2015), Ebola (Luthra et al., 2015), and rabies (Tan et al., 2007), and the 
protistan parasite Toxoplasma gondii (Qureshi et al., 2013). 
Trypanosoma brucei, a member of the early diverged phylogenetic order Kinetoplastida, is a 
vector-borne parasite that causes lethal disease in both humans and livestock (Brun and Blum, 
2012). In T. brucei, LC8 was identified in mass spectrometry analysis of the flagellar matrix 
(Broadhead et al., 2006; Oberholzer et al., 2011) and, surprisingly, as a subunit of the class I 
transcription factor A (CITFA) (Brandenburg et al., 2007; Nguyen et al., 2012). As CITFA is a 
core promoter-binding factor required for initiation of RNA polymerase (pol) I-mediated 
transcription, this represents the first time LC8 has been found to associate with basal transcription 
machinery. T. brucei is unique in that RNA pol I not only transcribes ribosomal gene units (RRNA), 
as in all other organisms, but is also used to transcribe gene arrays that encode its major cell surface 
proteins, namely the variant surface glycoprotein, or VSG, in the mammalian-infective 
bloodstream form (BF) and procyclin in the insect-stage procyclic form (Günzl et al., 2003). This 
production of functional mRNA by RNA pol I is possible in T. brucei due to a unique mRNA 
processing mechanism, called spliced leader (SL) trans-splicing, which caps mRNA post-
transcriptionally by an RNA pol II-independent process (Rudenko et al., 1991; Wirtz et al., 1994; 
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Zomerdijk et al., 1991a). By densely covering the cell in ~10 million copies of the same VSG 
protein, T. brucei is able to shield invariant proteins from antibody recognition (Schwede et al., 
2011). The source of this massive protein expression is a single VSG gene located in one of ~15 
bloodstream expression sites (BESs) that are monoallelically expressed (Hertz-Fowler et al., 
2008). Antigenic variation of VSG, which occurs by switching to the expression of another of the 
~2000 VSG genes in the trypanosome genome, allows for an indefinite infection to be maintained 
(Cross et al., 2014; Horn, 2014). The importance of VSG to T. brucei is highlighted by the fact 
that interference with VSG mRNA rapidly halts BF culture growth in the absence of 
immunological pressure and leads to the clearance of trypanosomes from infected mice (Sheader 
et al., 2005). 
While it was previously shown that the CITFA complex, consisting of subunits CITFA1-7 and 
LC8, is essential to RNA pol I-mediated transcription and binds the BES promoter in purified form 
(Brandenburg et al., 2007)), the specific role of individual complex members, including knowledge 
of the LC8 binding partner, has remained unclear. Furthermore, given that CITFA subunits except 
LC8 are conserved only among kinetoplastids and are without recognizable sequence motifs, that 
LC8 has never been implicated in the basal process of transcription initiation, and that LC8 has 
not been studied in a kinetoplastid organism, we set out to understand the specific role of LC8 in 
RNA pol I-mediated transcription. 
Kinetoplastids encode two distinct LC8 proteins, only one of which was found to be associated 
with CITFA. We found that this LC8, previously termed DYNLL1 (Brandenburg et al., 2007; 
Nguyen et al., 2012), is essential for cell viability in culture and that RNAi-mediated silencing of 
the gene led to defects in both cell cycle and transcription by RNA pol I. To understand LC8’s 
specific role in the latter, we identified an LC8 binding site near the N-terminus of the essential 
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CITFA2 subunit. Mutation of this site was lethal to trypanosomes, preventing the incorporation of 
this subunit into the CITFA complex. Moreover, we show that CITFA2 directly interacts with BES 
promoter DNA and is required for the CITFA complex to bind to the BES promoter in vivo, 
functions that crucially depend on the CITFA2-LC8 interaction. These data revealed an essential 
role for LC8 in T. brucei, and the first evidence that LC8 is required for the formation of a 
transcription pre-initiation complex in any organism. 
II-2. Materials and Methods 
DNAs and cell lines. pT7-LC8-stl, for conditional silencing of LC8 genes (accession numbers 
Tb927.11.18680 and Tb11.0845 [www.genedb.org or www.tritrypdb.org]), was generated by 
inserting portions of the LC8 coding region and its adjacent 3/ UTR, nucleotides +97 to +602 
relative to the translation initiation codon, into the pT7-stl vector (Brandenburg et al., 2007) in a 
sense-stuffer-antisense arrangement, according to a published protocol (Shi et al., 2000). 
Transfection of SacII-linearized pT7-LC8-stl into single marker (sm)BF cells (Wirtz et al., 1999) 
generated smLC8 cells. pCITFA7-PTP-NEO, pCITFA4-PTP-NEO (Nguyen et al., 2012), and 
pPTP-CITFA2-PURO (Brandenburg et al., 2007) are plasmids that were described previously, and 
were used to fuse the sequence of the composite PTP tag, consisting of a tandem protein A domain 
(ProtA), a Tobacco etch virus cleavage site, and a protein C (ProtC) epitope, to endogenous alleles. 
Similarly, the gene silencing vector pT7-PTP-stl (Park et al., 2014), and pT7-CITFA2-stl 
(Brandenburg et al., 2007), along with accompanying cell lines, were described previously. smC2-
PTP cells allow for the conditional silencing of CITFA2 through targeting the PTP tag coding 
sequence, and was generated in two steps: starting with a previously published smPTP cell line 
(Park et al., 2014), which conditionally expresses double stranded RNA targeting the PTP tag 
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sequence, we first used site-directed integration of SphI-linearized pPTP-CITFA2-PURO into one 
CITFA2 allele to fuse the PTP tag sequence to the 5/ end of the CITFA2 coding region. In a second 
step, the remaining CITFA2 allele was replaced by a PCR product in which 100bp of CITFA2 gene 
flanks surrounded the hygromycin phosphotransferase coding sequence. In order to conditionally 
express exogenous transgenes of CITFA2, pT7-trans was developed. We inserted into pT7-stl, 
using HindIII and XbaI restriction sites, a PCR product which contained (5/ to 3/) 490bp of the 
HSP70 genes 2 and 3 intergenic region, NdeI and NotI restriction sites, a hemagglutinin (HA) tag 
sequence ending with a stop codon, and 741bp of the β-/α-tubulin intergenic region. pT7-CITFA2-
HA was generated from pT7-trans through insertion of the full coding sequence of CITFA2 using 
NdeI and NotI restriction sites. pT7-NDel-HA was generated similarly, save that bases +4 through 
+31, corresponding to amino acids 2 through 10 of CITFA2 (PEVGTQVYW), were deleted by 
PCR. pT7-3Amut-HA was generated using a CITFA2 insert which had bases +16 through +24 
(ACTCAAGTT, coding for amino acids TQV) replaced with GCCGCGGCA, which coded for 
three alanines. Transfection of these three plasmids, after linearization by EcoRV, into smC2-PTP 
cells generated cell lines smC2-PTP-CITFA2-HA, smC2-PTP-NDel-HA, and smC2-PTP-3Amut-
HA. Transfection of these same plasmids into wild-type sm cells resulted in cell lines smC2-
CITFA2-HA, smC2-NDel-HA, and smC2-3Amut-HA. 
DNAs and recombinant protein. To generate recombinant proteins for pulldown assays and 
sucrose gradients, seven different recombinant protein expression plasmids were created. 
pCITFA2-PTH, which allowed for the expression of full-length wild-type recombinant 
(r)CITFA2, was produced by inserting the full coding sequence of CITFA2 into the expression 
vector pET100/D-TOPO (Invitrogen) using NdeI and NotI restriction sites. This resulted in 
rCITFA2 which had fused to its C-terminus a ProtC epitope, followed be a thrombin cleavage site, 
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and a 6xHis tag. Four additional plasmids were produced which only differed in the length of the 
integrated CITFA2 sequence: pCITFA2-N-PTH contains sequence for only the N-terminal half of 
CITFA2 (bases +1 to +624), while pCITFA2-C-PTH codes for the C-terminal half (bases +621 to 
+1263). pCITFA2-N1/4-PTH, coding for the N-terminal quarter of CITFA2, contained bases +1 
to +303, while pCITFA2-N2/4PTH, coding for the second quarter, contained bases +289 to +624. 
p3Amut-PTH, however, uniquely coded for mutated full-length rCITFA2 - the same triple-alanine 
mutation as detailed above for pT7-C2-3Amut. These vectors were transformed into BL21 
Escherichia coli, and protein expression was induced for 15 min to 1 hour at 37°C by adding 1 
mM IPTG. Shorter incubations were required for plasmids which included the C-terminus of 
CITFA2, as its expression appears to be toxic to E. coli (data not shown). Recombinant LC8 was 
generated by placing the entire LC8 coding sequence downstream of the glutathione S-transferase 
(GST) sequence in the pGEX-4T-2 vector (GE Healthcare) using BamHI and NotI restriction sites. 
Recombinant GST-LC8 was expressed in BL21 E. coli and purified by glutathione affinity 
chromatography (GE Healthcare) following the manufacturer’s recommendations. Thrombin 
digest and elution was then performed, such that, in all assays, LC8 was used as an untagged, 
recombinant protein.  
Generation of a purified anti-LC8 antibody. Immune serum against LC8 was generated by 
immunization of Sprague-Dawley rats with rGST-LC8, according to a standard protocol 
(Schimanski et al., 2006). rGST-LC8-specific antibodies were purified from serum by blot-
immobolized antigen, as previously detailed (Park et al., 2014). In contrast to immune serum, the 
purified antibody did not detect a non-specific band present in E. coli that co-migrated with 
thrombin-digested LC8 (data not shown). 
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Protein analysis. Immunoblot detections were performed using polyclonal antibodies directed 
against CITFA2 (Brandenburg et al., 2007), CITFA6, CITFA7 (Nguyen et al., 2012), and TFIIB 
(Schimanski et al., 2006). The PTP tag was detected with a monoclonal anti-ProtC antibody 
(Roche), while HA-tagged proteins were detected with a rat monoclonal anti-HA antibody 
(Roche). Extract preparation and tandem affinity purifications of PTP-tagged CITFA2, CITFA4, 
and CITFA7 were conducted according to the standard protocol (Schimanski et al., 2005b). Crude 
bacterial lysates of rCITFA2-PTH-expressing BL21 E. coli, used in protein pulldowns with rLC8, 
were prepared as follows: after inducing protein expression with 1 mM IPTG IPTG for 30 min at 
37°C, bacterial cultures were pelleted, and 0.2 g of the cell pellet was resuspended in 4 ml of 
HisTALON xTractor buffer (Clontech). 250 units of Benzonase (Sigma), 400 ng lysozyme, and 
250 µl of a protease inhibitor solution, prepared by resuspending 1 tablet of protease inhibitor 
(Roche) in 1 ml H20, was then added. Following a 10 min incubation, with shaking, at 4°C, the 
mixture was centrifuged at 3,200 g for 30 min at 4°C. The supernatant was taken and constitutes 
the crude bacterial lysate. For the pulldowns, rCITFA2-PTH was purified from 100 µl of the crude 
lysate using 20 µl equilibrated TALON metal affinity resin (Clontech), according to the 
manufacturer’s specifications. A 40 µl binding reaction containing the CITFA2-PTH-conjugated 
TALON resin, 100 mM KCl, 20 mM potassium glutamate, 20 mM HEPES-KOH (pH 7.7), 3 mM 
MgCl2, 100 ng/µl BSA, 150 mM sucrose, 2.5 µl of the protease inhibitor solution, and 100 ng 
rLC8 was incubated at 27°C for 1 hour, with shaking. The resin was washed 7 times with a buffer 
containing 400 mM KCl), 20 mM potassium glutamate, 20 mM HEPES-KOH (pH 7.7), 3 mM 
MgCl2, 10 ng/µl BSA,, 0.5 mM dithiothreitol (DTT), and 0.1% Tween-20. Proteins were eluted 
using HisTALON Elution Buffer (Clontech), and investigated by immunoblotting. To analyze 
rCITFA2-rLC8 interactions by sedimentation, 500 ng purified rLC8 was mixed with 200µl of 
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rCITFA2-PTH-containing crude bacterial lysates, and incubated for 30 min at 27°C. The binding 
reaction was then loaded onto a 4 ml 10-40% linear sucrose gradient, ultracentrifuged, and 
fractionated from top to bottom, as previously described (Brandenburg et al., 2007). Co-
immunoprecipitations (co-IPs) of CITFA2 were performed using trypanosome extract, as 
previously described (Nguyen et al., 2007). UV-crosslinking and electrophoretic mobility shift 
assays (EMSAs) of a radiolabeled BES promoter probe and purified CITFA, both visualized by 
autoradiography, were conducted as previously detailed (Brandenburg et al., 2007). Secondary 
structure analysis was carried out using PredictProtein (www.predictprotein.org/) (Rost et al., 
2004). 
RNA analysis. To analyze the effect of LC8 silencing on transcription by RNA pol I, total 
RNA was prepared by the hot-phenol method, as described previously (Park et al., 2014). For the 
analysis of rRNA, total RNA was separated in Reliant precast 1.25% SeaKem Gold agarose RNA 
gels (Lonza), and rRNA was detected by ethidium bromide staining. For semi-quantitative RT-
PCR analysis, total RNA was reverse transcribed with Superscript Reverse Transcriptase II 
(Invitrogen) using an oligo(dT) primer. Semiquantitative PCR was performed using cycle numbers 
that were empirically determined to be within the linear amplification range for each primer pair: 
5/-GATAAGCTTACGCGTTTCAACATTGAGAAGGAT ATTGC-3/ and 5/-
GATTCTAGACTCGAGTCTTTGACTCATCCGTGCTGG-3/ were used to amplify the LC8 
coding sequence and 3/ UTR, while primers amplifying α-tubulin and VSG2 were published 
previously (Nguyen et al., 2012). 
Chromatin immunoprecipitation (ChIP). CITFA2-HA and CITFA3 promoter occupancy 
were analyzed by ChIP assays, as described previously (Park et al., 2014), using monoclonal rat 
anti-HA antibody (Roche) and purified polyclonal anti-CITFA3 antibody, respectively. Negative 
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control precipitations were carried out using affinity beads not bound to antibody. Chromatin was 
sonicated until fragments averaged 200-400 bp in length. The precipitated DNA was analyzed by 
qPCR using consensus primers for the slightly varying copies of RRNA and BES promoters, and a 
primer pair for the β-/α-tubulin intergenic region, which were specified previously (Nguyen et al., 
2012; Park et al., 2014). The percent IP was calculated relative to the input material and corrected 
by subtracting the percent IP of the negative control ChIP. Each ChIP experiment was 
independently carried out 3-4 times, and statistical analyses were performed using percent IP 
averages. Comparisons between corrected percent precipitations of non-induced and induced cells 
were performed using Student’s T-test. Prior to the application of the T-test, an F-test was 
performed to assure that the assumption of equal variance between groups was not violated. If the 
F-test indicated that the difference in variation was significant, then the T-test was performed with 
the more conservative assumption of unequal variance. An unpaired, two-tailed test was used in 
all cases.  
Microscopy. To visualize changes in cell morphology and DNA content upon LC8 silencing, 
BFs were incubated with 4,6-diamidino2-phenylindol (DAPI) at a final concentration of 2 ng/µl 
for 45 min and imaged using a Zeiss AxioVert 200 microscope and Zeiss Axiovision 4.6.3.0 
software, as described previously (Park et al., 2014). For quantification of the percentage of cells 
which were multiflagellated, multi-kinetoplastid, or multi-nucleated, cells were scored as 
abnormal if they met any one of the following criteria: ≥3 kinetoplasts, ≥3 nuclei, ≥3 flagella, or 
more nuclei than kinetoplasts. 150 cells were scored from both the non-induced and induced 
populations. 
Flow Cytometry. In order to assess changes in the size and DNA content of a large number 
of cells upon LC8 silencing, flow cytometry experiments were performed. Non-induced and 1 day 
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induced smLC8 cultures were stained with propidium iodide, and counted using an LSR II flow 
cytometer (BD Biosciences), according to a previously described protocol (Li et al., 2009). 30,000 
cells were counted in each experiment, in triplicate, for each induction state, and ungated data was 
visualized using the FlowJo software package (Treestar Inc.). 
II-3. Results 
LC8 is essential for T. brucei viability, cytokinesis, and RNA pol I-mediated transcription. A 
survey of kinetoplastid genome data bases revealed conservation of two distinct LC8 genes. One 
encodes an LC8 protein that is closely related to both human DYNLL1 and DYNLL2 (~82%/88% 
identity/similarity; accession number for the T. brucei gene is Tb927.11.1868 at 
www.TritrypDB.org (Aslett et al., 2010) or www.GeneDB.org (Logan-Klumpler et al., 2012)) and 
was previously termed DYNLL1 (Brandenburg et al., 2007). A second LC8 is also present, yet this 
gene is more divergent from LC8s in other eukaryotes (~61%/85% identity/similarity to human 
DYNLL1 and 2; Tb927.11.320; Figure II-S1). Since a phylogenetic analysis did not reveal that 
these two LC8 proteins resemble the DYNLL1 and DYNLL2 dichotomy found in chordates 
(Figure II-S1C in the supplemental material), we propose to rename Tb927.11.1868 as LC8 and 
Tb927.11.320 as LC8dv (dv for divergent). Trypsin-derived peptides of these two proteins are 
different except for a four amino acid-long peptide (Figure II-S1A). Since previous mass 
spectrometric analyses of purified CITFA consistently identified LC8 but never LC8dv-derived 
peptides (Brandenburg et al., 2007; Nguyen et al., 2012), it is highly unlikely that LC8dv is a 
subunit of the transcription factor complex. We therefore concentrated our analysis on LC8. 
To investigate the importance of LC8 to BFs, we reduced its expression by RNA interference 
(RNAi), using a conditional gene silencing system which expressed double-stranded RNA 
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(dsRNA) targeting both the LC8 coding and 3/ untranslated region (UTR) upon addition of 
doxycycline (Wirtz et al., 1999). In three different clonal cell lines, derived from smBF cells and 
termed smLC8, culture growth arrested within 1 day, and the majority of cells were lost by 2 days 
of induction (Figure II-1A). By 3 days of induction, no living cells could be identified by 
microscopic examination. RNA monitoring revealed that doxycycline induction resulted in a clear 
decline of LC8 mRNA abundance after 1 day, while the levels of LC8dv and α-tubulin mRNA was 
unaffected, confirming that the knockdown was specific to LC8 (Figure II-1B). To evaluate 
whether this rapid death phenotype would allow us to detect effects on transcription by RNA pol 
I, we measured levels of VSG mRNA derived from the active VSG2 gene and of rRNA. While the 
VSG2 mRNA level dropped considerably after 1 day of induction, the rRNA level decreased only 
modestly in the same experiment, possibly due to greater stability of rRNA (Figure II-1B). 
Immunoblot monitoring of LC8-silenced cells showed a specific reduction in LC8 protein, while 
CITFA6 and TFIIB, an RNA pol II-specific factor, were either increased or unchanged during this 
short period (Figure II-1C), confirming the specificity of the knockdown. These data 
demonstrated that LC8 is essential for trypanosome viability, and they indicated that LC8 is also 
important, though perhaps indirectly, for transcription by RNA pol I. 
Since smBF cells and their derivatives have a doubling time of approximately 7 hours in our 
hands (Figure II-1A, -dox), propidium iodide staining, which allows for the quantification of the 
DNA content of individual cells, revealed a rapidly-progressing second phenotype. After only 1 
day of induction, the per-cell DNA content of induced cells had approximately tripled vs non-
induced cells, as revealed by flow cytometry of propidium iodide stained cultures (Figure II-1D).  
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Figure II-1. LC8 silencing has pleiotropic effects on BF trypanosomes. (A) Growth curve analysis 
of a representative clonal smLC8 BF cell line in the absence (- dox) and presence (+ dox) of the 
LC8 knockdown inducing compound doxycycline. (B) Total RNA prepared from non-induced (ni) 
and 1 day induced cells was reverse transcribed with Oligo-dT and analyzed by semiquantitative 
PCR using LC8, α-tubulin, and VSG2-specific oligonucleotides. rRNA was detected by ethidium 
bromide staining of total RNA. (C) Whole cell lysates of non-induced and 1 or 2 day induced cells 
were analyzed by immunoblotting using LC8, CITFA6 or, as a loading control, TFIIB-specific 
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(Figure II-1 legend cont.) antibodies. (D) Flow cytometry analysis, without gating, of non-
induced (blue) and 1 day induced cultures (red). Propidium iodide staining intensity (x-axis), 
which measures DNA content per cell, and cell counts (y-axis) from one representative experiment 
are shown. (E) Indirect fluorescence microscopy of non-induced and 1 day induced cells. 
Representative single cells from each culture were imaged using both phase contrast and DAPI 
fluorescence. Small and large areas of DAPI intensity represent kinetoplasts and nuclei, 
respectively. Scale bar is 10 µm. 
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Specifically, while non-induced cells demonstrated a curve with strong peaks representing cells 
with normal 2C and 4C DNA content, induced cultures had smaller 2C and 4C peaks, with the 
majority of cells displaying polyploidy (8C). This result was confirmed by DAPI fluorescence 
microscopy, which demonstrated that the majority of cells in culture (64%, n = 150) had increased 
in size, and were multi-flagellated, multi-kinetoplastid, and multi-nucleated (Figure II-1E), a 
phenotype that was observed in only two out of 150 non-induced cells. The increase in size was 
confirmed by flow cytometry of non-induced and LC8-silenced trypanosomes (Figure II-S2). This 
phenotype is not likely due to the loss of LC8 from the CITFA complex, as previously published 
knockdowns of other CITFA subunits failed to result in a similar phenotype (Brandenburg et al., 
2007; Nguyen et al., 2014; Nguyen et al., 2012; Park et al., 2014). It would be consistent, however, 
with a role for LC8 in cell cycle progression, which has been reported previously in other 
organisms (Asthana et al., 2012; Liu et al., 2003). 
LC8 binds to the N-terminus of CITFA2. In order to investigate the CITFA-specific role of 
LC8, we needed to determine LC8’s binding partner within the CITFA complex, since disrupting 
this interaction would likely only interfere with LC8’s RNA pol I-related function. While LC8 
binding sites are conserved from yeast to humans (Wickstead and Gull, 2007), a survey did not 
unambiguously reveal such a site in CITFA subunit sequences (data not shown). We recently 
discovered in a sedimentation analysis that the peaks of CITFA7 and CITFA2 in extract differed 
slightly from each other, possibly indicating the existence of CITFA complexes with partially 
different compositions (Nguyen et al., 2012). To compare the sedimentation profile of LC8 with 
those of the other CITFA subunits, we tandem affinity-purified CITFA via PTP-tagged CITFA7 
and sedimented the purified complex through a linear sucrose gradient (Figure II-2A). 
Fractionating the gradient from top to bottom and analyzing the protein content of each fraction  
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Figure II-2. LC8 binds to the N-terminus of CITFA2, promoting its dimerization. (A) 
Sedimentation of tandem affinity-purified CITFA by ultracentrifugation in a 10-40% linear 
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(Figure II-2 legend cont.) sucrose gradient. Fractions, taken from top to bottom, were separated 
by SDS-PAGE, stained with SYPRO Ruby and immunoblotted for specific detection of CITFA2, 
CITFA7, and LC8. CITFA7-P is so noted due to the presence of ProtC, which remains following 
TEV protease cleavage. Arrows highlight the relative absence of CITFA2 and LC8 in fraction 12. 
Taq DNA polymerase (95 kDa), IgG (150kDa), and apoferritin (AP) (444 kDa) were analyzed for 
molecular mass comparison (arrowheads). (B) Pulldown of recombinant, full-length (amino acid 
residues 1-422), wild-type CITFA2 with a C-terminal PTH tag, consisting of ProtC, a thrombin 
cleavage site (TCS), and the terminal 6xHis tag, in the presence of recombinant LC8. Crude extract 
(Inp), supernatant (S), and precipitate (P) were analyzed in relative amounts of 1:1:8 by 
immunoblotting, using ProtC- and LC8-specific antibodies. A negative control pulldown was 
conducted in the absence of CITFA2 (bottom panel). (C) Corresponding experiments with 
CITFA2-PTH fragments which are specified by residue numbers. (D) Alignment of the N-terminal 
CITFA2 sequences from Trypanosoma brucei brucei strain 427 (Tb427, accession numbers are 
listed in Table II-S1), Trypanosoma congolense (Tcon), Trypanosoma vivax (Tv), Trypanosoma 
cruzi (Tc), Trypanosoma grayi (Tgr), Trypanosoma rangeli (Tran), Leishmania tarentolae (Lta), 
Leishmania mexicana (Lmx), Leishmania major (Lm), Leishmania infantum (Li), and Leishmania 
donovani (Ldon). Positions with more than 50% identity or similarity are highlighted in black or 
gray, respectively. The proposed LC8 binding site is marked below the alignment (asterisks), while 
the two mutants used for further investigation, NDel and 3Amut, are indicated above. (E) Pulldown 
assay of full length rCITFA2-PTH carrying the 3Amut mutation (r3Amut-PTH). (F) Sucrose 
gradient sedimentation of rCITFA2-PTH alone, LC8 alone, or in combination, following co-
incubation (bottom two panels). Arrows indicate a co-sedimentation peak in fraction 10 that is not 
present when either protein was analyzed on its own.   
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by SDS-PAGE and SYPRO Ruby staining revealed a CITFA complex that peaked in fractions 12-
15 (Figure II-2A). The staining pattern and immunoblotting with specific antibodies, however, 
showed that while CITFA7 and other CITFA subunits were present in all four peak fractions, 
CITFA2 and LC8 were nearly absent from fraction 12, suggesting that CITFA2 may be the binding 
partner of LC8. 
To directly test this, we generated in E. coli recombinant LC8 with an N-terminal GST tag and 
CITFA2 with a C-terminal composite PTH tag containing a ProtC epitope, a thrombin cleavage 
site, and six histidine residues (6xHis). Incubating purified CITFA2-PTH, immobilized on beads, 
with purified LC8, after removal of the GST tag, co-precipitated LC8 in a CITFA2-PTH-dependent 
manner, strongly indicating a direct interaction between these two proteins (Figure II-2B). In 
order to confirm this result, and better specify the site of interaction, we repeated this pulldown 
experiment using recombinant protein portions of CITFA2. Precipitation of the N-terminal half of 
CITFA2, comprising amino acids 1-208, effectively precipitated LC8 from solution, while 
precipitation of the C-terminal half did not (Figure II-2C). We further divided the N-terminal half 
of CITFA2, and again found that the most N-terminal portion, this time residues 1-101, 
precipitated LC8, while the second quarter of CITFA2 failed to precipitate LC8. We then 
attempted to identify the LC8 binding site within this reduced region of CITFA2 using motifs 
validated in other organisms (Rapali et al., 2011b), as well as a report which used a directed 
evolution approach to quantitatively determine the affinity preferences of the LC8 binding site 
(Rapali et al., 2011a). In both of these publications, the LC8 binding site almost always contained 
a central glutamine (Q), with threonine (T) or valine (V) in the -1 and +1 positions. Three amino 
acids, threonine-glutamine-valine, at the N-terminus of CITFA2 (amino acids 6-8) were identified 
as the likeliest site of interaction, and are almost completely conserved among kinetoplastid 
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CITFA2 sequences (Figure II-2D). In the course of this study two mutations of CITFA2 were 
pursued: an N-terminal deletion of amino acids 2-10 (NDel) and a replacement of amino acids 6-
8 with alanines (3Amut). Precipitation of full length recombinant 3Amut-PTH failed to precipitate 
LC8 from solution, confirming that LC8 binds CITFA2 via this N-terminal sequence (Figure II-
2E). 
LC8 binding promotes CITFA2 dimerization. In other systems it was shown that LC8, 
acting as a dimer, binds to disordered regions of proteins, stabilizing their structure and allowing 
for areas present in the binding partner, such as coiled-coil domains, to promote dimerization, 
thereby resulting in the formation of a heterotetramer (Barbar and Nyarko, 2014, 2015; Rapali et 
al., 2011b). While secondary structure prediction software identified the N-terminus of CITFA2 
as unstructured, no domains known to promote protein dimerization were recognized (data not 
shown). In order to investigate the possibility that LC8 binding induces dimerization of CITFA2, 
we performed sucrose gradient sedimentation with recombinant CITFA2-PTH and LC8. CITFA2-
PTH, by itself, was found to peak in gradient fraction 7, which would be consistent with it existing 
as a monomer of 50 kDa (Figure II-2F), while the 10 kDa LC8 was found at the top of the gradient. 
When LC8 and CITFA2-PTH were allowed to interact before gradient sedimentation, however, 
both proteins exhibited a peak in fractions 9-10, consistent in size with a complex containing a 120 
kDa CITFA2/LC8 heterotetramer. Serendipitously, when CITFA2-PTH was expressed in E. coli, 
immunoblots against the C-terminal ProtC tag detected its full length form and a truncated form 
which is missing approximately 5 kDa (Figure II-2F, asterisks). This putative N-terminal 
truncation was not shifted upon addition of LC8, indicating that LC8 cannot form a heterotetramer 
with the truncated CITFA2. These results strongly indicate that LC8 promotes the dimerization of 
CITFA2. 
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The CITFA2-LC8 interaction is essential for cell viability and RNA pol I-mediated 
transcription. In order to assess the importance of the CITFA2-LC8 interaction, we established 
BF cell lines in which doxycycline triggers both silencing of endogenous CITFA2 and expression 
of an RNAi-resistant CITFA2 transgene. In T. brucei, effective gene silencing via the RNAi 
pathway requires strong expression of ~500 bp-long dsRNA (Shi et al., 2000). We recently showed 
that targeting the heterologous PTP tag coding sequence effectively interfered with mRNAs 
carrying the PTP sequence, while having no deleterious off target effect in BFs (Park et al., 2014). 
The smPTP cell line, a derivative of the established smBF cell line for gene knockdowns (Wirtz 
et al., 1999), constitutively expresses the tetracycline (TET) repressor and T7 RNA pol, and, upon 
induction, PTP dsRNA from a TET-controlled T7 promoter (Park et al., 2014). To apply this 
system to CITFA2, we replaced one CITFA2 allele in smPTP cells by hygromycin 
phosphotransferase and inserted the PTP-CITFA2-PURO plasmid into the second CITFA2 allele 
to obtain cell line smC2-PTP (Fig II-3A, left panel). As expected, induction of PTP dsRNA led to 
a loss of cell viability over three days induction (Figure II-3A, middle panel), which matched 
previously performed CITFA2 silencing experiments that targeted the CITFA2 coding sequence 
(Brandenburg et al., 2007). Immunoblotting of whole cell lysates confirmed that CITFA2 was 
exclusively expressed as a PTP fusion, and that depletion of PTP-CITFA2 was nearly complete 
after 1 day of induction (Figure II-3A, right panel). We next generated three CITFA2 rescue 
constructs which differed only in respect to the LC8 binding site (Figure II-3B). The constructs 
contained the complete wild-type, 3Amut, or NDel coding region with an HA tag sequence at the 
3/ end (CITFA2-HA), and were under the control of a TET-regulated T7 promoter (note that due 
to SL trans splicing, trypanosomes can utilize T7 pol for the effective production of functional 
mRNA (Stewart et al., 2010)). The constructs were transfected into smC2-PTP cells and targeted  
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Figure II-3. Mutation of the LC8 binding site is lethal. (A) Left, schematic of the CITFA2 locus 
(not to scale) in BF cell line smC2-PTP in which one allele has been replaced with a hygromycin 
resistance cassette (HYG), while the remaining allele has been fused to the PTP tag sequence by 
integration of pPTP-CITFA2-PURO, which harbors a puromycin resistance cassette (PURO). 
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(Figure II-3 legend cont.) Small gray rectangles indicate gene flanks with essential RNA 
processing signals. Doxycycline-induced expression of PTP dsRNA specifically targets PTP-
CITFA2 mRNA. Middle, smC2-PTP culture growth curve in the presence (+dox) and absence (-
dox) of doxycycline. Right, immunoblot monitoring of the CITFA2 knockdown using both anti-
CITFA2 and anti-PTP antibodies, with TFIIB serving as a loading control. Note that the absence 
of a ~55 kDa band in anti-CITFA2 antibody probing confirms exclusive expression of PTP-tagged 
CITFA2 in smC2-PTP cells. (B) Top, schematic depiction (not to scale) of the construct that 
harbored the CITFA2-HA transgene and was targeted to the silent RRNA intergenic region to 
conditionally express RNAi-resistant CITFA2-HA mRNA and rescue the PTP-CITFA2 
knockdown. Bottom, culture growth curves of representative smC2-PTP cell lines whose PTP-
targeted CITFA2 knockdown was rescued with wild-type (WT), 3Amut, or NDel CITFA2-HA 
expression. (C) RNA analysis of the rescue cell lines after either no induction (ni) or two days of 
doxycycline. (D) Immunoblotting of PTP-CITFA2 and CITFA2-HA proteins during a time course 
of doxycyline-induced PTP-CITFA2 knockdown (KD) and CITFA2-HA expression, with TFIIB 
serving as a loading control. Arrows indicate co-declines of 3Amut and NDel CITFA2-HA protein 
with PTP-CITFA2 in the corresponding cell lines.  
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to the ribosomal spacer region, a silent genomic locus commonly used for integration of exogenous 
plasmid constructs. As expected, the expression of wild-type CITFA2-HA almost completely 
rescued for the growth defect which resulted from PTP-CITFA2 silencing (Figure II-3B, left 
panel). In contrast, neither 3Amut nor NDel were able to rescue for the knockdown (Figure II-
3B, middle and right panels). RNA analysis confirmed the reduction in PTP-CITFA2 mRNA in 
all three cell lines, and the simultaneous expression of the HA-tagged transgenes (Figure II-3C). 
Furthermore, and consistent with the failed rescue of the PTP-CITFA2 knockdown by both mutant 
CITFA2-HA genes, RNA pol I-derived transcripts rRNA and VSG2 mRNA were strongly reduced 
in induced cells, while such defects were absent in the wild-type rescue line (Figure II-3C). 
Immunoblot monitoring confirmed the knockdown of PTP-CITFA2 after 24 hours of induction, 
and the expression of the three different rescue transgenes within 8 hours (Figure II-3D). The 
lethality of mutating the LC8 binding site in CITFA2 in conjunction with the specific decline of 
rRNA and VSG2 transcripts strongly indicated that the interaction between LC8 and CITFA2 is 
essential for RNA pol I-mediated transcription and BF viability in culture. 
Our next goal was to determine the specific defect in transcription upon interfering with the 
CITFA2-LC8 interaction. The 3Amut, and NDel rescue cell lines, however, were not informative 
in this regard, as immunoblots revealed that while both 3Amut and NDel mutant proteins were 
expressed upon induction, peak expression was transient, and protein levels fell sharply at 24 hours 
(Figure II-3D, arrows). This cannot be due to a decline in transgene mRNA, as it was found to be 
well expressed at 48 hours post induction (Figure II-3C). Given that the decline in mutant CITFA2 
levels coincided with the RNAi-mediated decline of PTP-tagged CITFA2, we hypothesize that 
wild-type CITFA2 might be stabilizing mutant CITFA2 through weak direct interaction. This 
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would be consistent with the view that LC8 drives dimerization of proteins which already have a 
propensity towards dimerization (Barbar and Nyarko, 2014). 
Mutant CITFA2 does not bind promoter DNA or interact with other CITFA subunits. We 
sought to obviate the problem of mutant instability by generating a cell line in which mutant 
CITFA2-HA and wild-type CITFA2 were expressed simultaneously. We transfected our same 
three CITFA2-HA transgene constructs into BF cells that contained two wild-type CITFA2 alleles, 
generating cell lines C2-WT-HA, C2-NDel-HA, and C2-3Amut-HA. Immunoblot monitoring 
revealed that both wild-type and NDel CITFA2-HA were able to achieve long-term, high level 
expression in the presence of wild-type CITFA2, while 3Amut, though durably expressed, never 
reached an equal protein level (Figure II-4A). This expression profile was consistent in 2-4 cell 
lines obtained with each construct. The low expression of 3Amut could be due to a disruption in 
the secondary structure of CITFA2 causing instability, as the three alanine residues would strongly 
promote the formation of an α-helix (Pace and Scholtz, 1998) in a region predicted to form a β-
strand. 
Given that CITFA is a promoter-binding transcription factor, we sought to determine if the 
well expressed NDel mutant was recruited to promoter DNA. ChIP using anti-HA antibody, 
specific for the transgene-derived CITFA2-HA, revealed that while wild-type CITFA2-HA was 
present at both RRNA and BES promoters, NDel CITFA2-HA was not (Figure II-4B). This lack 
of promoter binding could be the result of either a loss of DNA-binding by a complete CITFA 
complex, or a lack of assembly of the mutant CITFA2 into the CITFA complex. To differentiate 
between these two possibilities, we immunoprecipitated both wild-type and NDel CITFA2-HA, 
and analyzed for co-IP of other CITFA subunits (Figure II-4C). Precipitation of the wild-type 
protein resulted in the co-IP of LC8, CITFA6, and CITFA7, verifying that the introduced CITFA2- 
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Figure II-4. Mutation of the LC8 binding site prevents recruitment of CITFA2 to promoters and 
its assembly into the CITFA complex. (A) Comparison of constitutive wild-type (WT), NDel, or 
3Amut CITFA-HA expression in individual BF cell lines by immunoblotting, with TFIIB serving 
as a loading control. (B) Anti-HA ChIP assays in cell lines constitutively expressing wild-type or 
NDel CITFA2-HA. Precipitated DNA was analyzed using primer pairs which amplified the 
consensus BES promoter (BES prom), the consensus RRNA promoter (RRNA prom), and the β-/α-
tubulin intergenic region. Error bars represent one standard deviation, with asterisks indicating a 
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(Figure II-4 legend cont.) Student’s T-test P-value of < 0.05. (C) Anti-HA co-
immunoprecipitation with the same cell lines. Blots monitoring wild-type (WT) or NDel CITFA2-
HA immunoprecipitation were probed to detect the co-immunoprecipitation of LC8, CITFA6, 
CITFA7, and, as a loading control, TFIIB. Note that IgG light chain (IgG l.c.) was detected at the 
top of the CITFA6 immunoblot. (D) Sucrose gradient sedimentation of whole cell extracts, 
prepared from cell lines that constitutively express wild-type (WT), NDel, or 3Amut CITFA2-HA 
cell lines, were analyzed by immunoblotting fractions 4-20 using either anti-HA or anti-CITFA6 
immune serum. 
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HA had assembled with other CITFA subunits. NDel CITFA2-HA, however, failed to co-IP any 
of these proteins, showing that the lack of promoter binding by the mutant was due to a lack of 
stable association with other CITFA subunits. To confirm this result, and further investigate the 
assembly status of both wild-type and mutant CITFA2, we performed sucrose gradient 
sedimentation of BF extract. While wild-type CITFA2-HA had its major sedimentation peak in 
fractions 12-15, which coincided with the peak of CITFA6, both 3Amut and NDel peaked in 
fractions 6-7, and lacked a peak in 12-15 (Figure II-4D). This result confirms that CITFA2 must 
bind LC8 for CITFA complex assembly. Given that sedimentation in fractions 6-7 would be 
consistent with a 50-kDa protein, it also appears likely that CITFA2 exists as a monomer in the 
absence of LC8 binding in our extracts. Note that wild-type CITFA2-HA has a minor peak in 
fractions 8-9, likely representing a CITFA2 dimer and/or a CITFA2-LC8 heterotetramer. 
CITFA2 directly contacts BES promoter DNA and is required for promoter binding of 
CITFA in vivo. CITFA2 was shown to be of crucial importance to the initiation of transcription 
by RNA pol I from RRNA, BES and procyclin promoters, both in vivo and in vitro (Brandenburg 
et al., 2007). However, its specific function in the complex has not been determined. Early UV 
crosslinking of partially purified CITFA and radiolabeled BES promoter DNA resulted in a major 
labeled protein band of ~50 kDa (Brandenburg et al., 2007), which is the approximate size of 
CITFA subunits 1-3. Accordingly, depletion of CITFA1 in BFs caused a loss of CITFA3 
occupancy of RRNA and BES promoters, indicating that CITFA1 is important for the transcription 
factor’s ability to bind to RNA pol I promoters (Park et al., 2014). The BES promoter extends only 
to position -67 relative to the transcription initiation site (TIS) and harbors two distinct sequence 
elements (Pham et al., 1996; Vanhamme et al., 1995) both of which are required for efficient 
binding of CITFA to the BES promoter (Brandenburg et al., 2007). The two elements are separated 
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by 25 bp indicating that more than one CITFA subunit mediate DNA binding. Thus, to determine 
a potential DNA-binding role of CITFA2, we first used the sucrose gradient fractions of the 
purified CITFA complex (Figure II-2A), for a gel shift assay with an 82 bp-long radiolabeled BES 
promoter probe. Consistent with CITFA2 and LC8’s near absence from fraction 12 and their 
sedimentation peak in fraction 13 and 14, fraction 12 shifted the promoter only faintly (Figure II-
5A, arrow), while a strong shift signal was observed in fractions 13 and 14, indicating that CITFA2 
and LC8 are important for the ability of CITFA to bind the BES promoter. 
To better understand which CITFA subunits directly contact BES promoter DNA, we performed 
UV crosslinking using tandem affinity-purified CITFA from BFs that expressed PTP-CITFA7 
(Nguyen et al., 2012). Crosslinking this high purity eluate and a radiolabeled BES promoter 
revealed two specific protein bands in the 50-60 kDa range and a third band of ~40 kDa (Figure 
II-5, lane 3). Since the latter band was likely CITFA4, given that no other CITFA subunit is 40 
kDa, we repeated the experiment with a BF cell line that expressed CITFA4-PTP. After tandem 
affinity purification of a PTP-tagged protein, a ~4 kDa portion of the tag (ProtC) remains on the 
purified protein. Accordingly, in the CITFA4-PTP purification, the 40 kDa band shifted up 
(Figure II-5B, lane 2, CITFA4-P), unequivocally identifying CITFA4 as a direct contactor of 
promoter DNA. Likewise, using purified CITFA containing a PTP-tagged CITFA2 resulted in a 
shift of the uppermost crosslinked band, identifying CITFA2 as having direct DNA contact 
(Figure II-5B, lane 4, P-CITFA2). Since we have been unable to verify functional PTP tagging of 
CITFA1, we repeated this experiment with PTP-tagged CITFA3. A failure of tagged-CITFA3 to 
increase the size of any of the three bands (data not shown) makes it likely that CITFA1 is the 
third direct contactor of promoter DNA within the CITFA complex. 
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Figure II-5. CITFA2 directly contacts the BES promoter and is required for CITFA to bind to  
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(Figure II-5 legend cont.) RNA pol I promoters in vivo. (A) Sucrose gradient fractions of purified 
CITFA, shown in Figure II-2A, were used in an EMSA with a radiolabeled BES promoter that 
was visualized by autoradiography. Fraction 12, which contains minimal LC8 and CITFA and an 
abundance of other CITFA subunits, barely binds to the probe (arrow), while fractions 13-14, 
which contain an abundance of all CITFA subunits, effectively bound the promoter probe. (B) UV 
crosslinking analysis using tandem affinity-purified CITFA with radiolabeled BES promoter. 
After DNA digest, proteins were separated by SDS-PAGE and visualized by autoradiography. On 
the right, tagged and untagged CITFA subunits are identified. As explained in the text, the band 
that did not shift is putatively CITFA1 (put. CITFA1). (C) Anti-CITFA3 ChIP assay in a 
smCITFA2 cell line which was either not induced or in which PTP-CITFA2 was silenced for 2 
days. One and two asterisks represent P-values <0.05, <0.01, respectively.  
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To confirm the importance of CITFA2 to CITFA promoter binding in vivo, we analyzed 
CITFA occupancy at RRNA and BES promoters in non-induced BFs and in BFs in which CITFA2 
was silenced for two days. Since CITFA2 depletion did not affect the abundance of CITFA3 
(Figure II-5C, insert) and since absence of CITFA2 does not appear to disrupt the CITFA complex 
(see Figure 2A, fraction 12; Nguyen et al. 2012), we performed ChIP using a purified, ChIP-grade 
polyclonal anti-CITFA3 antibody (Park et al., 2014). Consistent with CITFA2 being a promoter 
binding protein, CITFA3 occupancy of BES promoters was completely lost upon CITFA2 
depletion (Figure II-5C). Although the CITFA3 occupancy of RRNA promoters was significantly 
reduced in the same experiments, CITFA3 association with RRNA promoters remained substantial. 
This might be due to structural differences between RRNA and BES promoters. In contrast to the 
short BES promoter, the RRNA promoter extends to position -257 relative to the TIS, harboring 
four distinct promoter domains (Janz and Clayton, 1994; Schimanski et al., 2004). Thus, it is 
possible that additional factors present at the RRNA promoter interact with CITFA and stabilize it 
in the absence of CITFA2. In either case, these data clearly demonstrate that CITFA2 is important 
for CITFA binding to both RRNA and BES promoters. 
LC8 depletion affects CITFA occupancy of RRNA and BES promoters. Finally, to verify that 
the recruitment failure of the CITFA2 NDel mutant to RNA pol I promoters is due to a loss of the 
CITFA2-LC8 interaction, we analyzed whether LC8 silencing affected CITFA occupancy of RRNA 
and BES promoters. Using the same cell line as in Figure II-1, we found a highly significant 
reduction in binding of CITFA3 to the BES promoter, despite the fact that LC8 silencing limited 
the analysis to one day of induction (Figure II-6). According to our observation that CITFA2 is 
less critical for CITFA3 occupancy of the RRNA promoter (see Figure II-5C), LC8 depletion 
affected RRNA promoter precipitation only modestly (Figure II-6). These results are consistent  
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Figure II-6. LC8 is required for recruitment of CITFA to the BES promoter. Anti-CITFA3 ChIP 
in smLC8 BFs without induction (ni) and after 1 day of LC8 silencing. Precipitated DNA was 
analyzed using the primer pairs previously noted. Three asterisks represent a P-value <0.001.  
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with the CITFA2-LC8 interaction being crucial for CITFA function and they verify LC8’s 
important role in multifunctional RNA pol I transcription in T. brucei. 
II-4. Discussion 
Here we have shown that LC8 has at least two essential functions in T. brucei, namely in cell cycle 
progression and, as part of CITFA, in RNA pol I transcription, which was the focus of this 
investigation. We found that LC8 directly interacts with the N-terminus of CITFA2, requiring a 
conserved N-terminal TQV motif for binding. Sedimentation of recombinant CITFA2-LC8 
complexes indicated that LC8 binding promotes the dimerization of CITFA2, resulting in a 
CITFA2-LC8 heterotetramer. Silencing of endogenous CITFA2 in conjunction with the expression 
of RNAi-resistant wild-type and mutant CITFA2 transgenes, revealed that the CITFA2-LC8 
interaction is essential for trypanosome viability in culture, specifically affecting the abundance of 
RNA pol I transcripts. Pursuing the specific defect in the RNA pol I system, we found that CITFA2 
is unable to bind promoter DNA or assemble with other CITFA subunits to form a complete CITFA 
complex in the absence of the CITFA2-LC8 interaction. Following up on a previous report which 
suggested a role for CITFA2 in promoter binding by CITFA (Brandenburg et al., 2007), we found 
that CITFA2, CITFA4 and, likely, CITFA1 directly contact promoter DNA. Accordingly, CITFA2 
silencing led to a defect in both RRNA and BES promoter binding of CITFA3, a result which was 
verified for the BES promoter by silencing LC8. These data suggest a model (Figure II-7) in which 
trypanosome LC8, by forming a dimer as in other organisms (Barbar et al., 2001; Benashski et al., 
1997), binds to the N-termini of two CITFA2 molecules, promoting or stabilizing their 
dimerization. Since CITFA2 and LC8 remain stably associated with the CITFA complex after 
tandem affinity purification and sucrose gradient sedimentation, even at 400 mM KCl (Figure II- 
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Figure II-7. Model of the CITFA2-LC8 interaction and function for BES promoter transcription. 
Formation of a CITFA2-LC8 heterotetramer is a prerequisite for its assembly into the CITFA 
complex. While a stable partial CITFA complex is formed without CITFA2-LC8, only a fully 
assembled CITFA complex that includes CITFA2 and LC8 is able to bind promoter DNA. The 
BES promoter, with its two sequence blocks essential for CITFA binding (yellow), is shown here 
along with the TIS. Please note that, for ease of visualization and understanding, LC8’s site of 
interaction with CITFA2 was not shown at its dimer interface, where it actually occurs. Promoter-
bound CITFA is able to, either directly or indirectly, recruit RNA pol I and enable transcription 
initiation. 
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2A; (Brandenburg et al., 2007; Nguyen et al., 2012); data not shown), it is likely that the full 
assembly of CITFA occurs independent of DNA. Finally, by contacting DNA directly through its 
CITFA2, CITFA4 and, likely, CITFA1 subunits, the transcription factor complex binds with high 
affinity to both elements of the BES promoter which, in turn, leads to RNA pol I recruitment and 
transcription initiation. Although we cannot exclude the possibility that CITFA2 dimerization 
leads to dimerization of the whole CITFA complex, the sedimentation profile of purified CITFA 
argues against this possibility. Consistent with an overall mass of CITFA of 323 kDa, which 
assumes a CITFA2-LC8 heterotetramer and monomers for all other subunits, full CITFA 
sedimented in-between the 150 and 444 kDa size markers (Figure II-2A). 
Our data and model are consistent with the view that LC8, rather than functioning as a linker 
between two different proteins, instead promotes homodimerization, thereby imparting new 
function (Barbar, 2008; Barbar and Nyarko, 2014, 2015; King, 2008). Is LC8 essential for CITFA2 
dimerization or does it rather stabilize a CITFA2 dimer by interacting with its predicted disordered 
N-terminus? Sedimentation analysis of recombinant CITFA2 and LC8 proteins (Figure II-2F) and 
of extracts containing NDel and 3Amut CITFA2-HA protein (Figure II-4D) suggested that in the 
absence of LC8, CITFA2 cannot form a dimer. However, when endogenous, wild-type CITFA2 
was depleted in trypanosomes, then NDel and 3Amut CITFA2 were co-lost (Figure II-3D) 
whereas the same proteins could be constitutively expressed in the presence of wild-type CITFA2 
(Figure II-4B). This stabilization of mutant CITFA2 by the wild-type protein suggests some 
degree of CITFA2 interaction in the absence of LC8. This finding is consistent with the 
demonstrated function of LC8 in structuring and stabilizing dimers of the human dynein 
intermediate chain (Nyarko et al., 2004; Williams et al., 2007); reviewed in (Barbar, 2008; Barbar 
and Nyarko, 2014), the Drosophila RNA-binding protein swallow (Kidane et al., 2013; Wang et 
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al., 2004), the human motor protein myosin Va (Hodi et al., 2006; Wagner et al., 2006), and the 
yeast nucleoporin Nup159 (Nyarko et al., 2013; Stelter et al., 2007). 
Given that some of LC8’s non-dynein binding partners, such as the human transcriptional 
repressor TRPS1 (Kaiser et al., 2003), estrogen receptor (Rayala et al., 2005; Rayala et al., 2006), 
and the NF-κB inhibitor IκBα (Jung et al., 2008) are involved in transcriptional regulation, and 
since proper B cell maturation was recently demonstrated to directly depend on the DYNLL1 
expression level (Jurado et al., 2012), it is worth considering if LC8 might be regulating 
multifunctional RNA pol I transcription in T. brucei. In accordance with this notion, our results 
indicated that depletion of CITFA2 (Figure II-5C) or LC8 (Figure II-6) affected CITFA3 
occupancy of the BES promoter more than that of the RRNA promoter, indicating that LC8 may 
have a specific role in BES transcription. However, CITFA2 was shown in vitro and in vivo to be 
essential for RNA pol I transcription initiating at RRNA, procyclin gene and BES promoters 
(Brandenburg et al., 2007). In addition, the LC8 binding site within CITFA2 is at least partially 
conserved among all kinetoplastids (Figure II-2D), including those which do not display antigenic 
variation and are not known to utilize RNA pol I for pre-mRNA synthesis, suggesting that if LC8 
does have a regulatory role for RNA pol I transcription, it is likely a general one. Nevertheless, the 
CITFA2-LC8 heterotetramer appears to have a crucial role in activating the CITFA complex. As 
previously determined, CITFA2 in BFs is expressed at about a fivefold lower level than CITFA7, 
indicating that the majority of CITFA complexes in a trypanosome are inactive, requiring binding 
of the CITFA2-LC8 heterotetramer for activation (Brandenburg et al., 2007; Nguyen et al., 2012). 
Thus, it is possible that formation of a productive CITFA2-LC8 heterotetramer is quantitatively 
controlled in the cell. It has been shown in other systems that phosphorylation of either LC8 or its 
binding partner can alter their interaction, ranging from minor changes in kinetics to a complete 
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elimination of binding (Benison et al., 2009; Gallego et al., 2013; Lei and Davis, 2003; Song et 
al., 2008; Song et al., 2007). This regulatory phosphorylation occurs at S88 in human LC8, which 
is conserved as S89 in the genus Trypanosoma (Figure II-S1B), allowing for such a regulation to 
exist. Furthermore, phosphorylation of CITFA2 at amino acid T6, one of the conserved residues 
in the LC8 binding motif, could also be used as a means to block LC8 binding, as is the case in 
Nek9, a kinase involved in mitotic progression (Gallego et al., 2013). 
Moreover, recent evidence suggests that CITFA is directly involved in the regulation of 
monoallelic VSG expression, which takes place outside the nucleolus in the so-called expression 
site body or ESB (Chaves et al., 1999; Navarro and Gull, 2001). ChIP assays consistently 
demonstrated that CITFA occupancy of the active BES promoter was several times higher than 
that of a silent BES promoter (Nguyen et al., 2014). Furthermore, the CITFA complex remained 
localized to the nucleolus and the ESB after depletion of CITFA1, which caused CITFA to 
dissociate from RRNA and BES promoters (Park et al., 2014). These results raised the possibility 
that sequestration of CITFA to the nucleolus and the ESB may be the trypanosomes’ means to 
restrict productive RNA pol I transcription to these compartments (Günzl et al., 2015). Since LC8 
has been implicated in sub-nuclear and sub-cellular localization of many of its binding partners 
(Barbar and Nyarko, 2014), sequestration or spatially controlled formation of CITFA2-LC8 may 
be a mechanism for localizing CITFA function. 
Although, an initial survey of CITFA sequences did not reveal a clear LC8 binding motif as 
originally defined in humans and yeast (Lo et al., 2001), the reasonable conservation of the LC8 
binding site within CITFA2 to the now more broadly defined consensus motifs (Rapali et al., 
2011a; Rapali et al., 2011b) suggests that it may be possible to bioinformatically identify other 
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kinetoplastid proteins that interact with LC8, shedding light onto additional roles of LC8 in this 
divergent group of organisms. 
Furthermore, our results add T. brucei to the list of pathogens that rely on LC8 for viability. 
LC8 silencing caused defects in both transcription and cytokinesis, and resulted in an extremely 
rapid death phenotype of cultured BF T. brucei that is rarely observed in this system. Although, to 
our knowledge, small molecule inhibition of LC8-ligand interactions have not been pursued so far, 
this may be a worthwhile anti-pathogenic strategy since LC8 knockdown in adult animals appears 
to not be lethal (Wang et al., 2014). 
In summary, this work is the first investigation of LC8 in any kinetoplastid organism, and 
reveals a novel use of LC8 in the basal process of transcription initiation by RNA pol I. It confirms 
the results from studies in other organisms regarding LC8’s binding motif and its role in protein 
dimerization, demonstrating that this function of LC8 is of ancient evolutionary origin. 
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II-5. Supplemental 
 
 
Table II-S1. Accession numbers of kinetoplastid CITFA2 genes 
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Figure II-S1. Kinetoplastids harbor two distinct, conserved LC8 genes. (A) Clustal Omega 
alignment of amino acid sequences (Sievers et al., 2011) deduced from TbLC8 (accession number 
Tb927.11.18680) and TbLC8dv (Tb927.11.320) coding regions. Identical and similar positions are 
indicated by asterisks and colons, respectively. Arginines and lysines, marking trypsin cleavage 
sites, are highlighted in green. The short common trypsin-derived peptide is marked by red Xs. (B) 
Multiple sequence alignment, carried out with the Clustal Omega server of the European 
Bioinformatics Institute (http://www.ebi.ac.uk/Tools/services/web/toolform.ebi?tool=clustalo) at 
default parameters, comprising DYNLL1 amino acid sequences from Homo sapiens (HsDYNLL1, 
accession number NP_001032584), Mus musculus (MmDYNLL1, NP_001001185), Gallus gallus 
(GgDYNLL1, XP_003642263), Xenopus tropicalis (XtDYNLL1, NP_001005077) and Danio 
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(Figure II-S1 legend cont.) rerio (DrDYNLL1, NP_998189), of DYNLL2 from the same 
organisms (HsDYNLL2, NP_542408; MmDYNLL2, NP_080832; GgDYNLL2, XP_004946822; 
XtDYNLL2, NP_001165079; DrDYNLL2, NP_956393), LC8 sequences from Drosophila 
melanogaster (DmLC8, NP_525075), Caenorhabditis elegans (CeDLC-1, NP_498422), 
Schizosaccharomyces pombe (SpDLC2, NP_594368), Arabidopsis thaliana (AtLC8, CAB46031) 
and from the kinetoplastids T. brucei (TbLC8), Trypanosoma vivax (TvLC8, TvY486_1100540 & 
TvY486_1100570), Trypanosoma cruzi (TcLC8, TCDM_13942), Leishmania major (LmLC8, 
LmjF.32.0230), Crithidia fasciculata (CfLC8, CfaC1_32_0390) and Bodo saltans (BsLC8, 
BS21670.1..pep & BS74770.1..pep), and divergent LC8 sequences from the same kinetoplastid 
organisms (TbLC8dv; TvLC8dv, TvY486_0034050; TcLC8dv, TcCLB.504109.24; LmLC8dv, 
LmjF.25.0260; CfLC8dv, CfaC1_28_0460; BsLC8dv, BS22550.1..pep). Positions with more than 
50% identity or similarity are highlighted in black or gray, respectively. (C) Phylogenetic Tree of 
the shown sequence alignment using the BIONJ neighbor-joining algorithm (Gascuel, 1997) with 
the Seaview version 4 software package (Gouy et al., 2010). Bootstrapping was performed with 
1000 replicates with values representing percentages. 
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Figure II-S2. LC8 silencing results in an increase in both cell size and DNA content. Ungated 
count data from one of three replicate experiments comparing non-induced (left) to 1 day induced 
(right) LC8 knockdown cells. The y-axis represents the per-cell DNA content, as measured by 
propidium iodide staining, while the x-axis represents the forward scatter area, or size, of the cells. 
Note the appearance of a third population of cells in the induced culture which exhibits an increase 
in both size and DNA content. Blue represents areas of low count density, while green, yellow, 
and red represent increasing densities of cells with a given value.   
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Chapter III 
A new strategy of RNA interference that targets heterologous 
sequences reveals CITFA1 as an essential component of class I 
transcription factor A in Trypanosoma brucei 
 
Abstract 
Conditional gene silencing by RNA interference in Trypanosoma brucei can be inconclusive 
if knockdowns are inefficient or have off-target effects. To enable efficient, specific silencing of 
single copy genes in mammalian-infective, bloodstream form trypanosomes, we developed a 
system that targets the heterologous and functional Trypanosoma cruzi U2AF35 3/ UTR (Tc3) or, 
alternatively, the sequence of the PTP tag which can be fused to any mRNA of interest. Two cell 
lines were created, single marker (sm)Tc3 and smPTP, which conditionally express Tc3 and PTP 
dsRNA, respectively. The system depends on manipulating both alleles of the gene of interest such 
that cells exclusively express the target mRNA as a fusion to one of these heterologous sequences. 
We have generated allele integration vectors in which the C-terminal part of a gene’s coding 
sequence can be fused to either heterologous sequence in a single cloning step. We first tested this 
system with CITFA7 which encodes a well-characterized subunit of the class I transcription factor 
A (CITFA), an essential factor for transcription initiation by RNA polymerase I. Targeting either 
Tc3 or PTP fused to the CITFA7 mRNA resulted in gene knockdowns that were as efficient and 
specific as targeting the endogenous CITFA7 mRNA. Moreover, application of this system to 
CITFA1, which could not be silenced by established methods, demonstrated that this gene encodes 
  
68 
  
an essential CITFA subunit that mediates binding of the transcription factor complex to RNA 
polymerase I promoters. 
III-1. Introduction 
Among kinetoplastid organisms, the tsetse borne, lethal human parasite Trypanosoma brucei 
allows for specific gene silencing through the RNA interference (RNAi) pathway (Kolev et al., 
2011; Ngo et al., 1998). This system is based on strong, conditional expression of a ~500 bp-long 
double-stranded (ds)RNA that targets a gene’s mRNA, and is available for both the insect-stage 
procyclic form (PF) and the mammalian-infective bloodstream form (BF) of the parasite (Wirtz et 
al., 1999). Given that direct transfection of dsRNA into cells is transient in nature and does not 
reach all cells in a sample (Ngo et al., 1998), conditional dsRNA expression from genome-
integrated vectors is the system of choice for gene silencing experiments in trypanosomes. The 
first step in developing such a system was the generation of trypanosomes expressing the bacterial 
tetracycline (Tet) repressor (TetR) that controlled tetracycline-inducible promoters (Wirtz and 
Clayton, 1995). Reproducible, tightly regulated Tet-inducible expression was originally 
established in trypanosomes that express the heterologous T7 RNA polymerase (pol) as well as 
TetR by a mutated T7 promoter (Wirtz et al., 1999). Two T. brucei brucei 427 cell lines were 
generated that have been widely used for RNAi experiments: the PF cell line 29-13 harboring the 
selectable NEO and HYG genes, which encode neomycin and hygromycin phosphotransferase, 
respectively, and the “single marker” (NEO) BF cell line (Wirtz et al., 1999). 
Several genome-integration vectors have been generated for Tet-inducible expression of gene-
specific dsRNA in T. brucei. The simplest vector type has opposing T7 promoters. Since gene 
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fragments can be cloned between the promoters in a single step, this type of vector, termed p2T7 
(LaCount et al., 2000) or pZJM (Wang et al., 2000), enabled the generation of RNAi libraries and 
a first successful forward genetic RNAi screen (Morris et al., 2002). However, the T7 promoters 
of these vectors, which are each regulated by a single TetR binding site, the Tet operator, were 
partially active even in the absence of tetracycline (Wang et al., 2000; Wirtz et al., 1999), which 
could be lethal to transformed trypanosomes in some cases. A more tightly regulated vector has 
been the stem-loop vector in which a target sequence is cloned in sense and antisense directions 
around a stuffer fragment (Bastin et al., 2000; Shi et al., 2000). In the original vector, the stem-
loop cassette is expressed from the strong EP1 procyclin gene promoter under the control of two 
Tet operators (Wirtz et al., 1999). Although it takes two to three cloning steps to produce a gene-
specific stem-loop construct, the tight regulation of its expression proved to be very useful in PFs 
(Tschudi et al., 2003). Procyclin is the major cell surface antigen of PFs and procyclin genes are 
highly expressed by virtue of a multifunctional RNA pol I which is recruited to the procyclin gene 
promoter (Günzl et al., 2003). However, since procyclin is not expressed in BFs and the procyclin 
promoter is several-fold less active in this life cycle stage (Biebinger et al., 1996), replacement of 
the procyclin promoter by a T7 promoter made the “pT7-stl” stem-loop construct more suitable 
for gene knockdowns in BFs; two Tet operators appear to be sufficient to minimize leakiness from 
the strong T7 promoter (Brandenburg et al., 2007). Recently established vectors that made 
conditional transgene expression in trypanosomes independent of T7 RNA pol revealed effective 
gene knockdowns in PFs (Sunter et al., 2012). Other vector improvements simplified the cloning 
procedure. The pQuadra system is based on a four component ligation assay and allows the 
generation of a stem-loop vector in a single cloning step (Inoue et al., 2005) whereas other 
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strategies made both dual T7 promoter and stem-loop construction compatible with the 
recombination-based Gateway® cloning system (Kalidas et al., 2011; Lacomble et al., 2009). 
In addition to different vector designs, the conditional gene silencing system in T. brucei has 
benefitted from several modifications. Since high T7 RNA polymerase levels appear to be toxic 
for trypanosomes, putting the expression of this enzyme under tetracycline control enhanced the 
success rate in obtaining PF cell lines that exhibited an inducible phenotype (Alibu et al., 2005). 
However, this modification did not generally improve the functionality of p2T7 constructs. 
Historically, the preferred genome integration site of inducible vectors has been the 
transcriptionally silent spacer of ribosomal RNA gene (RRNA) arrays. It appears that not all RRNA 
loci provide equal conditions for regulated dsRNA expression and, thus, a standard procedure has 
been to test several clonal cell lines to find the cells with the best knockdown efficiency. To avoid 
this position effect, Alsford et al. marked a specific RRNA locus such that vectors could be 
specifically and reproducibly targeted to this particular RRNA spacer, thereby reducing the 
variability of gene silencing experiments (Alsford et al., 2005). In an independent approach, 
Wickstead et al. found that targeting the p2T7 vector “p2T7-177” to a 177 bp-long, 
transcriptionally silent repeat region of trypanosome minichromosomes improved regulation of 
the T7 promoters (Wickstead et al., 2002). Nevertheless, despite these modifications and 
improvements, the RNAi-mediated gene knockdowns have remained inefficient in some cases. 
Furthermore, due to the need to express rather long dsRNA molecules, it is possible that siRNAs 
are produced that affect trypanosome proliferation by targeting the wrong RNA, causing a so-
called off-target effect. 
We have been using conditional gene silencing to characterize the T. brucei class I transcription 
factor A (CITFA) complex, which is indispensable for the multifunctional RNA pol I system in T. 
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brucei. This parasite uses RNA pol I to transcribe the RRNA array, as in all other eukaryotes, yet 
also employs it to express its major cell surface proteins - procyclins in PFs and variant surface 
glycoprotein (VSG) in BFs (Brandenburg et al., 2007; Nguyen et al., 2014; Nguyen et al., 2012). 
The latter is expressed from a single VSG gene, drawn from a large repertoire, in one of fifteen 40-
60 kb-long BF telomeric expression sites (BESs) (Hertz-Fowler et al., 2008). While trypanosome 
RRNA transcription is localized to the nucleolus, as in other eukaryotes, the active BES is 
transcribed outside this compartment (Chaves et al., 1998) in the DNase I-resistant expression site 
body, or ESB (Navarro and Gull, 2001). CITFA consists of the subunits CITFA1 to 7, which are 
conserved only among kinetoplastid organisms, and the dynein light chain DYNLL1 (also known 
as LC8). Data obtained thus far strongly indicate that CITFA is a promoter-binding transcription 
initiation factor: CITFA stably bound the BES promoter in gel shift assays and required both 
promoter elements for efficient binding, depletion or inhibition of CITFA resulted in a loss of 
transcription within 121-146 bp of the transcription initiation site, CITFA7 silencing strongly 
reduced promoter-proximal RNA pol I occupancy at RRNA repeats, and a genome-wide ChIP-seq 
analysis found CITFA7 occupancy within a BES to be restricted to the promoter region 
(Brandenburg et al., 2007; Nguyen et al., 2014; Nguyen et al., 2012). To analyze specific functions 
of individual subunits we have attempted to silence the expression of each subunit gene. Our 
previous results demonstrated that CITFA2 and CITFA7 are essential for RNA pol I transcription 
and trypanosome viability (Brandenburg et al., 2007; Nguyen et al., 2012). We also found that 
three of the eight subunits are required to maintain the integrity of the complex (TN Nguyen and 
A Günzl, unpublished results). However, we have been unable to generate an unambiguous 
CITFA1 knockdown. Although we targeted two different regions of the CITFA1 mRNA, the RNA 
levels were not significantly affected (data not shown). To circumvent this setback, we set out to 
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develop a generally applicable system in BFs for efficient and specific gene knockdowns that 
targets a heterologous sequence fused to the mRNA of interest. We herein demonstrate that the 3/ 
gene flank of the Trypanosoma cruzi U2AF35 gene (here abbreviated as Tc3) is functional in T. 
brucei, and that Tc3 can be specifically targeted when fused to a T. brucei mRNA. In addition, we 
show that the sequence of the composite PTP tag, consisting of a protein C epitope (ProtC), a TEV 
protease cleavage site, and tandem protein A domains (ProtA), is an equally good target for gene 
silencing. Employing this system, we were able to demonstrate that CITFA1 is an indispensable 
component of the CITFA complex and that it is required for CITFA to bind to the RRNA and BES 
promoters. 
III-2. Methods and Materials 
DNAs. pT7-CITFA7-stl (Nguyen et al., 2012) and pCITFA7-PTP-BLA (Nguyen et al., 2014) were 
described previously. For the generation of pT7-Tc3-stl, the entire 679 bp-long 3/ intergenic region 
of the T. cruzi U2AF35 gene (accession number TcCLB.510943.60; note that this gene has been 
annotated as U2AF26 instead of U2AF35), from position 703 to position 1,381 relative to the 
translation initiation codon, was amplified from T. cruzi genomic DNA and inserted into the pT7-
stl vector (Brandenburg et al., 2007) in a sense-stuffer-antisense arrangement according to a 
published protocol (Shi et al., 2000). A T924>C point mutation was introduced to remove an XbaI 
restriction site which would have interfered with the stem-loop cloning strategy. pT7-PTP-stl was 
generated analogously using the entire PTP coding sequence (498 bp) (Schimanski et al., 2005a). 
The cloning strategy required the removal of two MluI restriction sites which was achieved by 
introducing T153>C and T327>C point mutations. 
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The tagging vector pCITFA7-HA-Tc3-BLA (Figure III-S1) has two cassettes, a C-terminal 
tagging module and a selectable marker cassette. It is a direct derivative of pCITFA7-HA-BLA 
(Nguyen et al., 2012) and was obtained by replacing the T. brucei RPA1 3/ gene flank with Tc3 
using the vector’s XhoI and ClaI restriction sites. Furthermore, our tagging vectors are derived 
from pBluescript II SK+ which has a T7 promoter that, after integration into an endogenous allele, 
could lead to overexpression of downstream genes in T7 RNA polymerase-expressing sm BF and 
29-13 PF cells. We therefore removed 27 bp from pCITFA7-HA-Tc3-BLA beginning precisely at 
the T7 promoter and ending in the downstream KpnI restriction site. In the same way, we removed 
the T7 promoter from pCITFA7-PTP-BLA and termed the corresponding plasmid pCITFA7-PTP-
BLAv2 (Figure III-S2). pCITFA1-HA-Tc3-BLA was obtained from pCITFA7-HA-Tc3-BLA by 
replacing the CITFA7 sequence with 696 bp of the C-terminal CITFA1 coding region (position 
700 to position 1395) using the ApaI and NotI restriction sites. 
The following DNA oligonucleotides were used in semi-quantitative RT-PCR: 5/-
CCTACGGTGCAGCCATGCCGTTGG-3/ / 5/-TTCGGCACTGCCATATGCGAC-3/ (CITFA7 
coding sequence); 5/-CAATAACAGGAACAGCTGCACCAAG-3/ / 5/-
GAGGAAACTCAAGTGCATTG-3/ (Tc3); 5/-GTAGACAACAAATTCAACAAAG-3/ / 5/-
ATTTAGCTTTTTAGCTTCTGC-3/ (PTP). Oligonucleotides for VSG221, TFIIB and CITFA2 
amplification were previously described (Nguyen et al., 2012). Quantitative RT-PCR of CITFA1 
mRNA was carried out either with oligonucleotide pair 5/-
ATCGGATGTTGAGTCGCTGCGTTG G-3/ / 5/-AAAGTCATTCCATGCCACTGGAACC-3/ 
(CITFA1 coding sequence) or pair 5/-AATACGCCAG GCAGATTGATGC-3/ / 5/-
TTAAGCGTAGTCAGGTACGTCGTAAGG -3/ (CITFA7 coding / HS). BES and RRNA 
promoter consensus oligonucleotides and oligonucleotides specific to the TFIIB gene and the β-
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/α- tubulin intergenic region, used in qPCR, were previously specified (Nguyen et al., 2012; Park 
et al., 2011). 
Cells. BFs were cultured in HMI-9 medium as specified previously (Park et al., 2011). 
Transfections were done with 1-2 x 107 BF trypanosomes using the Amaxa Basic Parasite 
Nucleofector kit (Lonza). Specifically, trypanosomes were pelleted at room temperature at 1,500 
x g for 5 min and cell pellets were resuspended in 100 µl of Solution 1 containing 18% Supplement 
1. After mixing DNA (5 µg PCR product or 10 µg of plasmid DNA) into the resuspension, 
trypanosomes were electroporated using program X-001 on the Nucleofector 2b unit (Lonza). 500 
µl of pre-warmed HMI-9 medium was added immediately to the transfected cells which were then 
transferred to 50 ml of ~37°C warm medium. After allowing the cells to recover for 15 min at 
37°C, the cell culture was distributed into two 24-well plates. Trypanosomes were cultivated 
without antibiotic selection overnight after which additional medium containing selecting 
antibiotics was added to each well. Transfectants typically reached a transferrable cell density six 
to nine days later. Cells were cultured in 2.5 µg/ml G418, 1 µg/ml phleomycin and/or 2 µg/ml 
blasticidin. 
Cell lines C7HA-Tb3 and C7HA-Tc3 were obtained by transfecting wild-type BF 427 cells 
with PshAI-linearized plasmids CITFA7-HA-BLA and CITFA7-HA-Tc3-BLA, respectively. The 
basal BF cell lines for conditional expression of Tc3 or PTP dsRNA, smTc3 and smPTP, were 
obtained by transfecting sm cells with the EcoRV-linearized vectors pT7-Tc3-stl and pT7-PTP-
stl, respectively. These vectors were targeted to the transcriptionally silent RRNA spacer. 
smC7HA-Tc3 and smC7-PTP cell lines were generated by targeted integration of PshAI-linearized 
plasmids CITFA7-HA-Tc3-BLA and CITFA7-PTP-BLAv2, respectively, into the CITFA7 locus 
in the first step and by replacing in the second step the remaining CITFA7 wild-type allele with a 
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PCR product in which 100 bp of CITFA7 gene flanks surrounded the hygromycin 
phosphotransferase coding sequence. Cell line smC1HA-Tc3 was obtained analogously using the 
MfeI-linearized plasmid CITFA1-HA-Tc3-BLA. Correct DNA integrations were analyzed by 
PCR of genomic DNA with at least one oligonucleotide placed outside the cloned or amplified 
sequence (data not shown). 
For gene silencing experiments, dsRNA synthesis was induced with doxycycline, a more stable 
derivative of tetracycline, at 2 µg/ml. Cells were counted and diluted to 2 x 105 cells/ml daily. 
Antibodies and protein analysis. For the sedimentation analysis, extract was prepared from 
non-induced BFs and from CITFA1-silenced BFs as specified previously (Park et al., 2011). 100 
µl of extract was then loaded onto 4 ml 10-40% linear sucrose gradients, ultra-centrifuged and 
fractionated exactly as has been described (Brandenburg et al., 2007). Immunoblots of HA- and 
PTP-tagged proteins were probed with a rat monoclonal anti-HA antibody (Roche) and the mouse 
monoclonal anti-ProtC antibody HPC4 (Roche), respectively. Immune sera against CITFA7, 
TFIIB and U2A/ (also known as U2-40K) were described previously (Cross et al., 1993; Nguyen 
et al., 2012; Schimanski et al., 2006). To obtain recombinant CITFA3 for antibody production, the 
entire CITFA3 coding region was placed downstream of the glutathione S-transferase sequence in 
pGEX-4T-2 vector (GE Healthcare). Recombinant GST-CITFA3 was expressed in Escherichia 
coli strain BL21Star (DE3) and purified by glutathione affinity chromatography (GE Healthcare) 
following the manufacturer’s recommendations. Generation of anti-CITFA3 immune serum was 
achieved by immunization of female Sprague Dawley rats with purified GST-CITFA3 as detailed 
previously (Schimanski et al., 2006). Polyclonal anti-GST-CITFA3 antibodies were purified from 
rat immune serum through first pre-clearing the serum of antibodies that non-specifically interact 
with trypanosome proteins. This was done by separating whole cell lysates of a total of 4.5 x 108 
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wild-type PF trypanosomes in nine lanes on a 12% SDS-polyacrylamide gel. The gel was 
transferred to a PVDF membrane and blocked in Tris-buffered saline (TBS), pH 7.5, containing 
5% milk and 0.1% Tween20, for 2 hours. After washing twice in TBS the 50-55 kDa range of the 
membrane which contained CITFA3 was removed and the remaining membrane was incubated 
with 1 ml of antiserum and 9 ml of blocking solution at 4°C for 16 hours. 100 µg of recombinant 
GST-CITFA3 was then run on four different SDS-PAGE gels, which were then transferred and 
blocked as described above. The 70-80 kDa range of these four membranes, corresponding to size 
of GST-CITFA3, was excised, cut into small strips, and incubated with the pre-cleared antiserum 
and blocking solution mixture for 16 hours, at 4°C, with rotation. These membrane strips were 
washed three times with TBS, and then rinsed briefly one time with water. Antibodies were eluted 
by incubating the strips in 1 ml of 0.2 M glycine, pH 2.8, for 5 min. Eluted antibodies were then 
immediately quenched by adding 1 M Tris-HCl, pH 8.0, until the solution pH reached 7.5, after 
which bovine serum albumin was added to a final concentration of 1%. The purified antibody was 
aliquoted and stored at -20°C until use. 
RNA analysis. Total RNA was prepared by the hot phenol method as described previously 
(Nguyen et al., 2007). For the analysis of ribosomal (r)RNA, total RNA was separated in Reliant 
pre-cast 1.25% SeaKem Gold agarose RNA gels (Lonza), and rRNA was detected by ethidium 
bromide staining. Relative amounts of SL RNA and U2 snRNA were determined by primer 
extension of 10 µg of total RNA using the 5/-32P-end-labeled oligonucleotides SL-1394 and U2f 
(Günzl et al., 1992) and Superscript reverse transcriptase II (Invitrogen) according to the 
manufacturer’s specifications. Primer extension products were separated on denaturing 8% 
polyacrylamide-50 % urea gels and detected by autoradiography. For PCR analyses, total RNA 
was reverse transcribed with Superscript reverse transcriptase II and either oligonucleotide-dT or 
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random hexanucleotides (Roche). Semi-quantitative PCR was performed using cycle numbers 
which were empirically determined to be within the linear amplification range for each 
oligonucleotide pair. Oligonucleotide pairs used in qPCR were verified for their specificity and 
suitability by standard agarose gel electrophoresis. Additionally, for every round of qPCR 
reactions a melt curve analysis was included to ensure the amplification of only a single product, 
and linear regression analysis of a serial dilution of input material confirmed that the coefficient 
of determination (r2) was within the 0.98 to 1.0 range. 
Immunofluorescence microscopy. BF microscopy was carried out as published previously 
(Nguyen et al., 2012) except that coverslips with settled BF cells were incubated with a 1:100 
dilution of the affinity-purified, polyclonal rat anti-CITFA3 antibody, and were then, after 
washing, incubated with the 1:500 diluted anti-rat IgG antibody Alexa 488 (Invitrogen) and 4,6-
diamidino-2-phenylindol (DAPI) at a final concentration of 2 ng/µl. Imaging was performed using 
a Zeiss AxioVert 200 microscope and Zeiss Axiovision 4.6.3.0 software. CITFA3 localizations 
were captured using a FITC filter and a fixed exposure time of 6 s, while DAPI images were 
captured using a DAPI filter and a variable exposure time, which averaged 0.5 s. 
Chromatin immunoprecipitation (ChIP). Anti-CITFA3 ChIP assays, using the purified 
polyclonal anti-CITFA3 antibody, were performed with smC1HA-Tc3 cells that were either not 
induced or induced by doxycyline for 42 hour as recently described (Nguyen et al., 2014). In 
negative controls, chromatin was immunoprecipitated with a non-specific rat immune serum. The 
precipitated DNA was analyzed by qPCR using consensus oligonucleotides for the slightly varying 
copies of RRNA and BES promoters and an oligonucleotide pair specific for the β-/α- tubulin 
intergenic region. The percent immunoprecipitation (IP) was calculated relative to the input 
material and corrected by subtracting the percent IP of the negative control assays. 
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III-3. Results 
System outline. Our aim was to generate a system in which the same heterologous sequence can 
be functionally fused to any mRNA and provide a target for efficient and reproducible gene 
knockdown. In a first step, we would generate a single marker (sm) BF cell line that conditionally 
expresses dsRNA of a heterologous sequence (HS) without consequence on cell proliferation 
(Figure III-1). This smHS cell line would carry NEO used to generate sm cells (Wirtz et al., 1999) 
and the bleomycin resistance marker (BLE) as part of the stem-loop vector for conditional HS 
dsRNA expression. For a specific gene knockdown, the smHS cell line would be used in two 
consecutive transfections to enable specific knockdown of any single copy gene of interest, 
denoted here as gene X. In the first transfection, site-specific integration of a PCR amplification 
product of the hygromycin phosphotransferase coding region (HYG) surrounded by 5/ and 3/ flanks 
of gene X would lead to the knockout of one wild-type X allele while, in the consecutive 
transfection, targeted integration of plasmid X-HS-BLA (BLA stands for the selectable marker 
gene blasticidin-S deaminase) into the X locus would fuse the HS to gene X. The corresponding 
smX-HS cell line would exclusively express the X-HS fusion that can be targeted by doxycycline-
mediated induction of HS dsRNA synthesis (Figure III-1). 
The Trypanosoma cruzi U2AF35 3/ gene flank is functional in T. brucei. We speculated that a 
Trypanosoma cruzi 3/ gene flank could provide a HS in the form of a functional 3/ UTR because 
all trypanosomatids process their mRNAs by spliced leader (SL) trans splicing and 
polyadenylation (Günzl, 2010), making it likely that a T. cruzi gene flank is able to direct these 
RNA processing steps in T. brucei. At the same time, the T. cruzi intergenic sequences are 
divergent from their T. brucei counterparts and are unlikely to give rise to siRNAs that target  
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Figure III-1. Gene silencing system targeting a heterologous sequence (HS). The system is based 
on a single marker BF cell line that has been stably transfected with a stem-loop construct (sm-HS 
cell line) containing a doxycyline (dox)-inducible promoter for the expression of a heterologous 
dsRNA. In the absence of further genetic manipulations, induction of this dsRNA expression has 
no consequence on trypanosome proliferation. To enable a specific knockdown of any single copy 
gene X, two further consecutive transfections of smHS cells are necessary: one to eliminate an X 
allele by the hygromycin resistance marker (HYG), and one to integrate a plasmid into the 
remaining X allele which will fuse the HS to the X mRNA sequence. Doxycycline-induced (+ dox) 
expression of HS dsRNA will then target and destroy the X-HS mRNA hybrid. 
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T. brucei mRNAs. After comparing known T. cruzi 3/ UTRs (Brandao and Jiang, 2009) we chose 
to analyze the suitability of the 3/ UTR of the TcU2AF35 mRNA because its complete cDNA had 
been characterized, and the 3/ UTR length of 390 nt appeared to be sufficiently large for an efficient 
gene knockdown (Vazquez et al., 2003). Moreover, the complete intergenic region between 
TcU2AF35 (accession number TcCLB.510943.60, www.genedb.org) and its downstream neighbor 
TcCLB.510943.50, encoding putative delta-1-pyrroline-5-carboxylate dehydrogenase, is only 679 
bp long and should harbor all necessary RNA processing signals. Finally, U2AF35 encodes an 
essential RNA splicing factor that, in trypanosomes, is involved in the initial steps of the ubiquitous 
SL trans splicing process (Vazquez et al., 2009), which suggested that the TcU2AF35 3/ UTR 
could support a sufficient level of constitutive gene expression. 
We first tested the functionality of the TcU2AF35 3/ gene flank (Tc3) in T. brucei with the 
well-characterized CITFA7 gene. CITFA7 is an essential subunit of the CITFA complex and 
CITFA7 silencing in BFs led to clear defects in RNA pol I transcription, e.g. a decrease of the 
RNA pol I transcripts rRNA and VSG221 mRNA of the active VSG gene (Nguyen et al., 2012). 
Moreover, CITFA7 can be functionally tagged at the C-terminus and there is no haplo-
insufficiency effect after deleting one CITFA7 allele either in BFs or PFs (Nguyen et al., 2012). 
We generated two cell lines by targeting the integration of a plasmid to the endogenous CITFA7 
gene (Figure III-2A). In both cases, the HA tag sequence was fused 3/ to the CITFA7 coding 
region followed by the T. brucei (Tb)RPA1 3/ gene flank in the C7HA-Tb3 cell line or by the Tc3 
gene flank in the C7HA-Tc3 cell line. RPA1 is the largest subunit of RNA pol I. The TbRPA1 3/ 
gene flank is present in all our C-terminal tagging constructs and has supported the expression of 
a variety of factors such that the knockout of the remaining wild-type allele did not cause haplo- 
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Figure III-2. The 3/ gene flank and UTR of T. cruzi (Tc)U2AF35 are functional in T. brucei. (A) 
Schematic outline (not to scale) of the CITFA7 locus in control cell line C7HA-Tb3 and in cell 
line C7HA-Tc3. In both cell lines the HA tag sequence was fused to the CITFA7 coding region by 
targeted integration of the specified, linearized plasmid into one CITFA7 allele. The difference is 
that in C7HA-Tb3 and C7HA-Tc3 cells the manipulated CITFA7 allele is under the control of the 
T. brucei RPA1 (green) and the heterologous TcU2AF35 (red) 3/ gene flanks, respectively. The 
CITFA7 coding region, and the HA tag and BLA sequences are indicated by open, blue and black 
boxes, respectively. The smaller gray boxes surrounding BLA represent T. brucei gene flanks 
providing RNA processing signals. (B) Immunoblot of C7HA-Tb3 and C7HA-Tc3 whole cell 
lysates detecting CITFA7-HA with a monoclonal anti-HA antibody and, as a loading control, the 
transcription factor TFIIB with an anti-TFIIB polyclonal immune serum. Note that, due to 
phosphorylation, CITFA7 separates in multiple bands. 
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insufficiency phenotypes (Schimanski et al., 2005a). Accordingly, CITFA7-HA was easily 
detectable in C7HA-Tb3 cell lysates in multiple bands (Figure III-2B) that represent the various 
[un]phosphorylated forms of CITFA7 (Nguyen et al., 2012). In C7HA-Tc3 cells, Tc3 supported 
78% of the CITFA7-HA expression observed in C7HA-Tb3 cells (Figure III-2B). These results 
showed that, in T. brucei, the heterologous Tc3 sequence directed the processing of functional 
CITFA7-HA mRNA and the corresponding 3/ UTR supported an adequate level of CITFA7 
expression. 
Expression of Tc3 dsRNA does not affect BF trypanosome proliferation. Comparing the Tc3 
sequence to the T. brucei brucei Lister 427 genome returned a single, siRNA-sized stretch of 
identical sequence (27 bp) downstream of the non-syntenic gene Tb427.10.1000. Since this 
sequence motif was found only in a fraction of the heterogenous Tb427.10.1000 3/ UTRs 
(www.tritrypdb.org), we anticipated Tc3 dsRNA not to give rise to deleterious siRNAs. To test 
this, we inserted a stem-loop construct of the Tc3 sequence into the pT7-stl vector that has a 
tetracycline-inducible T7 promoter (Brandenburg et al., 2007). The vector, targeted to the 
ribosomal spacer, was transfected into BF sm cells which express both the tetracycline repressor 
and T7 RNA polymerase (Wirtz et al., 1999). Immediately after transfection, cells were cloned by 
limiting dilution. Three of the resulting cell lines were evaluated for their knockdown competence 
by transfecting them with the CITFA7-HA-Tc3-BLA construct and monitoring knockdown 
efficiencies on the RNA and protein levels (see below, and data not shown). Based on these results, 
one of the parent cell lines, termed smTc3, was chosen for all further experiments. As shown in 
Figure III-3A, induction of Tc3 dsRNA synthesis by doxycycline did not affect proliferation of 
smTc3 cells in culture, suggesting that no deleterious off-target effects occurred. 
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Figure III-3. Proliferation of smTc3 and smPTP cells is not affected by heterologous dsRNA 
expression. The smTc3 (A) and smPTP (B) cell lines are single marker BF cell lines in which 
stem-loop constructs were integrated into the RRNA spacer for inducible expression of Tc3 and 
PTP dsRNA, respectively. Addition of doxycycline to the medium did not inhibit cell proliferation 
in either cell line while it induced strong expression of Tc3 or PTP RNA, as analyzed by semi-
quantitative PCR of random hexamer-derived cDNA (inserts). 
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Generation of an alternative smPTP cell line. At this point, we considered testing a second 
heterologous sequence in parallel. We decided on the large PTP tag because we have utilized it 
repeatedly for tandem affinity purification (Schimanski et al., 2005a), indirect fluorescence 
microscopy (Park et al., 2011), and chromatin immunoprecipitation experiments (Lee et al., 2010; 
Park et al., 2011). The composite, heterologous PTP tag, designed for a modified tandem affinity 
purification approach (Schimanski et al., 2005a), comprises 166 amino acids and consists of 
human-derived ProtC (Stearns et al., 1988), a tobacco etch virus-derived protease cleavage site, 
and a tandem ProtA domain of Staphylococcus aureus (Rigaut et al., 1999). Importantly, the PTP 
tagging strategy has been based on integration of a PTP plasmid into an endogenous allele as 
shown in Figure III-1. Hence, we wanted to know whether the PTP tag sequence could be used 
as a target for efficient gene knockdowns as well. A bioinformatic analysis could not detect any 
sequence match longer than 18 bp between the PTP sequence and the T. brucei brucei 427 genome 
(data not shown). Analogously to cell line smTc3, we generated clonal smPTP cell lines that 
conditionally express PTP dsRNA. To pick the most efficient line for subsequent experiments, we 
determined PTP dsRNA levels before and after doxycycline induction by reverse transcription of 
total RNA using random hexamers and semi-quantitative PCR of the PTP sequence (Figure III-
3B and data not shown). Induction of PTP dsRNA by doxycycline in the chosen smPTP cell line 
did not affect trypanosome proliferation, again indicating that this heterologous dsRNA does not 
target vitally important endogenous T. brucei RNAs (Figure III-3B). 
The Tc3 3/ UTR and the PTP sequence are efficient knockdown targets. To test whether 
targeting either of the two HSs by RNAi leads to efficient gene knockdowns, we fused both of 
these sequences to the CITFA7 gene. As depicted in Figure III-1, this required two consecutive 
transfections of smTc3 and of smPTP cells so that they exclusively expressed CITFA7-HA mRNA 
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with the Tc3 3/ UTR and CITFA7-PTP mRNA, respectively. In the first transfection of smTc3 
cells, we integrated plasmid CITFA7-HA-Tc3-BLA into one of the two CITFA7 alleles and, in the 
second step, we eliminated the remaining CITFA7 allele by transfecting a PCR product (Arhin et 
al., 2004) that comprised the hygromycin phosphotransferase coding region surrounded by 100 
bp-long CITFA7 gene flanks (Figure III-4A). Three independently derived, clonal smC7HA-Tc3-
RNAi cell lines exhibited nearly identical growth defects upon induction of Tc3 dsRNA synthesis. 
As shown for one representative line in Figure III-4B, addition of doxycyline stopped culture 
growth after 24 hours and reduced the number of surviving trypanosomes within the next 48 hours. 
Since a very similar growth curve was obtained previously when CITFA7 mRNA was targeted 
directly in smC7 cells (Nguyen et al., 2012), this result suggested that targeting of the Tc3 3/ UTR 
resulted in effective depletion of CITFA7. 
Analogously to smC7HA-Tc3 cells, we generated the cell line smC7-PTP in which integration of 
plasmid pCITFA7-PTP-BLA fused the PTP sequence to the CITFA7 coding region in one CITFA7 
allele, and the hygromycin resistance marker replaced the remaining wild-type allele (Figure III-
4C). Again, inducing the synthesis of PTP dsRNA stopped proliferation of smC7-PTP cells after 
one day and led to cell death thereafter (Figure III-4D). Semi-quantitative RT-PCR analyses 
showed that CITFA7-HA, CITFA7-PTP and CITFA7 mRNA were strongly reduced after 1 day 
of induction in smC7HA-Tc3, smC7-PTP and smC7 cells, respectively (Figure III-4E). This 
reduction was observed despite the fact that the level of the control TFIIB mRNA increased in 
each of these experiments. As we have shown previously, silencing of CITFA subunit genes 
rapidly decreases the levels of RNA pol I transcripts in induced cells, including ribosomal RNA, 
the most abundant component in total RNA preparations, which in turn leads to relative increases 
of RNA pol II and III transcripts (Brandenburg et al., 2007; Nguyen et al., 2012). As anticipated  
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Figure III-4. Effective and specific CITFA7 silencing by targeting heterologous sequences.  
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(Figure III-4 legend cont.) (A) Schematic outline (not to scale) of the CITFA7 locus in 
smC7HA-Tc3 cells. One CITFA7 allele was replaced by the hygromycin resistance marker 
(HYG, yellow box) and the second CITFA7 allele modified by targeted integration of plasmid 
CITFA7-HA-Tc3-BLA. Coloring of boxes corresponds to the description in the legend of Figure 
2A. (B) Culture growth of a representative smC7HA-Tc3 cell line in the presence and absence of 
doxycyline. (C) Schematic outline (not to scale) of smC7-PTP cells in which integration of 
plasmid CITFA7-PTP-BLA fused the PTP sequence (cyan box) to the 3/ end of the CITFA7 
coding region. (D) Corresponding growth curve of a representative smC7-PTP cell line. (E) 
Semi-quantitative PCR analysis of oligo dT-primed and reverse transcribed CITFA7-HA, 
CITFA7-PTP, and CITFA7 mRNA in non-induced (n.i.) and one day induced trypanosomes of 
cell lines smC7HA-Tc3, smC7-PTP, and smC7, respectively. TFIIB mRNA was analyzed in 
parallel as a control. (F) Relative abundances of ribosomal RNA (rRNA) and of VSG221 and 
TFIIB mRNA were determined by ethidium bromide staining and semi-quantitative RT-PCR, 
respectively, in smC7HA-Tc3 and smC7-PTP cells that were non-induced or induced for one and 
two days. (G) Immunoblot detecting CITFA7-HA with an anti-HA antibody in smC7HA-Tc3 
cell lysates, CITFA7-PTP with an anti-ProtC antibody in smC7-PTP cell lysates, and wild-type 
CITFA7 with a polyclonal immune serum in smC7 cell lysates. Detection of TFIIB on the same 
blots served as a loading control. Cells were analyzed in their non-induced (n.i.) state or when 
they were grown in the presence of doxycycline for one and two days. 
  
  
88 
  
from these previous results, targeting the HSs that were fused to the CITFA7 mRNA led to a 
decrease of rRNA and of VSG221 mRNA from the active VSG gene (Figure III-4F). In addition, 
immunoblotting showed that the gene knockdowns led to a rapid loss of CITFA7 protein (Figure 
III-4G). Together, these results clearly demonstrated that the HS-targeted CITFA7 gene 
knockdowns were specific and efficient, affecting the abundance of RNA pol I transcripts in the 
same way as did silencing of CITFA7 by dsRNA of endogenous sequence, as previously shown 
(Nguyen et al., 2012). 
Tc3 3/ UTR mediated efficient CITFA1 silencing. Next, we applied this gene knockdown system 
to the CITFA1 gene, which we had not been able to silence efficiently thus far. Again, two 
consecutive transfections of smTc3 cells generated cell line smC1HA-Tc3 in which, after the 
knockout of one CITFA1 allele, targeted integration of plasmid CITFA1-HA-Tc3-BLA fused the 
HA sequence and the Tc3 gene flank to the remaining CITFA1 allele (Figure III-5A). In the 
absence of doxycyline smC1HA-Tc3 cells proliferated as fast as smTc3 cells, indicating that the 
Tc3 3/ UTR supported sufficient CITFA1 expression from a single allele and that the C-terminal 
HA tag did not impair the functionality of CITFA1 (Figure III-5B). Adding doxycyline to the 
medium was then similarly deleterious to trypanosome proliferation and viability as in the CITFA7 
knockdown: Trypanosome proliferation was affected one day after induction and trypanosome 
numbers started to decline after two days of induction (Figure III-5B). RT-qPCR analysis 
revealed that the Tc3-targeted knockdown reduced CITFA1 mRNA abundance relative to that of 
TFIIB mRNA by ~80% (Figure III-5C). Interestingly, we obtained slightly different results 
depending on which part of the cDNA was amplified. With oligonucleotides specific for the 
CITFA1 coding region, the reduction of CITFA1 mRNA was on average 77% whereas the 
reduction with an HS-  
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Figure III-5. Effective and specific CITFA1 silencing by targeting the TcU2AF35 3/ UTR. (A) 
Schematic outline (not to scale) of the CITFA1 locus in smC1HA-Tc3 cells. (B) Culture growth 
of a representative smC1HA-Tc3 cell line in the presence and absence of doxycyline. (C) RT-
qPCR analysis of CITFA1 mRNA in non-induced (n.i.) and one day induced trypanosomes. The 
oligo dT-derived cDNA was either amplified in the CITFA1 coding region (cod. region) or in the 
heterologous TcU2AF35 3/ UTR (heterologous seq.). CITFA1 mRNA abundance was normalized 
with that of TFIIB and its level in non-induced cells was set to 100 in each of three independent 
experiments. (D) Relative RNA abundances in total RNA preparations of non-induced cells and 
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(Figure III-5 legend cont.) of cells induced for 1, 2, or 3 days were analyzed by ethidium bromide 
staining (rRNA), semi-quantitative RT-PCR (VSG221, TFIIB and CITFA2 mRNA), or a primer 
extension assay (SL RNA, U2 snRNA). 
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specific oligonucleotide was 83%. Although this difference seems not that dramatic, we would 
like to point out that we have made similar observations with other gene knockdowns. 
Amplification of different parts of the reverse-transcribed mRNA revealed different knockdown 
efficiencies, with the targeted region typically resulting in the greatest reduction of mRNA 
abundance (AG laboratory, unpublished results). Further RNA analysis showed that, as expected, 
CITFA1 silencing decreased the abundance of the major RNA pol I transcripts rRNA and VSG221 
mRNA and, consequently, elevated the relative abundances of RNA pol II-synthesized TFIIB 
mRNA, CITFA2 mRNA and SL RNA, as well as that of the RNA pol III transcript U2 snRNA 
(Figure III-5D). Together, these results demonstrated that CITFA1 was efficiently and specifically 
silenced by targeting the Tc3 3/ UTR, identified CITFA1 as the third CITFA subunit that is 
essential for trypanosome viability in culture, and indicated that CITFA1 has an essential function 
in trypanosome RNA pol I transcription. 
CITFA1 is required for binding of the transcription factor complex to RNA pol I promoters. 
The analysis of specific functions of individual CITFA subunits has been hampered by the fact 
that amino acid sequences of CITFA subunits have not revealed functional motifs such as DNA 
binding domains. In addition, procedures intended to break up the complex into smaller functional 
units have failed thus far (data not shown). However, we recently found that depletion of CITFA7 
from cells resulted in the concomitant, rapid loss of other CITFA subunits within 2 days of CITFA7 
silencing, indicating that CITFA7 has a scaffold function and that the stability of CITFA subunits 
in trypanosomes depends on the integrity of the transcription factor complex (TN Nguyen and A 
Günzl, unpublished results). An immunoblot analysis of whole cell lysates showed that CITFA1-
HA was strongly depleted after 1 and 2 days of CITFA1 silencing (Figure III-6A). To assess the 
abundance of other CITFA subunits in these samples we used previously established immune sera  
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Figure III-6. CITFA1 is required for CITFA promoter binding in vivo.  
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(Figure III-6 legend cont.) (A) Immunoblot detecting the indicated CITFA subunits in whole 
cell lysates of non-induced cells (n.i.) and in cells in which CITFA1-HA was silenced for 1 or 2 
days (boxed panel) on the same blot. Detection of the spliceosomal U2A/ protein served as a 
loading control. (B) Sedimentation of extract by ultracentrifugation in a 10 to 40% linear sucrose 
gradient. Fractions 5 to 20, taken from top to bottom, were analyzed by immunoblotting. Note 
that the two CITFA1 blots were co-developed. For comparison, sedimentations of TEV protease 
(29 kDa), Taq DNA polymerase (95 kDa), IgG (150 kDa, 6.6S), the TRF4-SNAPc-TFIIA 
transcription factor complex (TST, 230 kDa), apoferritin (AP, 444 kDa, 17S), and thyroglobin 
(TG, 660 kDa, 19S) were analyzed in parallel gradients (arrowheads). Fractions with CITFA3, 6 
and 7 co-sedimentation peaks are indicated by red lettering and the shifted CITFA2 peaks by 
asterisks. (C) Immunoblot using the purified, polyclonal anti-CITFA3 antibody for detection of 
PTP-CITFA3 in PF PTPC3ee cells and untagged CITFA3 in PF and BF wild-type (WT) whole 
cell lysates. Loading was controlled by the detection of the RNA pol II transcription factor 
TFIIB. (D) Indirect immunofluorescence microscopy of CITFA3 in non-induced cells and cells 
in which CITFA1 was silenced for 42 hours. Nucleolar areas are indicated by white arrows. For 
the induced cells, an example was chosen in which the putative ESB was detected as an 
additional spot outside the nucleolus, bar: 5 µm. (E) Anti-CITFA3 ChIP experiments with non-
induced cells or with cells in which CITFA1 was silenced for one or two days. Occupancy by 
CITFA3 was determined by qPCR at RRNA and BES promoters and, as a control, at the β-/α- 
tubulin intergenic region (Tub). The percent precipitation was corrected by subtracting the 
percent precipitation from negative control precipitations using a comparable, non-specific 
immune serum. Each experiment including the negative control was carried out three times 
independently and differences in occupancy were statistically analyzed by a two-tailed, student’s 
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(Figure III-6 legend cont.) t-test assuming equal variance. Two asterisks indicate P-values that 
are <0.01. 
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against CITFA2, CITFA6 and CITFA7, and a newly generated polyclonal anti-CITFA3 antibody 
(see Figure III-6). The results demonstrate that, besides a minor reduction of CITFA2 on day 2, 
the CITFA subunits analyzed exhibited robust expression during the two-day-experiment 
suggesting that CITFA1, in contrast to CITFA7, is not required for overall complex integrity. To 
substantiate this notion, we analyzed the CITFA complex upon CITFA1 depletion by sucrose 
gradient sedimentation in which fractions were taken from top to bottom of the gradient (Figure 
III-6B). In non-induced cells the sedimentation profile was exactly as determined previously 
(Brandenburg et al., 2007; Nguyen et al., 2012): CITFA1, 3, 6, and 7 exhibited sedimentation 
peaks in fractions 13 and 14 while the less abundant CITFA2 peaked in fractions 14 and 15 shifting 
part of the complex one fraction down the gradient. Loss of CITFA1 decreased the sedimentation 
of CITFA2, 3, 6 and 7 by ~2 fractions (note that the sedimentation peak of the minor amount of 
detectable CITFA1 remained in fraction 13). However, the CITFA subunits still co-sedimented 
between the 6.6 S IgG marker (150 kDa) and the 230 kDa-large trypanosome TRF4-SNAPc-TFIIA 
transcription factor complex (Schimanski et al., 2005a). Since the CITFA complex without 
CITFA1 and without CITFA1 and 2 has a calculated mass of 221 kDa and 173 kDa, respectively, 
this result strongly indicates that CITFA1 depletion did not affect the integrity of the CITFA 
complex. Accordingly, a pull-down of CITFA3 in extract efficiently co-precipitated CITFA2, 6 
and 7 in both non-induced and CITFA1-depleted cells (Figure III-S3). 
The polyclonal anti-CITFA3 antibody was obtained by raising an immune serum in rats against 
a recombinant GST-CITFA3 fusion protein that was expressed in Escherichia coli and purified by 
glutathione affinity chromatography (data not shown), and by affinity purifying the antibody from 
serum with immobilized antigen. While the calculated molecular weight of CITFA3 is 47 kDa, the 
antibody recognized a single band of ~55 kDa in both BF and PF whole cell lysates (Figure III-
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6C). This band is the correct band because in cell lysates of the PF line PTPC3ee, expressing 
exclusively CITFA3 with an N-terminally fused PTP tag, the band shifted up by ~20 kDa, the size 
of the tag. Hence, the polyclonal antibody detected CITFA3 with high specificity. We therefore 
used this antibody for two further assays. Firstly, we analyzed CITFA3 localization in non-induced 
cells and in cells in which CITFA1 was silenced for 42 hours because there was a possibility that 
CITFA1 directs the CITFA complex to the nucleus or, within the nucleus, to the nucleolus and the 
ESB. We analyzed 70 randomly selected non-induced cells and 83 CITFA1-silenced cells in detail. 
In all cells CITFA3 exhibited subnuclear localization. In DAPI staining, the nucleolus becomes 
clearly visible as a spherical area of low DNA density resulting in a fainter DAPI stain (Daniels et 
al., 2012). In 93% of non-induced cells and in 86% of CITFA1-silenced cells, the CITFA3 signal 
was confined to the nucleolus (Figure III-6D). We also detected an additional, smaller 
extranucleolar spot in 11% and 6% of non-induced and induced cells, respectively (Figure III-
6D). This spot is likely the ESB, since we have shown previously that CITFA7 reliably colocalized 
with RNA pol I in an extranucleolar compartment of similar size and signal intensity (Nguyen et 
al., 2014; Nguyen et al., 2012). Since the vast majority of cells in this analysis exhibited CITFA3 
localization in the nucleolus independent of the CITFA1 knockdown, it appears that CITFA1 is 
not required for localizing the complex to the sites of RNA pol I transcription. 
Secondly, we conducted an anti-CITFA3 ChIP assay in non-induced and CITFA1-silenced 
cells (Figure III-6E). For the PCR analysis of precipitated DNA, we used consensus 
oligonucleotide pairs that recognize either all copies of the RRNA promoter or all BES promoters 
(Park et al., 2011). The antibody effectively precipitated RRNA promoter DNA whereas BES 
promoter DNA was enriched 7.8 fold less than the RRNA promoter. This was expected because 
we have recently obtained a similar result in anti-CITFA7 ChIPs due to the fact that CITFA 
  
97 
  
predominantly binds the promoter of the active BES and occupies promoters of silent BESs to a 
much lesser extent. This is in contrast to RRNA promoters which, according to a ChIP-seq analysis, 
appear to be generally occupied by CITFA (Nguyen et al., 2014). Hence, in this assay, most if not 
all RRNA promoters were precipitated while BES promoter enrichment was mainly restricted to 
the active BES. Independent of the enrichment efficiency, CITFA1 silencing reduced CITFA3 
occupancy of both promoter types. For the efficient RRNA precipitation, this reduction was highly 
significant (Figure III-6E). Since we showed that CITFA1 has no role in the formation of a stable 
CITFA complex or in localizing CITFA to the nucleolus, these results strongly indicate that 
CITFA1 has a specific function in binding of the complex to RRNA and BES promoters. 
III-4. Discussion 
We have established a system in BF T. brucei for specific and efficient gene silencing that is based 
on targeting a HS that is fused to the mRNA of a gene of interest. We have established two such 
HSs, namely the 3/ UTR of the T. cruzi U2AF35 gene and the coding sequence of the large PTP 
tag. The system is based on BF cell lines smTc3 and smPTP which inducibly express Tc3 and PTP 
hairpin RNAs, respectively. Two consecutive transfections are required to fuse the HS to the gene 
of interest in one allele and to eliminate the remaining allele. Although these transfections are time 
consuming, this system comes with distinct benefits. Since doxycycline did not alter the rate of 
proliferation of smTc3 and smPTP cell lines (Figure III-3) or affect trypanosome morphology as 
observed by light microscopy, it can be inferred that Tc3 and PTP dsRNA-derived siRNAs do not 
target genes that are important for trypanosome culture growth. Furthermore, since both of these 
cell lines have the regulatable stem-loop vector already integrated, an RRNA-specific position 
effect is highly unlikely. Moreover, the vectors pCITFA7-HA-Tc3-BLA (Figure III-S1) and 
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pCITFA7-PTP-BLAv2 (Figure III-S2) offer a straightforward cloning strategy for fusing the HS 
to the gene of interest. C-terminal coding sequences can be amplified and inserted into the ApaI 
and NotI restriction sites in a single step. The only requirement for successful targeting of the 
plasmid to an endogenous allele is a restriction site within the gene coding sequence that is 
surrounded by at least 100 bp of coding sequence on either side and can be used to linearize the 
plasmid. Since this system is based on targeting the same sequence independent of the gene of 
interest, we anticipate that it can provide unambiguous gene silencing data in those cases where 
targeting endogenous sequences was not successful or inefficient. Finally, it is likely that the 
system can be implemented in PF 29-13 cells as well. However, the knockout of wild-type alleles 
in 29-13 cells would have to be accomplished with the PURO marker instead of the HYG marker 
as shown in Figure III-1, because 29-13 cells already harbor HYG. 
The system also has its limitations, however. Firstly, it can only be applied to single copy genes 
because it is obligatory to produce a cell line that exclusively expresses the mRNA of interest as a 
HS fusion and no wild-type mRNA. Secondly, the system, as presented here, will not function if 
the expression of both alleles is required for trypanosome viability and proliferation. It should be 
noted, though, that we have so far generated many viable BF and PF cell lines which expressed 
various essential nuclear proteins exclusively as PTP fusions from a single allele. This has included 
RNA pol subunits, various transcription and RNA splicing factors, and kinases, suggesting that 
haplo-insufficiency rarely affects trypanosome viability in culture (see for example references 
(Badjatia et al., 2013; Lee et al., 2010; Li et al., 2008; Luz Ambrosio et al., 2009; Nguyen et al., 
2007). If haplo-insufficiency is a concern, it may be possible to integrate one HS plasmid into each 
endogenous allele instead of knocking one allele out. For this, the blasticidin marker gene has to 
be replaced with the puromycin marker which can be achieved by a single PCR amplification and 
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cloning step, since either the selectable marker cassettes or the coding region can be excised by 
restriction digests (Figures III-S1 and III-S2). Thirdly, the HS may negatively affect the 
expression of the mRNA or the functionality of the resulting protein. If the tag interferes with the 
function of the protein there are two options. The PTP tag can be fused to the N-terminus with our 
published pN-PURO-PTP vector (Schimanski et al., 2005a). Although in the N-terminal PTP tag 
the ProtA and ProtC domains have a different N- to C-terminal sequence order, the PTP dsRNA 
produced in smPTP cells effectively silenced a CITFA2 gene in which the PTP tag sequence was 
inserted after the initiation codon (JK Kirkham and A Günzl, unpublished data). Alternatively, Tc3 
can be employed without the HA tag, which was used here to enable specific detection of the 
protein translated from the fusion mRNA. In this case the 27 bp-long HA coding sequence needs 
to be removed from pCITFA7-HA-Tc3-BLA. Furthermore, if the gene of interest produces a 
mRNA whose regulation through its 3/ UTR is critical for cell viability, then replacing it either 
with Tc3 or with the T. brucei RPA1 3/ UTR in pC-PTP-BLA may be deleterious. In this case 
tagging the protein N-terminally with the PTP tag or replacing the RPA1 3/ gene flank with that of 
the gene of interest in pC-PTP-BLA may be a solution. 
Recently, a conditional gene knockout system has been established in T. brucei that employs 
Cre recombinase and loxP sites (Kim et al., 2013a; Kim et al., 2013b). As with our approach, this 
system requires the manipulation of both gene alleles, e.g. it also depends on two consecutive 
transfection steps. This system offers instantaneous removal of the gene of interest in the genome 
and an unambiguous assessment of gene essentiality. However, in contrast to our system, this 
approach is irreversible, preventing the analysis of temporary gene knockdowns or the titration of 
the gene silencing level. 
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Finally, we have successfully employed this new gene silencing approach to evaluate 
CITFA1’s role in the CITFA complex. We could unambiguously show that CITFA1 is essential 
for BF viability in culture and, as expected, has a vital role in rRNA and VSG mRNA expression. 
After CITFA2 and CITFA7, this is the third CITFA subunit whose knockdown led to rapid 
trypanosome death in culture, underscoring the indispensability of this transcription initiation 
factor for trypanosome viability. Furthermore, we showed that CITFA1 depletion strongly reduced 
CITFA occupancy at RRNA and BES promoters. Since we could not detect mislocalization of 
CITFA3 or the loss of CITFA subunits that are indicative of complex disruption as a consequence 
of CITFA1 silencing, it appears that CITFA1 has a direct role in binding to promoter DNA. Most 
interestingly, CITFA3 remained localized to the nucleolus/ESB after CITFA1 knockdown, which 
suggests that subnuclear CITFA localization is not mediated by its binding to DNA. This finding 
further supports a recently described model in which DNA-independent concentration and 
confinement of CITFA to the nucleolus and ESB restricts maximal transcription initiation by RNA 
pol I to these compartments (Nguyen et al., 2014). 
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III-5. Supplemental  
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Figure III-S1. Plasmid CITFA7-HA-Tc3-BLA. (A) Plasmid map drawn to scale. The plasmid is 
a derivative of pBluescript II SK+. Two gene cassettes were introduced in tandem. The first 
cassette comprises the Trypanosoma brucei CITFA7 C-terminal coding region (white box) fused 
to the HA tag (blue), followed by a stop codon and the Trypanosoma cruzi U2AF35 3/ gene flank 
(Tc3; red). The second cassette harbors the coding region of blasticidin-S deaminase (BLA, black) 
flanked by the intergenic region of the T. brucei heat shock protein 70 genes 2 and 3 (H23, gray) 
(Lee, 1996) and the T. brucei β-/α-tubulin intergenic region (T, gray). Note that the vector was 
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targeted for integration into the CITFA7 gene by linearizing it inside the CITFA7 sequence with 
PshAI. To use this vector for other genes, the CITFA7 sequence needs to be replaced with the C-
terminal coding sequence of a gene of interest using the KpnI/ApaI and NotI restriction sites. This 
sequence must also have a linearization site which should be surrounded by a minimum of 100 bp 
of gene sequence on either side. Furthermore, if the new sequence does not contain an NdeI 
restriction site, as the CITFA7 sequence does, then, if desired, the BLA resistance marker may be 
replaced using the NdeI and BstBI restriction sites. (B) Nucleotide sequence of the plasmid. 
Highlighting of inserted sequences corresponds to the map. The CITFA7 sequence is italicized. 
Important restriction sites and the stop codon following the HA sequence were highlighted in 
yellow and pink, respectively. 
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Figure III-S2. Plasmid CITFA7-PTP-BLAv2. (A) Plasmid map drawn to scale. The plasmid 
corresponds to pCITFA7-HA-Tc3-BLA described above except for the tagging cassette in which 
the CITFA7 sequence (white) is fused to the PTP tag sequence (cyan) via a NotI restriction site, 
followed by a stop codon and the T. brucei RPA1 (accession number Tb927.8.5090 at 
www.TriTrypDB.org) 3/ gene flank (gray). (B) Nucleotide sequence of the plasmid. The RPA1 
sequence is presented in white lettering with dark gray highlighting to distinguish it from the H23 
and T sequences. 
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Figure III-S3. Anti-CITFA3 co-immunoprecipitation. CITFA3 was immunoprecipitated in 
extract prepared from non-induced bloodstream form trypanosomes or from cells in which CITFA1 
was silenced for 2 days. Extract, supernatant (SN) and immunoprecipitate (IP) were analyzed by 
immunoblotting. x-Values indicate relative amounts loaded. A control (Ctrl) elution of protein G 
bead-coupled antibodies was carried out to detect IgG contamination. CITFA2, CITFA6, CITFA7 
and, as a negative control, TFIIB were detected with polyclonal immune sera on the same blot. 
Asterisks indicate the CITFA2 band just above the IgG contamination. Although CITFA3 was 
detected in a different gel that better separates proteins in the 50 kDa range, the CITFA3 signal in 
the precipitate was not distinguishable from that of the IgG heavy chain. Nonetheless, this 
experiment demonstrates that CITFA1 silencing did not affect the association of CITFA2, 
CITFA6, and CITFA7 with CITFA3 indicating that the CITFA complex remained intact upon 
CITFA1 depletion.   
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Chapter IV 
Transcription by the multifunctional RNA polymerase I in 
Trypanosoma brucei functions independently of RPB7 
 
Abstract 
Trypanosoma brucei has a multifunctional RNA polymerase (pol) I that transcribes ribosomal gene 
units (RRNA) and units encoding its major cell surface proteins variant surface glycoprotein (VSG) 
and procyclin. Previous analysis of tandem affinity-purified, transcriptionally active RNA pol I 
identified ten subunits including an apparently trypanosomatid-specific protein termed RPA31. 
Another ortholog was identified in silico. No orthologs of the yeast subunit doublet RPA43/RPA14 
have been identified yet. Instead, a recent report presented evidence that RPB7, the RNA pol II 
paralog of RPA43, is an RNA pol I subunit and essential for RRNA and VSG transcription in 
bloodstream form trypanosomes (Penate et al., 2009, EMBO Rep. 10:252-257). Revisiting this 
attractive hypothesis, we were unable to detect a stable interaction between RPB7 and RNA pol I 
in either reciprocal co-immunoprecipitation or tandem affinity purification. Furthermore, 
immunodepletion of RPB7 from extract virtually abolished RNA pol II transcription in vitro but 
had no effect on RRNA or VSG ES promoter transcription in the same reactions. Accordingly, 
chromatin immunoprecipitation analysis revealed cross-linking of RPB7 to known RNA pol II 
transcription units but not to the VSG ES promoter or to the 18S rRNA coding region. Interestingly, 
RPB7 did crosslink to the RRNA promoter but so did the RNA pol II-specific subunit RPB9 
suggesting that RNA pol II is recruited to this promoter. Overall, our data led to the conclusion 
that RNA pol I transcription in T. brucei does not require the RNA pol II subunit RPB7. 
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IV-1. Introduction 
Trypanosoma brucei has a multifunctional RNA polymerase (pol) I that transcribes the large 
ribosomal (RRNA) gene unit in all life cycle stages, and, uniquely, the telomeric expression site 
encoding the active variant surface glycoprotein (VSG) gene in its bloodstream form (BF) as well 
as gene units encoding procyclin in its procyclic form (PF). BFs evade the mammalian immune 
response by antigenic variation of their cell surface coat consisting of ~10 million identical VSG 
molecules expressed from a single gene. The variation occurs when parasites switch to the 
expression of a different VSG gene drawn from a large VSG gene repertoire (recently reviewed in 
(Horn and McCulloch, 2010)). Expression of the whole VSG coat from a single gene requires 
extremely high expression levels and it has been determined that the transcription rate of the active 
VSG gene is approximately 50 times higher than that of a β tubulin gene (Ehlers et al., 1987). Such 
high rates are the hallmark of RNA pol I transcription which in general accounts for more than 
50% of the transcriptional activity in a eukaryotic cell (Russell and Zomerdijk, 2005; White, 2008). 
However, utilization of RNA pol I for protein coding gene expression requires a deviating mode 
of gene expression. In the mouse, strong RRNA promoter-driven transcription of a reporter 
construct, led to reporter enzyme activities which were 20-50fold lower than in a control 
experiment with an RNA pol II promoter (Grummt and Skinner, 1985). Conversely, RRNA 
promoter-driven expression of a selectable marker gene in T. brucei increased parasite resistance 
around 30fold over RNA pol II-mediated expression of the same gene demonstrating that, in 
trypanosomes, RNA pol I can efficiently synthesize functional mRNA (Rudenko et al., 1991; 
Zomerdijk et al., 1991a). The opposite outcomes in these studies are most likely due to different 
modes of mRNA capping. In the budding yeast Saccharomyces cerevisiae and higher eukaryotes, 
RNA capping is co-transcriptional and specifically linked to RNA pol II because the capping 
enzymes bind to the phosphorylated carboxy-terminal domain (CTD) of the largest RNA pol II 
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subunit RPB1 (Bentley, 2005). Conversely, in trypanosomes and related organisms, protein-
coding gene transcription is polycistronic and individual mRNAs are processed from precursors 
by spliced leader (SL) trans splicing and polyadenylation. Since in trans splicing the capped SL, 
comprising the 5/-terminal part of the small nuclear SL RNA, is transferred to the 5/ end of each 
mRNA, this process constitutes a post-transcriptional capping mechanism that decouples capping 
from RNA pol II transcription (Günzl, 2010). 
Eukaryotic RNA pols I-III consist of twelve subunits which are either shared or paralogous 
to each other. In addition, yeast RNA pol I contains two RNA pol I-specific subunits, RPA49 and 
RPA34, which are not essential for yeast proliferation. The multifunctional nature of trypanosome 
RNA pol I has spurred the investigation of this enzyme. While the largest two subunits, RPA1 and 
RPA2, were discovered first (Jess et al., 1989; Schimanski et al., 2003; Smith et al., 1989), eight 
of the remaining ten core subunits could be identified bioinformatically after the T. brucei genome 
was completed (Kelly et al., 2005). The missing subunits were the orthologs of yeast RPA43 and 
RPA14. Since these two subunits form a functional doublet in yeast and humans, it was proposed 
that trypanosome RNA pol I may assemble the paralogous RNA pol II subunits RPB7 
(GeneDB/TritrypDB accession number Tb11.01.6090) and RPB4 (Tb927.3.5270) instead (Kelly 
et al., 2005), possibly to aid this polymerase in the synthesis of functional mRNA. This was an 
attractive hypothesis because the respective genes were readily detected in trypanosomatid 
genomes and because RPB4/7 analysis in other systems indicated specific functions of this protein 
doublet in RNA synthesis such as binding of an RNA processing factor (Mitsuzawa et al., 2003), 
direct RNA interaction (Újvári and Luse, 2005), and linking mRNA synthesis to mRNA decay 
(Lotan et al., 2007). Moreover and most recently, the RPB4/7 doublet was characterized as a 
potential “mRNA coordinator” in yeast that can be deposited on mRNA facilitating efficient 
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translation and thereby linking expression outcomes from gene transcription to translation (Harel-
Sharvit et al., 2010). 
Based on co-immunoprecipitation assays, RPB7 expression silencing experiments, co-
localization of RPB7 and the RNA pol I-specific subunit RPB6z (Tb11.03.0935), and in vitro 
transcription assays in BFs, Penate et al. recently concluded in their publication title that “RNA pol 
II subunit RPB7 is required for RNA pol I-mediated transcription in Trypanosoma brucei” (Peñate 
et al., 2009). However, tandem affinity purification of trypanosome RNA pol I in two different 
laboratories did not identify RPB7 as a co-purifying subunit (Nguyen et al., 2007; Nguyen et al., 
2006; Walgraffe et al., 2005). Moreover, isolation of RNA pol I from PF extract that was active in 
both non-specific and promoter-dependent transcription assays did not reveal a protein band of 
~20 kDa which is the apparent size of T. brucei RPB7 (Nguyen et al., 2007). This was of particular 
concern because RPB7 and its RNA pol I and III paralogues RPA43 and RPC25 were shown in 
yeast to be essential for promoter-dependent transcription initiation (Edwards et al., 1991; 
Peyroche et al., 2000; Zaros and Thuriaux, 2004). We therefore revisited the role of T. brucei 
RPB7 in RNA pol I transcription omitting RPB7 expression silencing which may affect gene 
expression independently of RNA pol function or may rapidly lead to secondary defects through 
a general shut-down of RNA pol II transcription. 
IV-2. Methods 
DNAs 
For the generation of BF cell lines that exclusively expressed RPB7 or RPB9 with a C-
terminal fusion of the composite PTP tag sequence, encoding tandem protein A (ProtA) domains, 
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a tobacco etch virus (TEV) protease site and the protein C epitope (ProtC), plasmids RPB7-PTP-
NEO and RPB9-PTP-NEO were first integrated into endogenous alleles. The plasmids were 
generated by inserting, respectively, 549 bp and 385 bp of the RPB7 and RPB9 (Tb11.02.5180) C-
terminal coding regions into pC-PTP-NEO (Schimanski et al., 2005b) using ApaI and NotI 
restriction sites. For pRPB9-PTP-NEO linearization, an AflII restriction site was engineered into 
the RPB9 sequence creating a silent mutation in RPB9 codon 58. In a second round of stable 
transfections, the remaining wild-type RPB7 and RPB9 alleles were knocked out by transfection 
of 10 µg of a chimeric linear DNA in which 100 bp-long gene flanks were fused to the coding 
region of the hygromycin phosphotransferase by standard PCR as described previously (Arhin et 
al., 2004). pRPB7-HA-BLA was created by pasting the RPB7 target sequence from pRPB7-PTP-
NEO into the published plasmid pRPA31-HA-BLA (Nguyen et al., 2007). For transfections, 
pRPB7-PTP-NEO/pRPB7-HA-BLA, pRPB9-PTP-NEO, and pPTP-RPB6z-PURO were 
linearized with restriction enzymes PmeI, AflII, and BmgBI, respectively. pPURO-PTP-RPB6z 
and transcription templates Rib-trm, VSG-trm, and SLins19 were described previously (Laufer et 
al., 1999; Nguyen et al., 2007). 
The following oligonucleotide pairs were used in semi-quantitative and quantitative (q)PCR 
analyses of DNA obtained in chromatin immunoprecipitation (ChIP) assays: consensus VSG ES 
promoter, 5/-TCTAAAAGAATCATATCC-3//5/-AAGCGTAGATGAGATTAAAGTC-3/; 
consensus RRNA promoter, 5/-AATACAACACACAATAGG-3//5/-
GTCTGAGAGCGGTCAGTTGC-3/; 18S rRNA coding region; 5/-
TCATCAAACTGTGCCGATTAC-3//5/-CTATTGAAGCAATATCGG-3/; SLRNA promoter, 5/-
CTACCGACACATTTCTGGC-3//5/-GCTGCTACTGGGAGCTTCTCATACC-3/; β-α tubulin 
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intergenic region, 5/-GCTGATTTCTGACAGATCTTCAAAC-3//5/-
GTGGATGCAGATAGCCTCACGCATG-3/. 
Cells 
PF and BF of Trypanosoma brucei brucei strain 427 were cultured as described previously 
(Günzl et al., 2000; Hirumi and Hirumi, 1989). Transfected cells were cloned by limiting dilution 
immediately after electroporation. BFs were selected with 2.5 µg/ml of G418, 1 µg/ml of 
hygromycin, and 2 µg/ml of blasticidin whereas PFs were selected with increasing antibiotic 
concentrations ranging from 15 to 40 µ/ml of G418 and from 10 to 20 µg/ml of hygromycin. DNA 
integrations were confirmed in each clonal cell line by PCR of total DNA using oligonucleotides 
that hybridize outside the cloned region. Protein tagging for each clonal cell line was confirmed 
by immunoblotting. 
Protein Analysis 
Tandem affinity purification of PTP-tagged RPB7 (RPB7-PTP) was carried out exactly as 
specified in the standard protocol (Schimanski et al., 2005b). Purified proteins were separated on 
a 10–20 % SDS–polyacrylamide gradient gel and detected with Pierce Gelcode Coomassie blue 
stain. The same protocol was used for the preparation of active RNA pol II, with the PTP tag fused 
C-terminally to subunit RPB9. However, in this purification the enzyme was kept on the anti-ProtC 
beads and not eluted. The beads were stored at -20°C until used in in vitro transcription assays. 
Co-immunoprecipitation assays were carried out with 100 μl of crude cell extract 
corresponding to 4 × 108 BF cells. PTP-RPB6z was precipitated with 40 μl settled volume of 
human IgG beads (GE Healthcare) which bind the ProtA domains of the PTP tag. RPB7-HA was 
precipitated with a rat monoclonal anti-HA antibody (Roche) that we bound to paramagnetic 
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protein G beads (GE Healthcare) to avoid a non-specific interaction of this antibody with the ProtA 
domains. After one hour on ice, the supernatant was taken off and the precipitate washed seven 
times with 700 µl of TET100 buffer (100 mM NaCl, 20 mM Tris pH 8.0, 3 mM MgCl2, 0.1% 
Tween 20). Precipitated PTP-RPB6z was eluted by resuspending the beads in 45 µl of TEV 
protease buffer (150 mM KCl, 20 mM Tris pH 7.7, 3 mM 1M MgCl2, 0.5 mM EDTA, 1 mM 
dithiothreitol [DTT], 0.1 % Tween 20) containing 40 units of AcTEV protease (Invitrogen) and by 
an incubation of the protease digest at 28°C for 30 min. Eluted proteins were mixed with 15 µl of 
4x standard SDS loading buffer and boiled for 10 min. Anti-RPB7-HA precipitates were directly 
released into SDS loading buffer. 
In immunoblots, PTP-tagged proteins were probed with the mouse monoclonal anti-ProtC 
antibodyHPC4 (Roche) in the presence of 1 mM CaCl2 and HA-tagged proteins with a rat 
monoclonal anti-HA antibody (Roche). Protein detection was achieved with peroxidase-labeled 
anti-mouse or anti-rat IgG secondary antibody (Vector Laboratories) in combination with the BM 
chemiluminescence blotting substrate (Roche) according to the manufacturer's protocol. 
Previously published antisera were used to detect the two largest RNA pol I subunits RPA1 and 
RPA2 (Schimanski et al., 2003) whereas for RPB1 detection a polyclonal anti-RPB1 immune 
serum was raised in rat against an Eschericha coli-expressed GST fusion protein comprising RPB1 
residues 1424 to 1766 according to a published procedure (Brandenburg et al., 2007). 
Chromatin Immunoprecipitation 
For each ChIP experiment, 1 x 108 bloodstream trypanosomes were fixed with formaldehyde 
and washed as published (Lee et al., 2006). Cells were sonicated in a Bioruptor UCD-200 
(Diagenode) for a total of 25 min (30 s on/30 s off) at 4 °C, with pulse setting on “high”. Following 
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a 10-min centrifugation at 25,000g and 4 °C to pellet cell debris, the supernatant was pooled and 
chromatin pre-cleared with antibody-free, bovine serum albumin-blocked ProtA Dynabeads 
(Invitrogen) for 1 hour at 4 °C while rotating. For immunoprecipitation of PTP-tagged proteins, 
0.75 ml of chromatin solution was incubated overnight at 4 °C with either a rabbit polyclonal anti-
ProtA antibody (Sigma) or a nonspecific rabbit immune serum as negative control. Sodium 
chloride was then added to a final concentration of 350 mM and the chromatin was captured with 
ProtA Dynabeads for 40 min at 4 °C. Subsequent washing of the beads and DNA preparation 
through RNase and proteinase K treatments were carried out as detailed previously (Lee et al., 
2010). In a final step, the DNA was purified using a MinElute kit (Qiagen) and eluted in 20 μl of 
water. 
The DNA was analyzed by standard qPCR assays using the SsoFast EvaGreen Supermix 
(BioRad) on a CFX96 cycler (BioRad) according to the manufacturer’s recommendations. 
Between two and five independent ChIP experiments were conducted for each cell line. For each 
amplification and ChIP experiment, triplicate qPCR samples were analyzed using the Bio-Rad 
CFX Manager software package. Each amplification product was analyzed for specificity by both 
agarose gel electrophoresis and melt curve analysis. Standard curves for oligonucleotide pairs were 
derived from input DNA dilution series and ranged in their r2 value from 0.98 to 1.0. Fold 
enrichment values were calculated as the ratio between starting quantities of positive and control 
precipitations. 
In vitro transcription 
The bloodstream in vitro transcription system will be described elsewhere in detail 
(manuscript in preparation). Briefly, BF cells were harvested from 6 liter of culture that was grown 
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to a cell density of 2 x 106 cells/ml. Cells were washed twice with Tryp wash solution (100 mM 
NaCl, 3 mM MgCl2, 20 mM Tris–HCl, pH 7.5), equilibrated in transcription buffer (150 mM 
sucrose, 20 mM potassium l-glutamate, 3 mM MgCl2, 20 mM HEPES–KOH, pH 7.7), and 
resuspended in 1.5 times the packed cell volume of transcription buffer containing 1 mM DTT, 10 
µg/ml leupeptin, and 10 µg/ml aprotinin. After adding 20 µl of phosphatase inhibitor cocktail 
(Sigma) and ~200 µl settled volume of 800 µm low binding silica beads (OPS Diagnostics), cells 
were broken by five cycles of shock freezing in liquid nitrogen, thawing and vortexing for 2 min 
in a 4°C cold room. Broken cells were extracted by mixing the sample quickly with one tenth 
volume of buffer C (1500 mM KCl, 20 mM HEPES-KOH pH 7.7, 3mM MgCl2) and by incubating 
the mix for 20 min on ice. After centrifugation at 25,000g and 2 °C for 10 min, the extract was 
separated from insoluble cell debris, diluted with 0.5 volumes of ice-cold transcription buffer, 
concentrated ~5x in a centricon-10 centrifugal filter device (Millipore), aliquoted, shock-frozen in 
liquid nitrogen, and stored at -80°C. For mock- or immuno-depletion of RPB7-PTP, 50 µl of BF 
transcription extract was mixed with transcription buffer-equilibrated protein G beads or IgG beads 
(settled volume of 30 µl), respectively, and incubated on ice for 1.5 hours. Beads were pelleted for 
2 min. at 3000 g and 2 oC and extract was separated from beads, shock-frozen, and stored at -80 
°C. 
Standard transcription reactions were carried out in a volume of 20 μl containing 4 μl of cell-
free extract, 20 mM potassium L-glutamate, 20 mM KCl, 3 mM MgCl2, 20 mM HEPES-KOH, pH 
7.7, 20 mM creatine phosphate, 0.48 mg/ml of creatine kinase, 2.5% polyethylene glycol, 0.2 mM 
EDTA, 0.5 mM EGTA, 4 mM DTT, 10 μg/ml leupeptin, 10 μg/ml aprotinin, 20 μg/ml RNA pol I 
promoter template (Rib-trm or VSG-trm), 7.5 μg/ml SLins19 template, 12.5 μg/ml unrelated 
plasmid DNA, 10 μg/ml leupeptin, and 10 μg/ml aprotinin. The reactions were pre-incubated on 
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ice for 10 min in the absence of nucleoside triphosphates (NTPs). After adding the NTPs to a final 
concentration of 0.5 mM, the reaction was incubated for 1 h at 27°C and stopped by adding Trizol 
solution (Invitrogen). Total RNA was prepared as described previously (Laufer et al., 1999). 
Newly synthesized RNAs were detected by primer extension of 32P-end-labeled oligonucleotides 
Tag-PE and SLtag which hybridize to unrelated oligonucleotide tags of VSG-trm/Rib-trm and 
SLins19 RNAs, respectively. Primer extension products were resolved on 6% polyacrylamide-
50% urea gels and visualized by autoradiography. In RNA pol II reconstitution assays, tandem 
affinity-purified RNA pol II, bound to anti-protein C matrix and equilibrated in transcription 
buffer, was added back to the reactions. The amounts corresponded to 0.35% and 0.7% of a 
standard PTP tandem affinity purification (Nguyen et al., 2007; Schimanski et al., 2005b). 
Indirect immunofluorescence light microscopy 
Immunolocalizations of procyclic cells were carried out as described previously (Luz 
Ambrosio et al., 2009). 
IV-3. Results and Discussion 
Interaction of RPB7 with RNA polymerases I and II in extract 
In a first step, we wanted to confirm an interaction between RPB7 and the RNA pol I subunit 
RPB6z in a BF extract that was active in both accurate RNA pol I and II transcription (Laufer and 
Günzl, 2001; Laufer et al., 1999). To avoid any cross-reactivity of polyclonal antisera, we 
generated a cell line in which RPB6z was N-terminally tagged with the composite PTP tag (PTP-
RPB6z; (Schimanski et al., 2005b)) and RPB7 C-terminally with the HA tag (RPB7-HA). These 
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proteins were then precipitated with antibodies directed against their tags. Since we have 
previously shown that PTP-RPB6z is fully functional (Nguyen et al., 2007) and since BF and PF 
cell lines which exclusively expressed C-terminally tagged RBP7 did not exhibit any growth defect 
(data not shown), we concluded that tagging of these two subunits did not interfere with their 
function. When we immunoprecipitated PTP-RPB6z from extract at low stringency conditions, the 
RNA pol I subunits RPA1 and RPA2 were efficiently co-precipitated whereas RPB7-HA, RPB1 
and a non-specific control were not (Figure IV-1A, left panels). Since there was the possibility 
that only a small amount of RNA pol I was active and bound to RPB7, we increased the relative 
amount of precipitate from 4x to 50x but still could not detect a signal above the background found 
with the spliceosomal U2-40K protein (Figure IV-1A, lower left panels). Similarly, when we 
precipitated RPB7-HA with a monoclonal anti-HA antibody, we saw efficient co-precipitation of 
RPB1 but not of the RNA pol I subunits RPA1, RPA2 and PTP-RPB6z (Figure IV-1A, right 
panels). Only when the precipitate was increased to 50x, we detected a faint PTP-RPB6z signal 
but a band of similar strength was detected with the U2-40K control suggesting that this was the 
background level due to the low stringency conditions applied. But even when the background 
signal was not taken into account, densitometry revealed that RPB7 is bound to RNA pol I in 
transcriptionally active extract to less than 1%. 
In a different approach investigating the interaction of RPB7 with RNA pols I and II, we 
tandem affinity-purified RPB7 complexes from extract prepared from PFs that exclusively 
expressed RPB7 as a C-terminal PTP tag fusion. Although protein tags can change the affinities 
of protein-protein interactions, the rationale here was that if RPB7 is an essential subunit for RNA 
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Figure IV-1. RPB7 does not detectably interact with RNA pol I in transcriptionally active extract. 
(A) Immunoblot analysis of PTP-RPB6z immunoprecipitation (PTP-RPB6z IP; left panels) and of 
RPB7-HA immunoprecipitation (RPB7-HA IP, right panels). For each immunoprecipitation, 
equivalent amounts of crude extract (Inp) and of supernatant (S) were analyzed and four or fifty 
times the relative amount of the precipitate (P). Asterisks indicate IgG heavy and light chain 
signals. Note the reduction in size of PTP-RPB6z to P-RPB6z upon TEV protease digest in the 
PTP-RPB6z immunoprecipitation. (B) Immunoblot analysis of TbRPB7-PTP purification. Crude 
extract (Inp), flow-through of the IgG sepharose column (FT-IgG), TEV protease eluate (TEV), 
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(Figure IV-1 legend cont.) flow-through of the anti-protein C matrix (FT-ProtC), and final eluate 
(Elu) were analyzed in relative amounts as indicated. Tagged RPB7 and endogenous RPB1 and 
RPA1 were successively detected on the same blot. (C) RPB7 co-purified proteins. The complete 
final eluate (Elu) of a standard RPB7-PTP purification was separated on a 10–20% 
SDS/polyacrylamide gradient gel and stained with Coomassie blue. For comparison, small aliquots 
of crude extract (Inp) and TEV protease eluate were co-analyzed. The band assignments on the 
right were according to previous RNA pol II purifications (Das et al., 2006; Devaux et al., 2006; 
Lee et al., 2009) and our own immunoblot results. RPB1 occurs in two bands, the upper one being 
phosphorylated (ph. RPB1). The question mark indicates several co-purified bands which have not 
been identified yet. The band pattern of RPB12 and RPB10 has not been determined yet. 
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pol I transcription then it should interact in a similar manner with this enzyme as it does with RNA 
pol II. The tandem affinity purification of RPB7-PTP by IgG chromatography and by anti-ProtC 
affinity chromatography efficiently concentrated RPB7 complexes in the final eluate (Figure IV-
1B, top panel). RPB1 was enriched throughout the purification whereas RPA1 was only detected 
in crude extract and the flow-through of the IgG column demonstrating that RPB7 is a bona fide 
RNA pol II subunit but not assembled into a stable RNA pol I complex to a detectable extent 
(Figure IV-1B, middle and bottom panels, respectively). Accordingly, when the final eluate was 
separated by SDS-PAGE and stained with Coomassie blue, an RNA pol II-specific band pattern 
(Das et al., 2006; Devaux et al., 2006) was detected and not bands characteristic for RNA pol I 
(Figure IV-1C). We therefore concluded that in both BF and PF extracts that are active in RNA 
pol I and II transcription, tagged RPB7 was quantitatively and stably associated with RNA pol II 
but not with RNA pol I at our detection level. 
3.2. Chromatin immunoprecipitation of RPB7 
Although the RPB4/7 doublet can be deposited on mRNA (Harel-Sharvit et al., 2010), the 
genome-wide occupancy profile of RPB7 in yeast was congruent with that of the RNA pol II 
subunit RPB3 (Jasiak et al., 2008). Hence, If RPB7 is an essential component of RNA pol I, it 
should be found with RPB6z at RNA pol I promoters in ChIP experiments because it is unlikely 
that major amounts of inactive polymerase that lack RPB7 are recruited to these promoters. Since 
we had previously shown that a polyclonal anti-ProtA antibody is of ChIP grade that can enrich 
DNA-bound transcription factors more than 50fold over control precipitations with a non-specific 
immune serum (Lee et al., 2010) and since we wanted to directly compare occupancies of RPB6z, 
RPB7 and the essential, RNA pol II-specific subunit RPB9 with each other, we generated clonal 
BF cell lines that exclusively expressed these three essential proteins as PTP fusions (data not 
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shown). As expected, RPB6z was clearly enriched at VSG ES and RRNA promoters that recruit 
RNA pol I (Figure IV-2). The weaker enrichment of RPB6z at VSG ES promoters in comparison 
to RRNA promoters is most likely due to the fact that RRNA transcription is spread over several 
repeat units whereas only one of fifteen VSG ESs is actively transcribed in an extranucleoloar 
compartment (Navarro and Gull, 2001). RPB7 and RPB9 did not significantly cross-link to VSG 
ES promoters. In contrast, occupancy of RPB7 was clearly established at RRNA promoters albeit 
to a lesser extent than for RPB6z. Since the RRNA promoter was also occupied by RPB9 (Figure 
IV-2), this finding suggests that RNA pol II is recruited to this site rather than RPB7 being a 
subunit of RNA pol I. This notion was strengthened by high RPB6z occupancy and concomitant 
absence of RPB7 and RPB9 in the 18S rRNA coding region downstream of the RRNA promoter. 
The presence of RNA pol II at the RRNA promoter correlates well with the previously reported 
finding that the most distal domain of the T. brucei RRNA promoter resembles the bipartite 
upstream sequence element (USE) of the SLRNA promoter in opposite orientation and that this 
ribosomal USE, as its SLRNA counterpart, bound the small nuclear RNA-activating protein 
(SNAP)50 in vitro (Schimanski et al., 2004). Therefore, it is possible that binding of the SNAP 
complex to the distal domain of the RRNA promoter nucleates an RNA pol II transcription pre-
initiation complex that recruits RNA pol II. This recruitment may be of functional significance 
because it was recently shown in the human system that noncoding RNA, derived from the RRNA 
promoter sequence, induces epigenetic regulation of RRNA transcription (Schmitz et al., 2010). 
The absence or low occupancies observed with RPB7 and RPB9 at RNA pol I transcription 
units cannot be due to inefficient cross-linking to DNA because both proteins were nearly 60fold 
enriched at SLRNA promoters and clearly detectable in the β-/α- tubulin intergenic region (Figure 
IV-2). In sum, these ChIP experiments demonstrated that RPB7 occupancy closely paralleled the 
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Figure IV-2. ChIP analysis of RPB6z, RPB7 and RPB9. (A) Chromatin of clonal BF cells which 
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(Figure IV-2 legend cont.) exclusively express either PTP-RPB6z, RPB7-PTP or RPB9-PTP was 
precipitated with a rabbit polyclonal anti-ProtA antibody (IP) and analyzed by semi-quantitative 
PCR. In negative control reactions, chromatin was precipitated with a non-specific rabbit immune 
serum and for a positive PCR control, a small aliquot of DNA isolated from total chromatin (Inp) 
was amplified. The occupancy of these subunits were determined for the consensus VSG ES and 
RRNA promoters, the 18S rRNA coding region, the SL RNA promoter and the β-/α- tubulin 
intergenic region. (B) Corresponding qPCR analysis shown as the fold enrichment over the 
negative immunopreciptation. These results are based on at least two independent ChIP 
experiments each of which was analyzed by three qPCR reactions. Note the different scales on the 
y axes. 
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occupancy of the RNA pol II subunit RPB9 at both RNA pol I and II transcription units whereas 
it did not correlate with the occupancy of RPB6z at these sites. These findings do not support an 
essential role of RPB7 in RNA pol I transcription. 
RPB7 depletion from extracts specifically affects RNA pol II transcription 
Previously, we have developed a homologous in vitro transcription system in procyclic T. 
brucei that was active in RNA pol I transcription and in RNA pol II-mediated SLRNA transcription 
(Laufer and Günzl, 2001; Laufer et al., 1999). However, to compare our results with those of 
Penate et al. (Peñate et al., 2009), we needed to establish the system in BF extract. We have been 
able to develop a small scale extract procedure that was applicable to BFs. We prepared extract 
from cells that exclusively expressed RPB7-PTP and depleted the extract of ~90% of RPB7 using 
PTP-binding IgG beads (Figure IV-3A). We then analyzed RNA pol I and II activity in assays in 
which the SLRNA promoter template SLins19 was co-transcribed either with the VSG ES promoter 
template VSG-trm or the RRNA promoter template Rib-trm. In previous work, we have 
unambiguously shown that SLins19 transcription is mediated by RNA pol II and VSG-trm and 
Rib-trm transcription by RNA pol I (Günzl et al., 2003). In comparison to mock-depleted extract, 
RPB7 depletion virtually abolished SLRNA transcription whereas it had no effect on VSG-trm and 
Rib-trm transcription (Figure IV-3B, compare lanes 1 and 2 and lanes 5 and 6). The defect on 
SLRNA transcription was not a non-specific artifact because adding back tandem affinity-purified 
and active RNA pol II (Das et al., 2006) partially restored transcriptional activity from the SLRNA 
promoter in a dose-dependent manner (lanes 3 and 4, and lanes 7 and 8). We therefore concluded 
that RPB7 cannot have an indispensable role in promoter-dependent transcription of RNA pol I. 
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Figure IV-3. In vitro transcription analysis of RPB7-depleted extracts. (A) Immunoblot of BF 
extract prepared from cells exclusively expressing RPB7-PTP that was either mock-depleted or 
RPB7-depleted by means of ProtA-interacting IgG beads. Detection of U2-40k served as a loading 
control. (B) Co-transcription reactions of the SLRNA promoter template SLins19 with the VSG 
ES promoter template VSG-trm or the RRNA promoter template Rib-trm. Reactions were carried 
out with either mock or RPB7-depleted (depl) extracts. Extracts were reconstituted with tandem 
affinity-purified RNA pol II. Transcription signals were obtained through primer extension of 
radio-labeled oligonucleotides that hybridize to unique tag insertions in the SLins19, VSG-trm and 
Rib-trm RNAs. Primer extension signals were separated on a 6% polyacrylamide-50% urea gel 
and visualized by autoradiography. On the right, signals for correctly initiated transcription from 
VSG ES, RRNA and SLRNA promoters are indicated. Marker, MspI-digested pBR322. 
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Penate et al. (Peñate et al., 2009) presented in vitro transcription results which indicated that 
RPB7 is important for VSG ES promoter-dependent transcription. However, they used a G-less 
cassette approach which did not discriminate between accurately initiated transcription and non-
specific read-through transcription raising the possibility that their transcription signals were 
generated in a promoter-independent manner. On the other hand, they did show that VSG ES 
promoter deletion in the template construct resulted in a loss of transcription signal, a finding 
which cannot be resolved in the light of our results. 
RPB7 does not detectably localize to the nucleolus. 
RNA pol I has been localized either throughout the nucleolus (Navarro and Gull, 2001) or to 
the nucleolar periphery (Landeira and Navarro, 2007; Peñate et al., 2009). However, in the latter 
case the signal was clearly inside the spherical structure of low DNA density that marks the 
nucleolus in a DAPI stain. Penate et al. showed a co-localization mask of RPB7 and RPA1, and 
argued that in the nucleolar periphery, which is the site of RNA pol I transcription (Landeira and 
Navarro, 2007), there is significant co-localization. However, their RPB7 localization did not 
reveal a clear nucleolar or ESB signal and it is possible that the co-localization of RPB7 and RPA1 
was derived from adjacent signals that could not be resolved in their analysis. To assess whether 
RPB7 can be found in the nucleolus we transiently transfected procyclic cells that expressed 
RPB7-PTP with a construct harboring a NOP10-GFP fusion gene (Ruan et al., 2007). NOP10 is a 
component of small nucleolar ribonucleoprotein particles and localized in the central part of the 
nucleolus (Boisvert et al., 2007). In the representative cell shown in Figure IV-4, DAPI staining 
revealed a large and clear nucleolus. RPB7-PTP was found in most parts of the nucleus closely 
following the perimeter of the nucleolus but not detectably extending into the nucleolus. As 
expected, in the same cell NOP10-GFP was found in a central nucleolar position.  
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Figure IV-4. Immunofluorescence light microscopy of procyclic trypanosomes showing 
constitutively expressed RPB7-PTP in red, transiently expressed Nop10-GFP in green, and DNA 
in blue. Scale bar is 6.5 µm. 
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Importantly, the co-localization demonstrates a clear gap between Nop10 and RPB7 representing 
the nucleolar periphery. The gap suggests that RPB7, in contrast to previous localizations of RNA 
pol I, does not localize to the nucleolus in detectable amounts and is present only at the nucleolar 
perimeter. This, however, is not surprising because RRNA repeats are tightly flanked by RNA pol 
II transcribed loci, and in procyclic cells, an apparent RNA pol II transcription unit partially 
overlaps with a procyclin gene unit (Liniger et al., 2001) suggesting that on DNA, RNA pol II-
based RPB7 should be present in close proximity to RNA pol I.  
IV-4. Conclusion 
In this study, we have revisited the role of RPB7 in T. brucei RNA pol I transcription. We did 
not find detectable interactions of RPB7 with RNA pol I in reciprocal co-immunoprecipitations or 
in tandem affinity purifications with RPB7 as bait. Moreover, RBP7 did not cross-link to RNA pol 
I transcription units independent of the RNA pol II subunit RPB9, and immunodepletion of RPB7 
from BF extracts did not affect VSG ES and RRNA promoter transcription whereas it did abolish 
SLRNA transcription by RNA pol II. Unlike RNAi-mediated expression silencing of RPB7, these 
approaches avoid potential secondary effects of an RNA pol II shut-down. While our data do not 
exclude a potential role of RPB7 in VSG expression, they show that RPB7 is not a bona fide subunit 
of RNA pol I and has no indispensable role in RNA pol I transcription in T. brucei. 
It should be noted here that RPA31 could be the missing RNA pol I paralog of RPB7 because 
it was essential for promoter-dependent RNA pol I transcription and found to be associated with 
RNA pol I only in the presence of RPB6z (Nguyen et al., 2007; Nguyen et al., 2006), the subunit 
ortholog that recruits RPA43 in yeast (Schimanski et al., 2006). Although RPA31 was described 
as a “novel” subunit because its sequence is only conserved among trypanosomatids (Nguyen et 
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al., 2007), recent characterizations of T. brucei TFIIB (Lee et al., 2009; Palenchar et al., 2006), 
TFIIH (Peyroche et al., 2002) and, in particular, mediator (Lee et al., 2010) revealed that 
trypanosomatid transcription factor sequences are extremely divergent to those of other eukaryotes 
and, therefore, may not reveal the identity of a protein. 
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IV-5. Response to “Role of RPB7 in RNA pol I transcription in Trypanosoma 
brucei” 
In their letter, Navarro et al. (Navarro et al., 2011) criticize our approaches and conclusion that 
RPB7 is not required for RNA polymerase (pol) I transcription in Trypanosoma brucei (Park et 
al., 2011). Our results are in sharp contrast to their previously published work which claimed that 
RPB7 is essential for RNA pol I transcription (Peñate et al., 2009). We used several independent 
criteria to evaluate the functional role of RPB7 in RNA pol I transcription, namely reciprocal co-
immunoprecipitation (co-IP), tandem affinity purification (TAP), chromatin immunoprecipitation 
(ChIP), in vitro transcription assays and indirect immunofluorescence (IF) microscopy. In no case 
did we find evidence that RPB7 has an RNA pol II-independent function in RNA pol I transcription 
or that this protein is stably associated with RNA pol I. We had hoped that the letter by Navarro et 
al. would help to resolve the discrepancy between our two studies; instead we had to read some 
rather far-fetched arguments why our results could be artifacts. 
Navarro et al. describe RPB7 to be essential for RNA pol I transcription and, at the same time, 
not to be a bona fide RNA pol subunit (Navarro et al., 2011). Conversely, though dissociable after 
transcription initiation (Harel-Sharvit et al., 2010), RPB7 has been described as an essential RNA 
pol II subunit that is required for promoter-dependent transcription initiation (Edwards et al., 1991) 
and ChIP assays demonstrated that RPB7 occupancy is congruent to that of the non-dissociable 
subunit RPB3 (Jasiak et al., 2008). Accordingly, we readily found T. brucei RPB7 as part of RNA 
pol II complexes and cross-linked to RNA pol II transcription units while no such link to RNA pol 
I was detectable (Park et al., 2011). Navarro et al. also state that they have “previously described 
a low-affinity interaction of RPB7 with RPA1” (Navarro et al., 2011). The term “low affinity”, 
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however, was not used in their original publication (Peñate et al., 2009) and their interpretation of 
low affinity remains unclear. 
The most obvious discrepancy between the two studies resides in the in vitro transcription 
outcomes. In our assays, RPB7 depletion of extract nearly abolished RNA pol II transcription but 
left RNA pol I transcription unaffected (Park et al., 2011) whereas a similar approach by Penate et 
al. interfered with RNA pol I transcription (Peñate et al., 2009). It should be noted that our system 
allows co-transcription of RNA pol I and II promoter templates and, due to primer extension-
derived transcription signals, monitors accurate transcription initiation. In comparison, the 
transcription signals provided by Penate et al. (Peñate et al., 2009) depended on a G-less cassette 
that was introduced downstream of the transcription initiation site. Hence, there is no 
discrimination between accurately initiated and non-specific read-through transcription. In 
addition, individual reactions were not internally controlled. This is particularly bothersome 
because their analysis was not quantitatively assessed, e.g. based on signal quantification of 
repeated experiments. 
According to Navarro et al. the lack of an effect on RNA pol I transcription in our assays could 
stem from residual amounts of RPB7 left in the extract (Navarro et al., 2011). Since our extracts 
were prepared from cells that exclusively expressed the essential RPB7 as a TAP tag fusion, this 
would mean that the tandem protein A domains of tagged RPB7 were masked in the RNA pol I 
complex but accessible in the RNA pol II complex. Having precipitated and purified more than 30 
different TAP-tagged proteins (see for example (Brandenburg et al., 2007; Lee et al., 2010; Lee et 
al., 2009)), we have not come across a single case in which the large tandem protein A domains of 
the TAP tag were inaccessible to IgG beads or antibodies. 
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Navarro et al. stated that in our co-IP analysis 25% of RPB7 interacted with RPB1 and only 
1% of RPB7 interacted with RPA1 (Navarro et al., 2011). This is not true. In fact, we did not find 
any interaction between RPB7 and the RNA pol I-specific subunit RPB6z in both reciprocal co-IP 
and RPB7 TAP whereas in both assays RPB7 was stably associated with RNA pol II. We did, 
however, acknowledge that, due to the ambiguousness of quantifying large amounts of 
immunoprecipitate, we could not exclude the possibility that a very small amount of RPB7 (<1%) 
was associated with RPB6z. 
In regard to the amount of active RNA pol I in extracts, a study in yeast found that up to 98% 
of RNA pol I was inactive. However, the inactivity was due to the dissociation of the transcription 
factor RRN3 from RNA pol I and not to the lack of an RNA pol I subunit, e.g. the RNA pol I 
paralog of RPB7 termed RPA43 (Milkereit and Tschochner, 1998). 
Navarro et al. criticize our ChIP approach because we, like many others, compare the 
enrichment of precipitated DNA over a negative control immunoprecipitation in which we use a 
comparable, non-specific immune serum. While the suggested normalization to input amount is 
valid, too, this kind of analysis promotes the usage of extremely low ratios of chromatin input and 
antibody beads. More importantly, our ChIP analysis demonstrated that identically tagged RPB7, 
RPB6z and RPB9 could be effectively and specifically cross-linked to chromatin. In all cases, we 
found congruency of RPB7 and RPB9 (RNA pol II) occupancies that did not correlate with RPB6z 
(RNA pol I) occupancy. In this regard, we find it inappropriate that Navarro et al. mention 
unpublished data in their support which cannot be evaluated yet. 
Concerning IF microscopy, we maintain that the co-localization mask provided by Penate et 
al. (Peñate et al., 2009) cannot discriminate between adjacent signals and true co-localization. 
Since they concluded that RPB7 is generally required for RNA pol I including transcription of 
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ribosomal RNA genes, our approach to localize RPB7-PTP in nucleoli of transiently transfected 
procyclics is valid. 
Importantly, a major difference between our study and that of Penate et al. was that we used 
functional protein tags (exclusive expression of essential, tagged proteins) and they used a 
polyclonal anti-RPB7 antiserum. Since it is very likely that trypanosome RNA pol I requires an 
RPA43 ortholog (Kuhn et al., 2007) representing an RPB7 paralog, Navarro et al. should make 
sure that their antibody does not cross-react with an RNA pol I-specific protein, e.g. TbRPA31 
(Nguyen et al., 2007), the protein we favor in retrospect to be the RNA pol I paralog of RPB7 (see 
conclusion section in (Park et al., 2011)). 
Finally, we are convinced that our data, in contrast to the title-based conclusion of Penate et 
al. (Peñate et al., 2009), demonstrate that RPB7 has no essential role in T. brucei RNA pol I 
transcription; it does not replace the function of an RPA43 ortholog. As we state in our publication, 
we cannot rule out a post-transcriptional or RNA pol II-based role of RPB7 in the expression of 
RNA pol I-synthesized transcripts because this was not the aim of our analysis. 
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Chapter V 
Mono-allelic VSG expression by RNA polymerase I in Trypanosoma 
brucei: expression site control from both ends? (Review) 
 
Abstract 
Trypanosoma brucei is a vector borne, lethal protistan parasite of humans and livestock in sub-
Saharan Africa. Antigenic Variation of its cell surface coat enables the parasite to evade adaptive 
immune responses and to live freely in the blood of its mammalian hosts. The coat consists of ten 
million copies of variant surface glycoprotein (VSG) that is expressed from a single VSG gene, 
drawn from a large repertoire and located near the telomere at one of fifteen so-called bloodstream 
expression sites (BESs). Thus, antigenic variation is achieved by switching to the expression of a 
different VSG gene. A BES is a tandem array of expression site-associated genes and a terminal 
VSG gene. It is polycistronically transcribed by a multifunctional RNA polymerase I (RNAPI) 
from a short promoter that is located 45-60 kb upstream of the VSG gene. The mechanism(s) 
restricting VSG expression to a single BES are not well understood. There is convincing evidence 
that epigenetic silencing and transcription attenuation play important roles. Furthermore, recent 
data indicated that there is regulation at the level of transcription initiation and that, surprisingly, 
the VSG mRNA appears to have a role in restricting VSG expression to a single gene. Here, we 
review BES expression regulation and propose a model in which telomere-directed, epigenetic 
BES silencing is opposed by BES promoter-directed, activated RNAPI transcription. 
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V-1. Introduction 
The tsetse borne, unicellular parasite Trypanosoma brucei, which belongs to the phylogenetic 
order Kinetoplastida, is the only known organism that has evolved a multifunctional RNA 
polymerase I (RNAPI) system. This system is used to transcribe ribosomal gene units (RRNA) in 
the nucleolus, as in all eukaryotes, yet also to transcribe gene units that encode the parasite’s major 
cell surface antigens (Günzl et al., 2003; Kooter and Borst, 1984). Trypanosomes have a unique 
mode of protein coding gene expression that allows them to utilize other RNA polymerases than 
RNAPII for the production of functional mRNA. In their genome, protein coding genes are 
arranged in long tandem arrays which are polycistronically transcribed. The precursor RNA is 
processed by spliced leader (SL) trans splicing and polyadenylation, resulting in mature, 
monocistronic mRNAs (Günzl, 2010; Michaeli, 2011; Preußer et al., 2012). Since in trans splicing 
the same capped leader sequence, derived from the SL RNA, is spliced onto the 5/ end of each 
mRNA, this process represents a post-transcriptional mode of capping that is decoupled from 
RNAPII transcription. Consequently, trypanosomes, in contrast to mammals (Grummt and 
Skinner, 1985), are able to use RNAPI to effectively and specifically express endogenous gene 
units that encode their major cell surface antigens (Rudenko et al., 1991; Zomerdijk et al., 1991a). 
This antigen, in mammalian-infective metacyclic and bloodstream form (BF) trypanosomes, is 
known as the variant surface glycoprotein (VSG), while the major cell surface antigen in insect-
stage procyclic form trypanosomes is procyclin. 
T. brucei causes Human and Animal African Trypanosomiasis (also known as Sleeping 
Sickness and Nagana, respectively) throughout sub-Saharan Africa (Fevre et al., 2006). The 
parasite lives freely in the bloodstream of its mammalian host, evading the immune system by 
antigenic variation of its cell surface coat. The coat consists of ten million copies of the same VSG, 
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shielding invariant membrane proteins from immune recognition (Schwede et al., 2011). T. brucei 
possesses roughly 2500 different VSG genes and pseudogenes (Cross et al., 2014), and periodic 
switching to the expression of an alternative VSG gene leads to antigenic variation. VSG genes are 
located in subtelomeric regions of 11 megabase, 5 intermediate-sized and ~100 minichromosomes 
covering, in total, ~30% of the genome (Ersfeld, 2011; Horn, 2014). However, the active VSG 
gene is invariably located next to the telomere within an expression site, with the coding region 
ending ~200-1800 bp upstream of the telomeric repeats. Metacyclic trypanosomes express a single 
VSG monocistronically from one of five metacyclic expression sites in which the RNAPI promoter 
is located ~1-4 kb upstream of the coding region (Cross et al., 2014; Ginger et al., 2002; Kolev et 
al., 2012). Conversely, BFs express the active VSG from one of fifteen polycistronic “bloodstream 
expression sites” (BESs) which comprise a tandem array of typically 8-9 expression-site associated 
genes (ESAGs) and a terminal VSG gene (Figure V-1) (Hertz-Fowler et al., 2008). ESAGs appear 
to be important for the successful infection of the mammalian host since they encode a variant 
heterodimeric transferrin receptor (ESAG6 and ESAG7), whose varying affinity for transferrins 
of different host species is thought to expand the parasite’s host range (Bitter et al., 1998). These 
also encode adenylate cyclases (ESAG4) that inhibit the innate immune system upon trypanosome 
lysis (Salmon et al., 2012). 
The BES promoter resides 45-60 kb upstream of the telomere (Zomerdijk et al., 1990). It 
extends only 67 bp upstream of the transcription initiation site and comprises two short sequence 
elements (Pham et al., 1996; Vanhamme et al., 1995). Both elements are required for efficient 
binding of the multi-subunit class I transcription factor A (CITFA) which is essential for RNAPI 
transcription in the trypanosome (Brandenburg et al., 2007). The active BES is transcribed  
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Figure V-1. Schematic outline of BES5 and interacting proteins 
Depiction of BES5 (to scale) as a representative BES according to the published sequence (Hertz-
Fowler et al., 2008). The diagram includes ESAGs (labeled 1, 2, 4-8 and 12), a VSG pseudogene 
(Ψ), 70 bp repeats preceding the terminal VSG gene, and the telomeric repeats (T). Note that some 
BESs have an additional promoter and an ESAG10 gene ~14 kb upstream of the depicted promoter 
(not shown). The green arrow and red X represent the promoter when the BES is in the active state 
and silent state, respectively. Activating factors that are predominantly associated with the active 
BES are indicated above the diagram in green whereas factors which are implied in BES silencing 
are listed below the diagram in red. Filled and empty arrowheads indicate positive and negative 
ChIP results, respectively. Histone H1 and SPT16 associate predominately with silent sites 
whereas TbISWI and NLP were shown to interact equally with expression sites in both states. 
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outside the nucleolus (Chaves et al., 1998), apparently in a small compartment termed the 
expression site body (ESB) (Navarro and Gull, 2001). In BFs the switch to the expression of 
another VSG occurs by two principal ways: either the active BES is silenced while one of the silent 
BESs is activated, or a DNA recombination event replaces the VSG gene in the active BES with a 
VSG gene from the repertoire. 
Antigenic variation and mono-allelic VSG expression in T. brucei have been a research focus 
for decades. Several factors involved in BES silencing have been identified (see below) and BES 
silencing has been linked to DNA replication/ORC1 (Benmerzouga et al., 2013; Tiengwe et al., 
2012), chromosome maintenance (Kim et al., 2013b), and association of BESs with the nuclear 
lamina (DuBois et al., 2012). In addition, cohesin plays a critical role in maintaining the activated 
state of the BES during the cell cycle (Landeira et al., 2009). Recently, excellent and detailed 
reviews have addressed antigenic variation in trypanosomes and the biology of BES silencing 
(Alsford et al., 2012; Glover et al., 2013; Horn, 2014; Horn and McCulloch, 2010; Rudenko, 2010). 
Here we focus on the most recent findings of factors that appear to be directly involved in BES 
regulation, and propose a model in which BES-specific telomeric silencing is opposed by a 
mechanism that activates transcription initiation at the promoter of the active BES. 
V-2. Telomeric Silencing 
The active VSG gene, independent of whether it resides in metacyclic or bloodstream 
expression sites, is invariably located near the telomere, indicating that the telomere has an 
essential function in regulating VSG expression. Accordingly, repression of RNAPI-mediated 
transcription by the telomere was directly demonstrated by integrating a plasmid with seeds for de 
novo telomere formation either at BESs or, internally, at RRNA loci (Glover and Horn, 2006). At 
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the latter, tight repression extended only 2 kb upstream of telomeric repeats whereas, at inactive 
BESs, repression reached at least 5 kb in these experiments. The more extended repression of silent 
BESs was consistent with previous findings in which integration of RNAPI promoter-driven 
reporter cassettes at different positions of a silent BES were repressed, even when placed 14 kb 
upstream of the telomere (Horn and Cross, 1997). Several lines of evidence suggest that the 
pronounced silencing of BESs is dependent on the telomere. Depletion of the telomeric protein 
RAP1 led to de-repression of silent BESs, co-expression of multiple BES-encoded VSG genes, and 
the formation of additional extranucleolar RNAPI foci (Yang et al., 2009). Furthermore, depletion 
of the disruptor of telomeric silencing B (DOT1B), which methylates lysine 76 of trypanosome 
histone H3 (Janzen et al., 2006), similarly led to de-repression of silent BESs (Figueiredo et al., 
2008). Direct evidence for repression of a BES from the telomere stems from a recent study in 
which induced expression of a VSG transgene, inserted into one of the RRNA loci, surprisingly led 
to a short-term, reversible attenuation of the active BES, indicating that VSG mRNA plays a direct 
role in the regulation of mono-allelic VSG expression (Batram et al., 2014). Interestingly, a time 
course experiment showed that this silencing of the active BES spread from the telomere towards 
the BES promoter in a DOT1B-dependent manner (Batram et al., 2014). Together, these data 
strongly indicated that BES silencing is directed by the telomere. Furthermore, it is likely that the 
VSG gene on silent BESs is protected from RNAPI transcription by more than one mechanism 
because DOT1B knockout cells could still shut down the active VSG gene upon ectopic VSG 
expression but were unable to attenuate expression of the remainder of the active BES (Batram et 
al., 2014). 
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V-3. BES transcription attenuation 
Inactive BESs are completely silent only in regard to their telomere-proximal regions, 
including the terminal VSG gene. VSG mRNA from inactive BESs is 104 to 105-fold less abundant 
than that from the active BES (Figueiredo et al., 2008; Yang et al., 2009). Despite this strong 
difference, several observations have shown that transcription does initiate at silent BESs at a 
clearly detectable level. The first evidence came from a study in which insertion of a selectable 
marker gene 1 kb downstream of a “silent” BES promoter led to resistant parasites (Navarro and 
Cross, 1996). BES sequences are highly similar, especially at the promoter and in the proximal 
downstream region, differing from each other only by a few single nucleotide polymorphisms. 
However, the first genes within BESs are ESAG7 and ESAG6 which encode the heteromeric 
transferrin receptor and harbor short hypervariable regions that distinguish them from each other 
(Zomerdijk et al., 1991b). Analysis of ESAG6 cDNA sequences, which on BESs are located ~5 kb 
downstream from the promoter, revealed that 20% of the ESAG6 mRNA in BFs was derived from 
various silent BESs whereas 80% stemmed from the active BES, demonstrating that, even in the 
absence of selective pressure, productive transcription did occur in the promoter-proximal domain 
of inactive BESs (Ansorge et al., 1999). Subsequently, a vast cDNA clone analysis along whole 
BESs showed that silent BESs contributed much more to the promoter-proximal cDNA pool than 
to pools of promoter-distant cDNAs, revealing that transcription that initiated at silent BESs was 
attenuated along the BES (Vanhamme et al., 2000). Recently, this approach was repeated with 
single cells, confirming that silent BESs are transcribed in their promoter-proximal region and that 
transcription was attenuated further downstream within a single trypanosome (Kassem et al., 
2014). Finally, the demonstration that BES silencing spreads gradually from telomere to promoter 
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and BES reactivation occurs gradually in the opposite direction (Batram et al., 2014) strongly 
supports the notion that transcription is attenuated at silent BESs. 
V-4. Regulation of BES transcription Initiation 
Although the promoters of inactive BESs are not “silent”, there is now convincing evidence 
that there is substantial regulation at BES promoters. Consistently, promoter-proximal RNA levels 
were found to be much higher from the active versus silent BESs. Thus, when the neomycin 
phosphotransferase gene (NEO) was inserted 1 kb downstream of the promoter of an inactive BES, 
it conferred parasite resistance to a low concentration of the drug G418 (1 µg/ml) while the same 
gene, when inserted at the identical position of an active BES, boosted resistance at least 100-fold 
(Navarro and Cross, 1996). The finding that in BFs 80% of ESAG6 mRNA stemmed from the 
active BES suggested that there is at least a 50-fold stronger ESAG6 expression from the active 
BES than from the average silent BES. When Yang et al. (2009) introduced a luciferase gene 
immediately downstream of the active or a silent BES promoter, the active BES produced 1500-
4000-fold more light units than the silent BES. 
More direct evidence for BES regulation at the level of transcription initiation came from the 
analysis of CITFA. CITFA consists of seven subunits, CITFA1-7, which are conserved only 
among kinetoplastid organisms, and the dynein light chain DYNLL1 (also known as LC8). 
Silencing of CITFA1, CITFA2 and CITFA7 was lethal to BFs grown in culture and strongly and 
specifically reduced the abundance of rRNA and VSG mRNA (Brandenburg et al., 2007; Nguyen 
et al., 2012; Park et al., 2014). Accordingly, depletion of CITFA2 from extract virtually abolished 
RNAPI transcription in vitro, as assayed by ~100 bp-long primer extension products, and the 
purified CITFA complex produced a specific gel shift with the BES promoter (Brandenburg et al., 
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2007). Moreover, a ChIP-seq analysis indicated that within a BES, CITFA7 occupancy was 
restricted to the promoter region (Nguyen et al., 2014). Together, these findings identified CITFA 
as a basal and general transcription initiation factor for RNAPI transcription in trypanosomes. 
Interestingly, marking the active BES and a silent BES ~500 bp downstream of the 
transcription initiation site (Figueiredo et al., 2008) revealed that CITFA2 and CITFA7 
predominantly occupied the promoter of the active BES relative to that of the marked silent BES, 
a phenotype that was maintained after consecutive in situ switches between the two marked sites 
(Nguyen et al., 2014). In accordance with CITFA’s role as an RNAPI transcription initiation factor, 
higher CITFA occupancy at the active versus the silent BES promoter correlated with a ~70-fold 
higher abundance of promoter-proximal, unspliced RNA and a ~17-fold higher occupancy of the 
RNAPI-specific subunit RPB6z at the marker gene (Nguyen et al., 2014). Finally, CITFA7 
silencing led to a strong reduction of RNAPI occupancy and of promoter-proximal RNA levels, 
which directly demonstrated that CITFA binding to the promoter is required for high transcription 
rates in vivo (Nguyen et al., 2014). These data unequivocally showed that mono-allelic BES 
expression entails a mechanism that functions at the BES promoter, apparently limiting access of 
CITFA to silent BES promoters and/or ensuring maximal promoter occupancy of CITFA at the 
active BES. 
It should be noted that this mechanism is not an “all or nothing”-mechanism because, in these 
experiments, the marked silent BES promoter was consistently occupied by CITFA above the level 
of negative control experiments. This finding is in accordance with promoter-proximal 
transcription occurring at silent BESs (see above) and it likely explains why hypersensitive DNase 
I sites in the promoter region, indicative of a bound transcription factor, were not restricted to the 
active BES but were also detected at a silent BES (Navarro and Cross, 1998). It appears that 
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trypanosomes cannot completely shut down transcription initiation from silent BESs. 
Alternatively, low level transcription of the promoter-proximal part of silent BESs might serve a 
biological function. For instance, co-expression of different forms of the heteromeric transferrin 
receptor, e.g. ESAG6 and ESAG7, could ensure initial survival in different mammalian hosts. 
 
V-5. Factors involved in BES transcription regulation 
There is strong evidence that inactive BESs are silenced epigenetically. Thus, while silent 
BESs have a nucleosomal structure, the active BES is largely depleted of nucleosomes (Figueiredo 
and Cross, 2010; Stanne and Rudenko, 2010). Direct evidence that nucleosomes are important for 
BES promoter silencing stems from depleting histone H3, which rapidly led to a ~11-fold de-
repression of a GFP gene introduced downstream of the promoter of a silent BES (Alsford and 
Horn, 2012). In addition, CAF-1b, a replication-dependent histone chaperone, and the replication-
independent chaperone ASF1A, were shown to be important for the inheritance and maintenance 
of the silenced state of BESs (Alsford and Horn, 2012). Interestingly, silencing the gene of either 
chaperone led to apparent nucleosome depletion and a de-repression of the promoter-proximal 
BES region. However, it did not affect expression of the corresponding VSG gene suggesting that 
nucleosomal structure is particularly important for the regulation of BES promoter activity. 
Several chromatin remodeling and modifying proteins have been implicated in BES repression 
so far. The first epigenetic factor found to play a role in BES regulation was the chromatin 
remodeler TbISWI (Hughes et al., 2007). Depletion of this factor increased the mRNA abundance 
of a reporter gene inserted promoter-proximally into a silent BES up to 60-fold, whereas only a 
fivefold increase of the corresponding silent VSG mRNA was observed. TbISWI was found to 
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occupy the entire length of both silent and active BESs, but was not enriched at BES promoters 
(Stanne et al., 2011). Although the specific function of TbISWI remains to be determined, these 
results suggest that TbISWI controls RNAPI transcription elongation rather than initiation. 
Similar de-repression of a promoter-proximal reporter gene was observed when the histone 
deacetylase DAC3 (Wang et al., 2010), the linker histone H1 (Pena et al., 2014; Povelones et al., 
2012), or the nucleoplasmin-like protein NLP (Narayanan et al., 2011) was depleted. The function 
of DAC3 appears to be promoter-specific since expression of the VSG gene in the marked BES 
was unaffected at both the mRNA and the protein level (Wang et al., 2010). However, direct 
association of DAC3 with BESs has not been demonstrated yet and it remains a possibility that 
DAC3’s control of BES silencing is indirect. 
The role of histone H1 in BES promoter repression has been more deeply investigated. Histone 
H1 is important for chromatin architecture and generally functions in chromatin condensation and 
transcription repression (Happel and Doenecke, 2009). Accordingly, co-silencing of the T. brucei 
H1 multigene family opened up chromatin globally with the strongest effect on silent BES 
promoters (Pena et al., 2014). Metabolic labeling of nascent RNA then showed that histone H1 
depletion resulted in an approximately six-fold higher promoter-proximal transcription rate at a 
silent BES, indicating that relaxation of the nucleosome structure in the promoter region led to an 
increase of the transcription initiation rate at the silent BES (Pena et al., 2014). 
NLP is a ubiquitous nuclear protein and, accordingly, was found to be associated with all 
genomic loci analyzed, including the active and silent BESs (Narayanan et al., 2011). Despite this 
apparent general association with genomic DNA, NLP seems to be particularly important for BES 
promoter regulation. Depletion of NLP de-repressed a silent BES 45-65-fold, as measured by 
fluorescence derived from a promoter-proximal GFP gene. Moreover, NLP silencing also reduced 
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promoter-proximal gene expression from the active BES about threefold (Narayanan et al., 2011). 
While it was speculated that NLP may have a dual function in BES silencing and in promoting 
processive transcription at the active BES (Narayanan et al., 2011), it is equally possible that loss 
of NLP enabled competition between silent and the active BES for the RNAPI transcription 
machinery. However, the specific function of NLP in BES regulation remains to be determined. 
SPT16 is a subunit of the trypanosome FACT (“facilitates chromatin transcription”) complex 
(Patrick et al., 2008) and appears to have a direct role in BES promoter silencing because it was 
found highly enriched at a silent BES promoter (Denninger et al., 2010). Accordingly, SPT16 
silencing increased promoter-proximal GFP expression from a silent BES up to 25-fold, yet de-
repression did not extend to the VSG genes of silent BESs. However, the de-repression effect was 
strongly correlated with an arrest in the G2/early M cell cycle phase, raising the possibility that 
SPT16 does not generally facilitate BES repression in the bloodstream trypanosome. Moreover, 
SPT16 depletion strongly reduced VSG expression from the active BES, suggesting a separate 
BES-related function of SPT16 in facilitating processive RNAPI transcription. Overall, the 
specific function of FACT in the multifunctional RNAPI system remains unclear. While SPT16 
has been co-purified with RNAPII of the related organism Leishmania major (Martinez-Calvillo 
et al., 2007), its association with T. brucei RNAPI remains to be shown. 
The epigenetic factors discussed so far, including RAP1 and DOT1B (see section 2, Telomeric 
silencing, above), function in BES silencing. The only such factor found to be important for 
efficient transcription of the active BES is the high mobility group protein TDP1, which belongs 
to a family of architectural chromatin proteins (Narayanan and Rudenko, 2013). Interestingly, 
TDP1 exhibited an inverse occupancy pattern to the core histone H3 at RNAPI-transcribed loci 
and was up to fivefold more abundant at the active BES promoter relative to a silent BES promoter. 
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Accordingly, TDP1 depletion decreased the abundance of pre-rRNA and VSG mRNA from the 
active BES. In addition, TDP1, a nuclear protein, exhibited predominant localization to the 
nucleolus and the ESB, and its DNA association was found throughout the active BES and RRNA 
gene units. Thus, it appears that TDP1 facilitates high rates of processive RNAPI transcription 
required for trypanosome survival (Narayanan and Rudenko, 2013). 
V-6. A model of BES regulation 
It is difficult to integrate the data from BES de-repression studies because, for most factors, 
specific functions in BES silencing have not been determined yet. Nevertheless, recent data 
strongly indicated that BES regulation occurs at both ends of expression sites. RAP1 and DOT1B 
depletion studies have clearly shown that BESs are silenced by a telomere-directed mechanism. 
Moreover, the demonstration that BES silencing spreads from the telomere towards the promoter 
(Batram et al., 2014) strongly supports a telomere-directed BES silencing mechanism. However, 
it is unlikely that this is the only mechanism regulating mono-allelic BES expression. If this was 
the case one would expect full activation of promoter-proximal transcription once telomeric 
silencing retreats beyond the promoter region, which should result in a leveling of the transcription 
rate between active and silent BESs (given the extremely high expression level of the active BES, 
it is unlikely that a trypanosome can support full activation of all fifteen BESs). However, in all 
cases reported, de-repression of silent BESs is, at best, moderate with the promoter-proximal 
expression level remaining manifold below that of the active BES. Furthermore, RAP1 silencing 
did not strongly affect promoter-proximal transcription of de-repressed BESs and had only a minor 
influence on the high expression level of the active BES (Yang et al., 2009). Similarly, DOT1B 
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silencing did not affect expression of the active BES at all (Figueiredo et al., 2008). These results 
strongly argue for the presence of a separate mechanism involved in BES regulation. 
Transcription attenuation has been proposed to be that mechanism and, as discussed, there is 
clear evidence that it does occur on silent BESs (Kassem et al., 2014; Vanhamme et al., 2000). 
Moreover, some data suggested that transcription attenuation is caused by inefficient transcript 
processing (Vanhamme et al., 2000) rather than by repressive chromatin. However, recent data do 
not support this scenario. The finding that RAP1 silencing caused gradual BES de-repression with 
the greatest effect on telomere-proximal genes, strongly indicated that transcription elongation on 
silent BESs is “antagonized” by telomere-directed spreading of repressive chromatin (Yang et al., 
2009). Furthermore, upon removal of the apparent transcription elongation barrier, e.g. 
pronounced telomeric silencing, by RAP1 (Yang et al., 2009) or DOT1B (Figueiredo et al., 2008) 
depletion, promoter-proximal expression remained magnitudes below that of the active site, 
making it unlikely that transcription attenuation accounts for the strong difference in promoter-
proximal transcription observed between active and silent BESs. Hence, transcription attenuation 
appears to be a consequence of epigenetic silencing rather than a regulatory mechanism, and seems 
to be in place to prevent the low level of transcription that does initiate at silent BESs from reaching 
the distally located VSG gene. 
Based on the RAP1 silencing results on BES de-repression, Yang et al. (2009) suggested that 
there has to be a mechanism functioning on the BES promoter that could explain the striking 
difference in promoter-proximal expression levels between the active and de-repressed/silent 
BESs. The strongest support for this idea stems from the demonstration that CITFA, which is 
absolutely required for RNAPI transcription, is predominantly associated with the active BES 
promoter, versus a silent site, strongly indicating that there is a mechanism in place that allows 
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CITFA to preferentially interact with the active BES. In addition, the fact that depletion of several 
epigenetic factors increased promoter-proximal transcription with no or very little effect on the 
downstream VSG gene further supports the notion of a promoter-dependent regulatory mechanism. 
Taking these data into account, we propose a model in which BESs are regulated by two 
opposing forces, namely telomere-directed epigenetic silencing acting on silent BESs and 
activated transcription initiation at the active BES (Figure V-2). In this model, the active BES 
promoter has unrestricted access to CITFA and RNAPI, allowing it to achieve the high 
transcription rate necessary for productive VSG expression. In addition, productive RNAPI 
transcription at the active BES is ensured by the presence of TDP1. At the same time, telomeric 
silencing at the active BES is impaired or pushed back so far that RNAPI transcription can extend 
productively past the VSG gene. In contrast, in this model, silent BES promoters are unable to 
recruit CITFA and RNAPI in sufficient amounts to allow for high transcription rates. In addition, 
a telomere-directed repressive epigenetic gradient spreading from the telomere into the BES causes 
transcription attenuation to prevent the low level of transcription, initiating at inactive BESs, from 
reaching the VSG gene. 
How are BES promoters differentially regulated? An obvious mechanism that could prevent 
CITFA from interacting with silent BES promoters and from recruiting RNAPI is a repressive 
chromatin structure at the promoter. The epigenetic factors whose depletion led to promoter-
proximal BES de-repression, e.g. DAC3, histone H1 and NLP, may be important to build up a 
repressive chromatin structure at the promoter. If this is correct, depletion of these factors should 
lead to higher CITFA and RNAPI occupancies at de-repressed promoters. An alternative idea for 
the low promoter activity at “silent BESs” has been put forward in studies of CITFA. CITFA was 
found to be concentrated in both the nucleolus and the ESB (Nguyen et al., 2014), and it retained 
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Figure V-2. Model of BES regulation in T. brucei 
In the model of BES regulation, two opposing forces antagonize each other. The active BES is 
characterized by high transcription initiation rates and the lack of telomere-dependent epigenetic 
silencing, allowing unrestricted transcription elongation past the terminal VSG gene (green arrow). 
High processive transcription rates are facilitated by CITFA and TDP1. In silent BESs, low level 
RNAPI transcription initiation is opposed by BES-specific telomeric silencing that spreads 
towards the BES promoter causing transcription attenuation. This silencing depends on a 
nucleosomal structure, DOT1B and RAP1. RAP1 was shown to bind to telomeric repeats but the 
association of DOT1B with BESs remains to be determined (dotted line). Epigenetic factors may 
work together to build up a repressive chromatin structure at the promoter of silent BESs, 
preventing efficient binding of CITFA to its cognate DNA sequence elements. Alternatively, 
CITFA sequestration may limit the availability of the initiation factor for inactive BESs (not 
shown). 
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this localization even when its promoter-binding capability was impaired by depletion of the 
essential subunit CITFA1 (Park et al., 2014). It was therefore suggested that sequestration of 
CITFA into the nucleolus and the ESB could restrict maximal RNAPI transcription to these 
compartments. This idea is in line with a previous study in which BFs were forced to co-express 
two BESs simultaneously by antibiotic selection. The two marked BESs were consistently detected 
in close spatial proximity (Chaves et al., 1999), as if they were competing for an essential 
expression factor. Furthermore, it may explain why de-repressed BES promoters remain much less 
active than the promoter from the active BES. 
Finally, this model of two opposing forces is supported by the monitoring of the shut-
down/reactivation of the active BES upon ectopic expression of VSG mRNA (Batram et al., 2014). 
In these experiments the active BES was gradually inactivated from the telomere towards the 
promoter, most likely by an active, telomere-directed process of repressive chromatin spreading, 
whereas the reactivation of the same BES occurred in the reverse direction, possibly by removal 
of nucleosomes by the transcription machinery. An important question emanating from this study 
is how does the ectopically expressed VSG mRNA cross-talk to the active BES? Although this 
question is beyond the scope of this article, it is tempting to speculate that the VSG mRNA 
sequestered an important factor for RNAPI transcription, allowing repressive chromatin to spread 
onto, and silence, the active BES. 
V-7. Conclusion 
Mono-allelic VSG expression in T. brucei differs from other allelic exclusion systems, such as 
var gene expression in Plasmodium falciparum (Guizetti and Scherf, 2013; Kirkman and Deitsch, 
2012) or olfactory receptor expression in mammals (Magklara and Lomvardas, 2013) by the fact 
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that the active VSG gene must be transcribed at an extremely high rate to enable rapidly 
proliferating trypanosomes to completely cover themselves with VSG. The careful measurement 
of RNA abundances and half lives indicated that the active VSG gene is transcribed at a 50-fold 
higher rate than a β-tubulin gene (Ehlers et al., 1987). At the same time, T. brucei must ensure that 
VSG genes on other BESs are not expressed. The parasite achieves this balancing act apparently 
by restricting full RNAPI transcription initiation to the active BES and by shielding VSG genes on 
silent BESs by a telomere-dependent silencing mechanism that causes attenuation of RNAPI 
transcription. 
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Chapter VI 
Discussion and future directions 
 
VI-1. Gene silencing by targeting heterologous sequences is a new and flexible 
tool for studying T. brucei 
 Previous work on CITFA revealed that it was a promoter-binding factor required for all 
transcription by RNA pol I in T. brucei (Brandenburg et al., 2007). CITFA was shown to consist 
of 8 subunits, CITFAs 1-7 (Brandenburg et al., 2007; Nguyen et al., 2012), conserved only among 
kinetoplastids, and a dynein light chain LC8 that is conserved among eukaryotes (Wickstead and 
Gull, 2007). CITFA was previously shown to co-localize to the sites where transcription by RNA 
pol I occurs, and was also shown to be present at RRNA and BES promoter (Brandenburg et al., 
2007; Nguyen et al., 2012). For an overview of transcriptional regulators known to bind to active 
and silent BESs, including CITFA, please see Figure V-2 on page 139. While CITFA2 and 
CITFA7 were previously shown to be essential for transcription by RNA pol I, the specific role of 
CITFA subunits in transcription was unclear. Furthermore, while it had been demonstrated that 
CITFA was localized to the nucleolus and the expression site body, or ESB, where VSG 
transcription takes place, its means of restriction to these compartments was unknown. While 
pursuing the above, we attempted to silence CITFA1 by producing double stranded RNA (dsRNA) 
targeting CITFA1’s coding sequence and 3/ untranslated region (UTR), which failed, even though 
this approach had been successfully used in our lab with other genes.  
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As detailed in Chapter II and Chapter III, we were able to solve this problem, and 
investigate the role of CITFA1, by developing a new system for gene silencing that relied on 
targeting heterologous sequences. We demonstrated that it was possible to specifically silence 
CITFA7 and CITFA1 using two different fused heterologous sequences (Park et al., 2014), one 
being a tandem affinity tag while the other was a 3/ UTR from another member of the genus, 
Trypanosoma cruzi. The phenotype produced upon CITFA7 silencing was in accordance with a 
previously published silencing of CITFA7 that targeted its coding sequence (Nguyen et al., 2012), 
showing that our approach was valid. The lack of a phenotype upon replacing CITFA7’s 
endogenous 3/ UTR with one from T. cruzi suggests that the genomic elements required for RNA 
processing are shared between these two species. The main purpose of this work, however, was to 
develop a tool for specific gene silencing that was less reliant on targeting endogenous sequences, 
and there are numerous advantages to using this approach. Firstly, some genes, as was shown in 
Chapter III, were unaffected when dsRNA targeting their coding sequences or UTRs were 
expressed. Only though fusion of a targetable heterologous sequence could silencing be achieved. 
Secondly, gene silencing by production of dsRNA has traditionally required expression of a 500 
bp long targeting sequence (Shi et al., 2000). This makes targeting smaller proteins or genes with 
shorter UTRs difficult, as they may not have the required sequence length for decisive silencing. 
Thirdly, due to the length of the dsRNA, the cells likely produce many different siRNAs, 
increasing the chance for a deleterious off target effect. However, as tested, induced expression of 
the two heterologous dsRNAs did not affect cell proliferation, eliminating such a possibility in this 
approach. Finally, our heterologous sequence targeting approach allows for genes with a high 
degree of similarity to be specifically and individually silenced. In the extreme case, it would even 
be possible to silence only one allele of a given gene, in order to study the effects of gene dosage. 
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Likewise, this method will allow for homologues of T. brucei proteins found in related species to 
be investigated for functional equivalency in T. brucei. Tagging an endogenous gene and targeting 
it for knockdown via a fused PTP tag or T. cruzi 3/ UTR, would allow for rescue studies to be 
performed with homologues from other kinetoplastids, or, as was demonstrated in Chapter II, 
mutants which vary only slightly from their wild-type counterparts. The importance of the 
phosphorylation sites in CITFA7 (Nguyen et al., 2012), for example, could be studied by 
attempting to rescue for the knockdown of the wild type protein with a mutant in which 
phosphorylated residues are mutated to comparable amino acids which cannot accept a 
phosphorylation. In short, the ability to specifically knock down target genes, regardless of their 
sequence length or homology, is a powerful tool that could enhance almost any genetic studies of 
protein function. 
VI-2. CITFA1 is required for transcription but not CITFA complex assembly 
Once we had established this new method for gene silencing, we were able to return to our original 
interest in determining the specific function of individual CITFA subunits. We were able to 
demonstrate that silencing CITFA1 was lethal to bloodstream form (BF) trypanosomes, which 
emphasizes the essential nature of this complex, as CITFA2 and CITFA7 silencing were similarly 
lethal (Brandenburg et al., 2007; Nguyen et al., 2012). The loss of RNA pol I-synthesized 
transcripts upon CITFA1 silencing confirmed CITFA’s role as a RNA pol I transcription factor. 
CITFA1 silencing also resulted in a loss of CITFA from the RRNA and BES promoters, indicating 
that CITFA1 has a role in DNA binding. Interestingly, however, a loss of CITFA1 protein was not 
accompanied by a loss of other CITFA subunits or a change in CITFA’s localization. This reveals 
that the CITFA complex does not rely on CITFA1 for assembly, and suggest that CITFA is able 
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to localize to the ESB in the absence of DNA binding. Given that little is known about the nature 
of the ESB, beyond that it includes RNA pol I, CITFA, the active BES, and resulting VSG mRNA 
(Navarro and Gull, 2001), it may be possible to use DNA-disassociated CITFA, induced by 
CITFA1 silencing, to investigate the proteins that are likely binding to and anchoring CITFA in 
the ESB.  
 Though CITFA1 was shown to be important for CITFA to bind RNA pol I promoters, and 
is likely a direct DNA contactor, this has yet to be conclusively shown. Tagging and purifying 
CITFA1 would allow for UV crosslinking studies to be performed side-by-side with CITFA 
purified by either a tagged CITFA2, CITFA4, or CITFA7. A shift in the lower of the two ~50 kDa 
bands observable when purified CITFA is subjected to UV crosslinking (Figure II-5B) would 
agree with other data, and would indicate that CITFA1, in addition to the already proven CITFA2 
and CITFA4, is a direct DNA contactor.  
VI-3. The CITFA2-LC8 interaction is essential for RNA pol I-mediated 
transcription in T. brucei 
In addition to our general interest in determining the specific functions of individual CITFA 
subunits, we decided to investigate LC8 because of its role in transcription in other organisms, 
reviewed by Rapali et al., (2011b). LC8 silencing caused a severe defect in mitotic progression, 
resulting in cells which were multinucleated yet had failed to divide. This agrees with work 
performed in HeLa cells, which also showed a mitotic block upon LC8 silencing (Asthana et al., 
2012). In addition to this phenotype, a drop in RNA pol I-synthesized transcripts was noted, with 
the drop in VSG mRNA being more pronounced than the effect upon RRNA. Given the severity of 
the apparent cytokinesis defects, pursuit of the role of LC8 in RNA pol I-mediated transcription 
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required identifying, and disrupting, LC8’s interaction with the CITFA complex. We determined 
that LC8 interacted with a conserved 3-amino acid strength, TQV, at the N-terminus of CITFA2, 
and that this interaction promoted dimerization of CITFA2. Mutation or removal of this sequence 
eliminated the interaction between CITFA2 and LC8 both in vitro and in vivo. We were also able 
to show that this interaction is essential for trypanosome viability, and that disrupting it 
dramatically reduced RRNA and VSG mRNA levels. Furthermore, we showed that without this 
interaction, CITFA2 is unable to assemble into the CITFA complex or bind RNA pol I promoters. 
Lastly, we identified CITFAs 2, 4, and, likely, 1 as direct DNA contactors, and showed that without 
CITFA2, the remaining CITFA complex, though stable, was unable to bind promoter DNA or 
initiate transcription by RNA pol I. For a model summarizing these interactions between CITFA2 
and LC8, and the assembly of the CITFA complex, please see Figure II-7, page 59. These data 
represent a massive step forward in understanding the roles of individual CITFA subunits, and is 
the first demonstration of LC8 being required for basal transcription. It also shows that LC8’s 
function as a dimerizing ‘hub’ protein is of ancient evolutionary origin. 
VI-4. Does LC8 have additional function in CITFA or in RNA pol I-mediated 
transcription?  
Our data are consistent with the view that LC8, rather than functioning as a linker between two 
different proteins, instead promotes homodimerization, thereby imparting new function (Barbar, 
2008; Barbar and Nyarko, 2014, 2015; King, 2008). It would be interesting to determine, however, 
if this was LC8’s only role in the CITFA complex, as our work is far from conclusive in this regard. 
This could be tested by substituting the N-terminus of CITFA2 with sequences known to induce 
dimerization, such as coiled coil domains. If an N-terminal deletion CITFA2 mutant with the 
  
157 
  
addition of such domains was able to rescue for the knockdown of wild-type CITFA2, then it 
would be likely that LC8’s only function in binding CITFA2 is to promote its dimerization. It 
would be interesting to test in these cells if LC8 was still present in CITFA that contained the 
mutant CITFA2. If LC8 were still present, it would indicate that LC8 may be interacting with other 
members of the complex. Though not as conserved as the LC8 site in CITFA2 (VGTQV), other 
CITFA subunits have sites which would be of almost comparable LC8 binding strength, according 
to binding strength assessments offered by Rapali et al. (2011a). CITFA5, both a and b 
homologues, contain a sequence, RVTQV, which is not conserved with other kinetoplastids. Given 
that CITFA5b amino acid sequence has 72% identity to CITFA5a, and that both have been 
identified by mass spectrometry in tandem affinity-purified CITFA eluates, it is tempting to 
speculate that these subunits are dimerized by LC8. Our lab has also performed experiments 
investigating a possible LC8 binding site in CITFA7, AGVQV, which is fairly well conserved in 
trypanosomatids, though not in Leishmania spp (data not shown). Unpublished data showed that 
CITFA7 and LC8 interacted in a yeast-two-hybrid assay and mutating this putative binding site in 
CITFA7 increased the expression from silent BESs in BF trypanosomes (Tu N Nguyen, Bao N 
Nguyen & A Günzl, unpublished), raising the possibility that a CITFA7-LC8 heterotetramer is 
responsible for localizing the CITFA complex to nucleolus and ESB. While it may seem unlikely 
for LC8 to be involved in more than one element of the same complex, it has been demonstrated 
with the estrogen receptor and KIBRA that LC8 is involved at multiple points in the activation of 
the estrogen response pathway (Rayala et al., 2005; Rayala et al., 2006). 
It is possible that LC8 has additional effects upon the CITFA complex, or that it affords the 
cell an additional point of regulation to control the expression of either RRNA or VSG mRNA. The 
conservation of the TQV sequence in CITFA2 that binds LC8 with other, non-VSG expressing 
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kinetoplastids, supports the idea that LC8 is not playing a role in only VSG expression, though this 
may not be the case. The amino acids surrounding the TQV-motif are not entirely conserved, and 
are within close enough proximity to affect the CITFA2-LC8 interaction (Rapali et al., 2011a). It 
would be interesting, therefore, to express a CITFA2 sequence from a related kinetoplastid in T. 
brucei, either as an entire unit, or as a chimera, with just the N-terminal portion fused to an N-
terminally truncated T. brucei CITFA2, in order to determine if the CITFA2s present in related 
organisms were able to interact with LC8 or rescue the knockdown of endogenous CITFA2. 
It has been shown in other organisms that phosphorylation of either LC8 or its binding partner 
can alter their interaction (Benison et al., 2009; Gallego et al., 2013; Lei and Davis, 2003; Song et 
al., 2008; Song et al., 2007). This regulatory phosphorylation occurs at S88 in human LC8, which 
is conserved as S89 in the genus Trypanosoma (Figure II-S1B), allowing for such a regulation to 
exist. Furthermore, phosphorylation of CITFA2 at amino acid T6, one of the conserved residues 
in the LC8 binding motif, could also be used as a means to block LC8 binding, as is the case in 
Nek9, a kinase involved in mitotic progression (Gallego et al., 2013). The phosphorylation state 
of CITFA2 and LC8 in T. brucei are, however, unknown. Before an investigation of the importance 
of phosphorylation of these proteins is performed, it will be necessary to determine whether these 
sites are phosphorylated in trypanosomes. 
It should be noted that the above hypotheses regarding the function of LC8 in T. brucei are, in 
part, made possible by the work presented in Chapter II. Previous to this work, nothing was 
known regarding LC8 binding partners or binding site preferences in T. brucei. While the high 
degree of identity between human and trypanosome LC8 made it likely that characteristics were 
shared, the early divergence of kinetoplastids from other eukaryotic lineages made this uncertain. 
Our work, though only detailing one LC8 interaction, demonstrates that LC8 appears to bind 
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motifs similar to those detailed in other organisms, and that its role in promoting or stabilizing 
dimerization is the same. This means that the vast array of studies detailing LC8’s binding 
preferences can now be tentatively used to predict potential LC8 binding partners in kinetoplastid 
organisms. Once additional studies on LC8 in these organisms have been performed, if they are 
also consistent with the non-kinetoplastid literature, it will allow for rapid progress in our 
understanding of LC8 in these organisms by allowing use of predictive bioinformatics.  
VI-5. Does LC8 have functions in T. brucei outside of dynein and CITFA? 
In addition to the above means of investigating LC8 function, it would likely be informative 
to tandem affinity-purify LC8 and characterize LC8-containing protein complexes by sucrose 
gradient sedimentation and mass spectrometry. However, it is currently unclear whether LC8 can 
be functionally tagged. This approach may even allow for the binding preferences of LC8 in T. 
brucei to be further established by sequence analysis in silico, if enough co-purifying proteins have 
recognizable LC8 binding motifs.  
VI-6. CITFA and the ESB 
The work contained in Chapter II demonstrated that, upon CITFA2 silencing, CITFA3 is 
stable, but is lost from RNA pol I promoters. LC8 silencing produced a similar effect, with CITFA6 
also being shown to be stable in this case. CITFA2, therefore, represents the second CITFA 
subunit, with the first being CITFA1, to reveal that binding DNA is not required for CITFA 
assembly. This concept is intriguing, as it suggests a CITFA complex that assembles and localizes 
to sites of RNA pol I-mediated transcription independent of DNA and independent of RNA pol I, 
as an RNA pol I subunit has never co-precipitated or co-purified with CITFA. How then is CITFA 
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localizing to the nucleolus and ESB so effectively? One way to approach this question would be 
to tandem affinity purify the CITFA complex after CITFA1 silencing, and subject the purified 
material to mass spectrometry. This may enhance the likelihood of identifying the proteins 
responsible for CITFA’s localization, as it would ensure that CITFA is not interacting with DNA. 
While there is no evidence that CITFA interacts with RNA, it is possible that a CITFA-RNA 
interaction mediates its localization. While it was previously demonstrated that the accumulation 
of RNA pol I in the ESB is unaffected by DNase I treatment, implying that this compartment is 
not reliant on DNA binding or transcription (Navarro and Gull, 2001), which our data agrees with 
(Park et al., 2014), a similar experiment with RNase has not yet been performed. If CITFA’s 
localization would be RNA-dependent, then preparation of total RNA from purified CITFA in 
conjunction with RNA-seq may reveal the identity of the interacting RNA, a method known as 
RNA immunoprecipitation sequencing, or RIP-seq. If RNase or nuclease treatment does not affect 
CITFA localization, it would reveal that the ESB had a protein-based architecture.  
VI-7. The increasing therapeutic potential of LC8 
Our results add T. brucei to the list of pathogens that rely on LC8 for viability. LC8 silencing 
caused defects in both transcription and cytokinesis, and resulted in an extremely rapid death 
phenotype of cultured BF T. brucei that is rarely observed in this system. The importance of LC8 
to infectious agents has also been shown for HIV (Jayappa et al., 2015), Ebola (Luthra et al., 2015), 
rabies (Tan et al., 2007), and Toxoplasma gondii (Qureshi et al., 2013), previously. Additionally, 
LC8 has been shown to have a role in promotion of cancerous phenotypes (Asthana et al., 2012; 
Vadlamudi et al., 2004). Given the nearly universal nature of LC8 (Wickstead and Gull, 2007), 
and the lack of available small molecule inhibitors, LC8 therapeutics remain strictly conceptual. 
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However, it may be feasible to target LC8’s binding partners, kinases, or phosphatases, if such 
were able to be detailed. While not promising in the near term, the reliance of various pathogens 
on this molecule make it an exciting potential target. 
VI-8. The role of RPB7 in RNA pol I transcription  
 We investigated whether RPB7, a known subunit of RNA pol II, was being utilized by 
RNA pol I in T. brucei, a claim published by the research group of Dr. Miguel Navarro (Spanish 
National Research Council, Granada, Spain) (Peñate et al., 2009). Immunoprecipitation and 
tandem affinity purification of RPB7 identified numerous RNA pol II subunits, yet failed to 
produce any subunits of RNA pol I, as shown in Chapter IV. Consistent with these results, ChIP 
experiments revealed a profile for RPB7 consistent with it functioning solely within RNA pol II. 
In vitro transcription assays revealed that depletion of RPB7 had no effect on either VSG or RRNA 
transcription, while it did affect an RNA pol II-transcribed gene. Lastly, immunofluorescence 
showed that RPB7 failed to co-localize with a nucleolar marker, the site in which RNA pol I-
mediated transcription occurs. Taken together, these data clearly show that RPB7 is a bona fide 
RNA pol II subunit, while they fail to provide any evidence for an involvement of RPB7 in 
transcription by RNA pol I  
 Both we and the Navarro group published letters addressing the incongruent nature of the 
data from our two research teams (Günzl et al., 2011; Navarro et al., 2011). While specific 
arguments will not be fully covered here, a few key points are worth making. First, we feel that 
our data are clear and decisive on the topic of RPB7 involvement in RNA pol I. Secondly, it is 
possible, due to their using polyclonal antisera, that the Navarro group has correctly detailed the 
importance of a protein for RNA pol I-mediated transcription that is simply not RPB7. Since it is 
  
162 
  
very likely that trypanosome RNA pol I requires an RPA43 orthologue (Kuhn et al., 2007), the 
identity of which has not yet been determined in T. brucei and which would be an RPB7 paralog, 
it is possible that their antisera and experiments have identified the function of this protein, instead. 
We avoided this potential problem by tagging RPB7, which allowed us to use specific antibodies 
for RPB7 detection and purification. In addition, the data by Penate et al. (2009) overwhelmingly 
depended on RPB7 silencing. Since this likely affected expression of nearly all protein coding 
genes, it is possible that they were observing secondary effects on RNA pol I transcription. 
Therefore, we avoided this approach and used biochemical assays that directly addressed RPB7’s 
role in RNA pol I-mediated transcription. 
 We do not claim, however, that RPB7 has no effect upon transcription by RNA pol I or the 
transcripts it produces. RPB7 is an interesting member of RNA pol II, as it forms a heterodimer 
with RPB4 and appears to participate in cellular processes which are separate from the immediate 
transcription process by RNA pol II, as reviewed in Sharma (2013). These include DNA repair, 
mRNA export and decay, and translation. Thus, it is possible that some of the phenotypes that Dr. 
Navarro’s group attributes to RPB7’s role in RNA pol I are, in fact, the result of RPB7’s role 
outside of the context of RNA polymerases entirely. It will be interesting to see if future 
investigations of RPB7 (an RPB4 homolog has not been identified in trypanosomes yet) implicate 
these proteins in the same diverse functions in T. brucei as they have in other organisms. 
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